US20090274791A1 - Food Articles With Delivery Devices and Methods for the Preparation Thereof - Google Patents
Food Articles With Delivery Devices and Methods for the Preparation Thereof Download PDFInfo
- Publication number
- US20090274791A1 US20090274791A1 US11/988,320 US98832006A US2009274791A1 US 20090274791 A1 US20090274791 A1 US 20090274791A1 US 98832006 A US98832006 A US 98832006A US 2009274791 A1 US2009274791 A1 US 2009274791A1
- Authority
- US
- United States
- Prior art keywords
- food article
- oil
- food
- omega
- primary
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 184
- 238000000034 method Methods 0.000 title claims abstract description 117
- 238000002360 preparation method Methods 0.000 title description 21
- 239000000203 mixture Substances 0.000 claims description 297
- 239000003094 microcapsule Substances 0.000 claims description 207
- 239000000126 substance Substances 0.000 claims description 121
- 238000011068 loading method Methods 0.000 claims description 115
- 239000003921 oil Substances 0.000 claims description 91
- 235000019198 oils Nutrition 0.000 claims description 90
- 235000020660 omega-3 fatty acid Nutrition 0.000 claims description 80
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 69
- 229940012843 omega-3 fatty acid Drugs 0.000 claims description 69
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 64
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 60
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 59
- 229920000159 gelatin Polymers 0.000 claims description 58
- 235000019322 gelatine Nutrition 0.000 claims description 58
- 108010010803 Gelatin Proteins 0.000 claims description 40
- 239000008273 gelatin Substances 0.000 claims description 40
- 235000011852 gelatine desserts Nutrition 0.000 claims description 40
- 235000011194 food seasoning agent Nutrition 0.000 claims description 33
- 235000021323 fish oil Nutrition 0.000 claims description 30
- -1 triglyceride ester Chemical class 0.000 claims description 28
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims description 25
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 24
- 238000005054 agglomeration Methods 0.000 claims description 24
- 230000002776 aggregation Effects 0.000 claims description 24
- 239000003963 antioxidant agent Substances 0.000 claims description 22
- 235000013322 soy milk Nutrition 0.000 claims description 22
- 235000019688 fish Nutrition 0.000 claims description 21
- 230000008569 process Effects 0.000 claims description 21
- 241000251468 Actinopterygii Species 0.000 claims description 19
- 240000008042 Zea mays Species 0.000 claims description 17
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 17
- 235000009508 confectionery Nutrition 0.000 claims description 17
- 235000005822 corn Nutrition 0.000 claims description 17
- 235000015067 sauces Nutrition 0.000 claims description 17
- 235000013361 beverage Nutrition 0.000 claims description 16
- 235000013339 cereals Nutrition 0.000 claims description 15
- 229920000388 Polyphosphate Polymers 0.000 claims description 14
- 239000001205 polyphosphate Substances 0.000 claims description 14
- 235000011176 polyphosphates Nutrition 0.000 claims description 14
- 230000003078 antioxidant effect Effects 0.000 claims description 13
- 229920002472 Starch Polymers 0.000 claims description 12
- 239000006041 probiotic Substances 0.000 claims description 12
- 235000018291 probiotics Nutrition 0.000 claims description 12
- 235000014347 soups Nutrition 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 239000008107 starch Substances 0.000 claims description 12
- 235000015277 pork Nutrition 0.000 claims description 11
- 230000000529 probiotic effect Effects 0.000 claims description 10
- 235000015872 dietary supplement Nutrition 0.000 claims description 8
- 235000018102 proteins Nutrition 0.000 claims description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 8
- 235000012773 waffles Nutrition 0.000 claims description 8
- 241001125048 Sardina Species 0.000 claims description 7
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 7
- 244000061456 Solanum tuberosum Species 0.000 claims description 7
- 235000008452 baby food Nutrition 0.000 claims description 7
- 235000008429 bread Nutrition 0.000 claims description 7
- 235000013351 cheese Nutrition 0.000 claims description 7
- 150000002148 esters Chemical class 0.000 claims description 7
- 235000015205 orange juice Nutrition 0.000 claims description 7
- 235000015927 pasta Nutrition 0.000 claims description 7
- 235000011888 snacks Nutrition 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 7
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims description 6
- 229940075999 phytosterol ester Drugs 0.000 claims description 6
- 241001454694 Clupeiformes Species 0.000 claims description 5
- 108010011756 Milk Proteins Proteins 0.000 claims description 5
- 102000014171 Milk Proteins Human genes 0.000 claims description 5
- 241000269851 Sarda sarda Species 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 235000019513 anchovy Nutrition 0.000 claims description 5
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 235000013611 frozen food Nutrition 0.000 claims description 5
- 235000021239 milk protein Nutrition 0.000 claims description 5
- 229920001277 pectin Polymers 0.000 claims description 5
- 239000001814 pectin Substances 0.000 claims description 5
- 235000010987 pectin Nutrition 0.000 claims description 5
- 235000019512 sardine Nutrition 0.000 claims description 5
- 235000021119 whey protein Nutrition 0.000 claims description 5
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 4
- 244000215068 Acacia senegal Species 0.000 claims description 4
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 4
- 241000273930 Brevoortia tyrannus Species 0.000 claims description 4
- 241000276438 Gadus morhua Species 0.000 claims description 4
- 229920000084 Gum arabic Polymers 0.000 claims description 4
- 229920000881 Modified starch Polymers 0.000 claims description 4
- 108010073771 Soybean Proteins Proteins 0.000 claims description 4
- 235000010489 acacia gum Nutrition 0.000 claims description 4
- 239000000205 acacia gum Substances 0.000 claims description 4
- 229940072056 alginate Drugs 0.000 claims description 4
- 235000010443 alginic acid Nutrition 0.000 claims description 4
- 229920000615 alginic acid Polymers 0.000 claims description 4
- 235000014633 carbohydrates Nutrition 0.000 claims description 4
- 150000001720 carbohydrates Chemical class 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 235000013372 meat Nutrition 0.000 claims description 4
- 230000000813 microbial effect Effects 0.000 claims description 4
- 235000008519 pasta sauces Nutrition 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 229940001941 soy protein Drugs 0.000 claims description 4
- 239000011573 trace mineral Substances 0.000 claims description 4
- 235000013619 trace mineral Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 3
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 3
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 3
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 3
- 229920001661 Chitosan Polymers 0.000 claims description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 3
- 240000003768 Solanum lycopersicum Species 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims description 3
- 239000011230 binding agent Substances 0.000 claims description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 239000002738 chelating agent Substances 0.000 claims description 3
- 229940045110 chitosan Drugs 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 230000002538 fungal effect Effects 0.000 claims description 3
- 229960000292 pectin Drugs 0.000 claims description 3
- 239000002562 thickening agent Substances 0.000 claims description 3
- 235000012184 tortilla Nutrition 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 2
- 102000009027 Albumins Human genes 0.000 claims description 2
- 241000251730 Chondrichthyes Species 0.000 claims description 2
- 241000252203 Clupea harengus Species 0.000 claims description 2
- 229920000858 Cyclodextrin Polymers 0.000 claims description 2
- 241000723298 Dicentrarchus labrax Species 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 241001125831 Istiophoridae Species 0.000 claims description 2
- 241001417902 Mallotus villosus Species 0.000 claims description 2
- 239000005913 Maltodextrin Substances 0.000 claims description 2
- 229920002774 Maltodextrin Polymers 0.000 claims description 2
- 239000004368 Modified starch Substances 0.000 claims description 2
- 108010058846 Ovalbumin Proteins 0.000 claims description 2
- 241000269980 Pleuronectidae Species 0.000 claims description 2
- 241000277331 Salmonidae Species 0.000 claims description 2
- 241000736062 Scomber scombrus Species 0.000 claims description 2
- 241001223864 Sphyraena barracuda Species 0.000 claims description 2
- 229940088623 biologically active substance Drugs 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 229930014097 furanoid Natural products 0.000 claims description 2
- 150000004676 glycans Chemical class 0.000 claims description 2
- 229940035034 maltodextrin Drugs 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 235000010981 methylcellulose Nutrition 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 239000011707 mineral Substances 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 claims description 2
- 235000019426 modified starch Nutrition 0.000 claims description 2
- 229940092253 ovalbumin Drugs 0.000 claims description 2
- 239000010773 plant oil Substances 0.000 claims description 2
- 229920001282 polysaccharide Polymers 0.000 claims description 2
- 239000005017 polysaccharide Substances 0.000 claims description 2
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 2
- 229940032147 starch Drugs 0.000 claims description 2
- 150000003431 steroids Chemical class 0.000 claims description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims 1
- 240000000385 Brassica napus var. napus Species 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000011257 shell material Substances 0.000 description 85
- 238000009472 formulation Methods 0.000 description 84
- 239000004615 ingredient Substances 0.000 description 63
- 239000006014 omega-3 oil Substances 0.000 description 57
- 239000000843 powder Substances 0.000 description 55
- 239000000047 product Substances 0.000 description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 51
- 239000000796 flavoring agent Substances 0.000 description 41
- 235000019634 flavors Nutrition 0.000 description 37
- 229920000642 polymer Polymers 0.000 description 35
- 238000000265 homogenisation Methods 0.000 description 31
- 235000020357 syrup Nutrition 0.000 description 31
- 239000006188 syrup Substances 0.000 description 31
- 235000016709 nutrition Nutrition 0.000 description 29
- 235000000346 sugar Nutrition 0.000 description 27
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 25
- 150000004665 fatty acids Chemical class 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 24
- 230000035764 nutrition Effects 0.000 description 24
- 235000014113 dietary fatty acids Nutrition 0.000 description 23
- 229930195729 fatty acid Natural products 0.000 description 23
- 239000000194 fatty acid Substances 0.000 description 23
- 238000002156 mixing Methods 0.000 description 23
- 150000003839 salts Chemical class 0.000 description 22
- 235000006708 antioxidants Nutrition 0.000 description 20
- 235000010675 chips/crisps Nutrition 0.000 description 20
- 239000001828 Gelatine Substances 0.000 description 18
- 239000007788 liquid Substances 0.000 description 18
- 210000004080 milk Anatomy 0.000 description 18
- 238000001816 cooling Methods 0.000 description 17
- 235000015243 ice cream Nutrition 0.000 description 17
- 235000013336 milk Nutrition 0.000 description 17
- 239000008267 milk Substances 0.000 description 17
- 239000003925 fat Substances 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 15
- 244000046052 Phaseolus vulgaris Species 0.000 description 15
- 241000238557 Decapoda Species 0.000 description 14
- 239000002245 particle Substances 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- 239000004971 Cross linker Substances 0.000 description 13
- 235000016623 Fragaria vesca Nutrition 0.000 description 13
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 13
- 235000013365 dairy product Nutrition 0.000 description 13
- 239000000839 emulsion Substances 0.000 description 13
- 238000009928 pasteurization Methods 0.000 description 13
- 235000013618 yogurt Nutrition 0.000 description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 12
- 230000008901 benefit Effects 0.000 description 11
- 235000005911 diet Nutrition 0.000 description 11
- 239000002502 liposome Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- 244000307700 Fragaria vesca Species 0.000 description 10
- 244000299461 Theobroma cacao Species 0.000 description 10
- 239000000853 adhesive Substances 0.000 description 10
- 235000013330 chicken meat Nutrition 0.000 description 9
- 230000037213 diet Effects 0.000 description 9
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 229920000715 Mucilage Polymers 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 235000015165 citric acid Nutrition 0.000 description 8
- 229960004106 citric acid Drugs 0.000 description 8
- 235000013399 edible fruits Nutrition 0.000 description 8
- 235000020191 long-life milk Nutrition 0.000 description 8
- 235000012149 noodles Nutrition 0.000 description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 7
- 239000004278 EU approved seasoning Substances 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 239000006057 Non-nutritive feed additive Substances 0.000 description 7
- 241000482268 Zea mays subsp. mays Species 0.000 description 7
- 239000002253 acid Substances 0.000 description 7
- 235000017803 cinnamon Nutrition 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 230000002354 daily effect Effects 0.000 description 7
- 238000004945 emulsification Methods 0.000 description 7
- 229940013317 fish oils Drugs 0.000 description 7
- 235000013312 flour Nutrition 0.000 description 7
- 235000012907 honey Nutrition 0.000 description 7
- 238000001694 spray drying Methods 0.000 description 7
- 235000013311 vegetables Nutrition 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 6
- 208000024172 Cardiovascular disease Diseases 0.000 description 6
- 108700035965 MEG3 Proteins 0.000 description 6
- 102100023075 Protein Niban 2 Human genes 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 235000012970 cakes Nutrition 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 6
- 235000019219 chocolate Nutrition 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- 235000008504 concentrate Nutrition 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 235000013861 fat-free Nutrition 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 235000019645 odor Nutrition 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 235000010378 sodium ascorbate Nutrition 0.000 description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 6
- 150000003626 triacylglycerols Chemical class 0.000 description 6
- 241000234282 Allium Species 0.000 description 5
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- 235000009499 Vanilla fragrans Nutrition 0.000 description 5
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000036772 blood pressure Effects 0.000 description 5
- 235000014121 butter Nutrition 0.000 description 5
- 235000013409 condiments Nutrition 0.000 description 5
- 235000015203 fruit juice Nutrition 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- 239000006072 paste Substances 0.000 description 5
- 239000004033 plastic Substances 0.000 description 5
- 229920003023 plastic Polymers 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 229940083542 sodium Drugs 0.000 description 5
- 229960005055 sodium ascorbate Drugs 0.000 description 5
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 5
- 239000007921 spray Substances 0.000 description 5
- 230000009469 supplementation Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 5
- 235000007319 Avena orientalis Nutrition 0.000 description 4
- 244000075850 Avena orientalis Species 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 240000007594 Oryza sativa Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 125000003342 alkenyl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 4
- 235000010323 ascorbic acid Nutrition 0.000 description 4
- 239000011668 ascorbic acid Substances 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- CREMABGTGYGIQB-UHFFFAOYSA-N carbon carbon Chemical compound C.C CREMABGTGYGIQB-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000005354 coacervation Methods 0.000 description 4
- 238000010411 cooking Methods 0.000 description 4
- 235000014510 cooky Nutrition 0.000 description 4
- 235000021185 dessert Nutrition 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000013350 formula milk Nutrition 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000007407 health benefit Effects 0.000 description 4
- 208000019622 heart disease Diseases 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 238000010979 pH adjustment Methods 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 235000014438 salad dressings Nutrition 0.000 description 4
- 235000013570 smoothie Nutrition 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000017106 Bixa orellana Species 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 244000131522 Citrus pyriformis Species 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 240000009088 Fragaria x ananassa Species 0.000 description 3
- 235000008414 Fromage frais and quark Nutrition 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical class C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 241000220225 Malus Species 0.000 description 3
- 244000081841 Malus domestica Species 0.000 description 3
- 235000014435 Mentha Nutrition 0.000 description 3
- 241001072983 Mentha Species 0.000 description 3
- 240000005561 Musa balbisiana Species 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 235000010582 Pisum sativum Nutrition 0.000 description 3
- 240000004713 Pisum sativum Species 0.000 description 3
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 3
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 3
- 244000290333 Vanilla fragrans Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 235000012665 annatto Nutrition 0.000 description 3
- 239000010362 annatto Substances 0.000 description 3
- 229960005070 ascorbic acid Drugs 0.000 description 3
- 235000021014 blueberries Nutrition 0.000 description 3
- 235000015496 breakfast cereal Nutrition 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000019519 canola oil Nutrition 0.000 description 3
- 239000000828 canola oil Substances 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 235000015228 chicken nuggets Nutrition 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 235000020186 condensed milk Nutrition 0.000 description 3
- 235000012495 crackers Nutrition 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 235000018823 dietary intake Nutrition 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 235000019541 flavored milk drink Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 235000015219 food category Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000011617 hard cheese Nutrition 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 235000008446 instant noodles Nutrition 0.000 description 3
- 235000015110 jellies Nutrition 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 235000014569 mints Nutrition 0.000 description 3
- 235000013379 molasses Nutrition 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- 235000020200 pasteurised milk Nutrition 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 3
- 235000013606 potato chips Nutrition 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 235000013324 preserved food Nutrition 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000014059 processed cheese Nutrition 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 235000021484 savory snack Nutrition 0.000 description 3
- 235000014102 seafood Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000003381 stabilizer Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 244000188595 Brassica sinapistrum Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 229920002101 Chitin Polymers 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 2
- 235000005976 Citrus sinensis Nutrition 0.000 description 2
- 240000002319 Citrus sinensis Species 0.000 description 2
- 241001137251 Corvidae Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 101000904173 Homo sapiens Progonadoliberin-1 Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 240000008415 Lactuca sativa Species 0.000 description 2
- 108010000817 Leuprolide Proteins 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 244000203593 Piper nigrum Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- 102100024028 Progonadoliberin-1 Human genes 0.000 description 2
- 241001486234 Sciota Species 0.000 description 2
- 235000003434 Sesamum indicum Nutrition 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 101000996723 Sus scrofa Gonadotropin-releasing hormone receptor Proteins 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 235000009470 Theobroma cacao Nutrition 0.000 description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 2
- 108060008539 Transglutaminase Proteins 0.000 description 2
- 244000077233 Vaccinium uliginosum Species 0.000 description 2
- 244000263375 Vanilla tahitensis Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 235000020224 almond Nutrition 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 2
- 235000021016 apples Nutrition 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000021342 arachidonic acid Nutrition 0.000 description 2
- 229940114079 arachidonic acid Drugs 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 235000012019 baked potatoes Nutrition 0.000 description 2
- 235000021015 bananas Nutrition 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 235000012813 breadcrumbs Nutrition 0.000 description 2
- 235000010633 broth Nutrition 0.000 description 2
- 235000001046 cacaotero Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 235000014658 canned/preserved pasta Nutrition 0.000 description 2
- 235000011627 canned/preserved ready meals Nutrition 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 229940105329 carboxymethylcellulose Drugs 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000010541 chilled noodles Nutrition 0.000 description 2
- 235000012846 chilled/fresh pasta Nutrition 0.000 description 2
- 235000016019 chocolate confectionery Nutrition 0.000 description 2
- 239000008370 chocolate flavor Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 235000019987 cider Nutrition 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- 230000001332 colony forming effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 235000012869 dehydrated soup Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 235000013325 dietary fiber Nutrition 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000014505 dips Nutrition 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 235000020187 evaporated milk Nutrition 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 235000008378 frozen soup Nutrition 0.000 description 2
- XLXSAKCOAKORKW-UHFFFAOYSA-N gonadorelin Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 XLXSAKCOAKORKW-UHFFFAOYSA-N 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 235000014109 instant soup Nutrition 0.000 description 2
- 229960004903 invert sugar Drugs 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 150000002617 leukotrienes Chemical class 0.000 description 2
- GFIJNRVAKGFPGQ-LIJARHBVSA-N leuprolide Chemical compound CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)CC1=CC=C(O)C=C1 GFIJNRVAKGFPGQ-LIJARHBVSA-N 0.000 description 2
- 229960004338 leuprorelin Drugs 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 238000010197 meta-analysis Methods 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 239000011104 metalized film Substances 0.000 description 2
- 235000021243 milk fat Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 235000014571 nuts Nutrition 0.000 description 2
- 239000007968 orange flavor Substances 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 235000014594 pastries Nutrition 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000015108 pies Nutrition 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000012434 pretzels Nutrition 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- 235000012045 salad Nutrition 0.000 description 2
- 235000021003 saturated fats Nutrition 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- 235000019830 sodium polyphosphate Nutrition 0.000 description 2
- 239000002047 solid lipid nanoparticle Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 235000015113 tomato pastes and purées Nutrition 0.000 description 2
- 235000010692 trans-unsaturated fatty acids Nutrition 0.000 description 2
- 102000003601 transglutaminase Human genes 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 235000014388 unprocessed cheese Nutrition 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 235000008924 yoghurt drink Nutrition 0.000 description 2
- LGHXTTIAZFVCCU-SSVNFBSYSA-N (2E,4E,6E,8E)-octadeca-2,4,6,8-tetraenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O LGHXTTIAZFVCCU-SSVNFBSYSA-N 0.000 description 1
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 1
- TWSWSIQAPQLDBP-CGRWFSSPSA-N (7e,10e,13e,16e)-docosa-7,10,13,16-tetraenoic acid Chemical compound CCCCC\C=C\C\C=C\C\C=C\C\C=C\CCCCCC(O)=O TWSWSIQAPQLDBP-CGRWFSSPSA-N 0.000 description 1
- 125000000923 (C1-C30) alkyl group Chemical group 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- LDGWQMRUWMSZIU-LQDDAWAPSA-M 2,3-bis[(z)-octadec-9-enoxy]propyl-trimethylazanium;chloride Chemical compound [Cl-].CCCCCCCC\C=C/CCCCCCCCOCC(C[N+](C)(C)C)OCCCCCCCC\C=C/CCCCCCCC LDGWQMRUWMSZIU-LQDDAWAPSA-M 0.000 description 1
- URQMEZRQHLCJKR-UHFFFAOYSA-N 3-Methyl-5-propyl-2-cyclohexen-1-one Chemical compound CCCC1CC(C)=CC(=O)C1 URQMEZRQHLCJKR-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000219198 Brassica Species 0.000 description 1
- 235000003351 Brassica cretica Nutrition 0.000 description 1
- 235000011371 Brassica hirta Nutrition 0.000 description 1
- 244000140786 Brassica hirta Species 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000003343 Brassica rupestris Nutrition 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 125000000739 C2-C30 alkenyl group Chemical group 0.000 description 1
- 0 CCC=C[1*]C(C)=O Chemical compound CCC=C[1*]C(C)=O 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 208000034657 Convalescence Diseases 0.000 description 1
- 241000199912 Crypthecodinium cohnii Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 241000199914 Dinophyceae Species 0.000 description 1
- TYLNXKAVUJJPMU-DNKOKRCQSA-N Docosahexaenoic acid ethyl ester Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(=O)OCC TYLNXKAVUJJPMU-DNKOKRCQSA-N 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 235000021292 Docosatetraenoic acid Nutrition 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 1
- 239000000940 FEMA 2235 Substances 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 102100024515 GDP-L-fucose synthase Human genes 0.000 description 1
- 241000447437 Gerreidae Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000234295 Musa Species 0.000 description 1
- 235000000380 Nyssa aquatica Nutrition 0.000 description 1
- 240000005295 Nyssa aquatica Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 206010034203 Pectus Carinatum Diseases 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- 241000191998 Pediococcus acidilactici Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000006002 Pepper Substances 0.000 description 1
- 235000016761 Piper aduncum Nutrition 0.000 description 1
- 235000017804 Piper guineense Nutrition 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241000246354 Satureja Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- 241000233671 Schizochytrium Species 0.000 description 1
- 241000238371 Sepiidae Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 244000057717 Streptococcus lactis Species 0.000 description 1
- 235000014897 Streptococcus lactis Nutrition 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 241000519996 Teucrium chamaedrys Species 0.000 description 1
- 241000233675 Thraustochytrium Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- ISXSJGHXHUZXNF-LXZPIJOJSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] n-[2-(dimethylamino)ethyl]carbamate;hydrochloride Chemical compound Cl.C1C=C2C[C@@H](OC(=O)NCCN(C)C)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 ISXSJGHXHUZXNF-LXZPIJOJSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- TWSWSIQAPQLDBP-UHFFFAOYSA-N adrenic acid Natural products CCCCCC=CCC=CCC=CCC=CCCCCCC(O)=O TWSWSIQAPQLDBP-UHFFFAOYSA-N 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- DNEHKUCSURWDGO-UHFFFAOYSA-N aluminum sodium Chemical compound [Na].[Al] DNEHKUCSURWDGO-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960004543 anhydrous citric acid Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229940072107 ascorbate Drugs 0.000 description 1
- 125000003289 ascorbyl group Chemical group [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 235000021168 barbecue Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000012411 boiled sweets Nutrition 0.000 description 1
- 235000014448 bouillon/stock cubes Nutrition 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 235000012186 breakfast bars Nutrition 0.000 description 1
- 235000010634 bubble gum Nutrition 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 235000013574 canned fruits Nutrition 0.000 description 1
- 235000020992 canned meat Nutrition 0.000 description 1
- 235000014613 canned/preserved soup Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 230000003293 cardioprotective effect Effects 0.000 description 1
- 230000010036 cardiovascular benefit Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015111 chews Nutrition 0.000 description 1
- 235000014696 chilled pizza Nutrition 0.000 description 1
- 235000009520 chilled ready meals Nutrition 0.000 description 1
- 235000008478 chilled snacks Nutrition 0.000 description 1
- 235000008520 chilled soup Nutrition 0.000 description 1
- 235000014500 chocolate coated biscuits Nutrition 0.000 description 1
- 235000014651 chocolate spreads Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000014156 coffee whiteners Nutrition 0.000 description 1
- 230000008133 cognitive development Effects 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 235000014541 cooking fats Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 235000019543 dairy drink Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000012906 dessert mixes Nutrition 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000008242 dietary patterns Nutrition 0.000 description 1
- 235000020785 dietary preference Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 235000008936 dinner mixes Nutrition 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000015071 dressings Nutrition 0.000 description 1
- 235000015432 dried pasta Nutrition 0.000 description 1
- 235000015929 dried ready meals Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 235000014654 dry sauces/powder mixes Nutrition 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000008753 endothelial function Effects 0.000 description 1
- 235000021183 entrée Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000010462 extra virgin olive oil Substances 0.000 description 1
- 235000021010 extra-virgin olive oil Nutrition 0.000 description 1
- 235000014089 extruded snacks Nutrition 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000016022 filled biscuits Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000010641 flavoured powder milk drink Nutrition 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000012465 frozen bakery product Nutrition 0.000 description 1
- 235000010610 frozen noodles Nutrition 0.000 description 1
- 235000012396 frozen pizza Nutrition 0.000 description 1
- 235000014132 frozen ready meals Nutrition 0.000 description 1
- 235000008410 fruit bars Nutrition 0.000 description 1
- 235000011494 fruit snacks Nutrition 0.000 description 1
- 235000014198 functional gum Nutrition 0.000 description 1
- 235000012883 functional spreadable oils and fats Nutrition 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940029982 garlic powder Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000007897 gelcap Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 235000014168 granola/muesli bars Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000014479 gravy granules Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- YEXZTHNGURCFSJ-UHFFFAOYSA-N henicosa-2,4,6,8,10-pentaenoic acid Chemical compound CCCCCCCCCCC=CC=CC=CC=CC=CC(O)=O YEXZTHNGURCFSJ-UHFFFAOYSA-N 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000015143 herbs and spices Nutrition 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000008173 hydrogenated soybean oil Substances 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 235000015094 jam Nutrition 0.000 description 1
- 235000014361 jams and preserves Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 125000002463 lignoceryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 235000015261 liquid stocks and fonds Nutrition 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 235000011475 lollipops Nutrition 0.000 description 1
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 235000015036 low fat salad dressings Nutrition 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 235000021184 main course Nutrition 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000015090 marinades Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000021180 meal component Nutrition 0.000 description 1
- 235000021486 meal replacement product Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 239000000320 mechanical mixture Substances 0.000 description 1
- 235000015875 medicated confectionery Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003595 mist Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 235000010460 mustard Nutrition 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002077 nanosphere Substances 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 239000002353 niosome Substances 0.000 description 1
- 235000019520 non-alcoholic beverage Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010508 nut-based spreads Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000021032 oily fish Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000010661 oregano oil Substances 0.000 description 1
- 238000006053 organic reaction Methods 0.000 description 1
- 235000009004 other sauces, dressings and condiments Nutrition 0.000 description 1
- 235000008368 other snack bars Nutrition 0.000 description 1
- 235000015976 other sugar confectionery Nutrition 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000010603 pastilles Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000008105 phosphatidylcholines Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000008373 pickled product Nutrition 0.000 description 1
- 235000009537 plain noodles Nutrition 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 235000021087 polyunsaturated fatty acids-rich diet Nutrition 0.000 description 1
- 235000019275 potassium ascorbate Nutrition 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- CONVKSGEGAVTMB-RXSVEWSESA-M potassium-L-ascorbate Chemical compound [K+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] CONVKSGEGAVTMB-RXSVEWSESA-M 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 235000008476 powdered milk Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000008428 probiotic yoghurt drink Nutrition 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 235000015504 ready meals Nutrition 0.000 description 1
- 235000020989 red meat Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000012242 regular mayonnaise Nutrition 0.000 description 1
- 235000008449 regular salad dressings Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000003303 reheating Methods 0.000 description 1
- 235000021462 rice dishes Nutrition 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 235000014612 sandwich biscuits Nutrition 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000009561 snack bars Nutrition 0.000 description 1
- 235000012852 snack noodles Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000011497 sour milk drink Nutrition 0.000 description 1
- 235000012884 soy based sauces Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000008522 spreadable oils and fats Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 235000011476 stock cubes Nutrition 0.000 description 1
- 235000013948 strawberry juice Nutrition 0.000 description 1
- 235000015260 sugar-free gum Nutrition 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000002483 superagonistic effect Effects 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 1
- 235000019587 texture Nutrition 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 150000003595 thromboxanes Chemical class 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- 235000014047 toffees, caramels and nougat Nutrition 0.000 description 1
- 235000008371 tortilla/corn chips Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
- VXKHXGOKWPXYNA-PGBVPBMZSA-N triptorelin Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)NCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC=1N=CNC=1)NC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 VXKHXGOKWPXYNA-PGBVPBMZSA-N 0.000 description 1
- 229960004824 triptorelin Drugs 0.000 description 1
- 239000002691 unilamellar liposome Substances 0.000 description 1
- 239000008371 vanilla flavor Substances 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 235000014348 vinaigrettes Nutrition 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 239000010698 whale oil Substances 0.000 description 1
- 235000011844 whole wheat flour Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 235000009764 yeast-based spreads Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1315—Non-milk proteins or fats; Seeds, pulses, cereals or soja; Fatty acids, phospholipids, mono- or diglycerides or derivatives therefrom; Egg products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C2260/00—Particular aspects or types of dairy products
- A23C2260/15—Frozen dairy products
- A23C2260/152—Frozen fermented milk products, e.g. frozen yoghurt or yoghurt ice cream; Frozen milk products containing living microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the disclosure generally relates to food articles comprising delivery devices. Methods of preparing such food articles are also disclosed.
- Polyunsaturated fatty acids for example, omega-3 fatty acids
- omega-3 fatty acids are vital to everyday life and function.
- Such compounds play critical roles in the structure of cell membranes and they form the foundation for the synthesis of many cell mediators (e.g., prostaglandins and leukotrienes).
- cell mediators e.g., prostaglandins and leukotrienes.
- These cell mediators are an important part of human physiology and can affect, for example, cell proliferation, cell signaling, gene expression, coagulation, and inflammation.
- omega-3 fatty acids and their derivates are known to be primary components of brain and nerve tissue.
- omega-3 fatty acids can reduce thrombogenisis and inflammation by altering certain pathways leading to the production of inflammatory mediators (e.g., prostaglandins, leukotrienes and thromboxanes).
- inflammatory mediators e.g., prostaglandins, leukotrienes and thromboxanes.
- omega-3 fatty acids are known to positively affect heart function, hemodynamics, and arterial endothelial function. The American Heart Association has reported that omega-3 fatty acids can reduce cardiovascular and heart disease risk.
- the primary source of such polyunsaturated fatty acids is through diet. Diets rich in polyunsaturated fatty acids like omega-3 fatty acids are known to have beneficial effects for heart disease, cancer, arthritis, allergies, and other chronic diseases.
- Diets rich in polyunsaturated fatty acids like omega-3 fatty acids are known to have beneficial effects for heart disease, cancer, arthritis, allergies, and other chronic diseases.
- Arch. Intern. Med . (1991) 151:1173-1180; Appel et al. “Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch.
- the disclosed subject matter in one aspect, relates to compounds and compositions and methods for preparing and using such compounds and compositions.
- the disclosed subject matter relates to articles of food comprising delivery devices.
- the disclosed subject matter relates to methods of preparing such food articles.
- the disclosed subject matter relates to homogenized formulations that comprise microcapsules, and to food articles prepared with or comprising homogenized formulations.
- the disclosed subject matter relates to methods of making and using the disclosed homogenized formulations and food articles prepared from and comprising them.
- FIG. 1 is a schematic of a process for applying the disclosed microencapsulated nutrients on to chips.
- Ranges can be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed.
- references in the specification and concluding claims to parts by weight of a particular element or component in a composition denotes the weight relationship between the element or component and any other elements or components in the composition or article for which a part by weight is expressed.
- X and Y are present at a weight ratio of 2:5, and are present in such ratio regardless of whether additional components are contained in the compound.
- a weight percent of a component is based on the total weight of the formulation or composition in which the component is included.
- a “subject” is meant an individual.
- the “subject” can include domesticated animals (e.g., cats, dogs, etc.), livestock (e.g., cattle, horses, pigs, sheep, goats, etc.), laboratory animals (e.g., mouse, rabbit, rat, guinea pig, etc.), and birds.
- “Subject” can also include a mammal, such as a primate or a human.
- Certain materials, compounds, compositions, and components disclosed herein can be obtained commercially or readily synthesized using techniques generally known to those of skill in the art.
- the starting materials and reagents used in preparing the disclosed compounds and compositions are either available from commercial suppliers such as Ocean Nutrition Canada (Dartmouth, Nova Scotia), Aldrich Chemical Co., (Milwaukee, Wis.), Acros Organics (Morris Plains, N.J.), Fisher Scientific (Pittsburgh, Pa.), or Sigma (St.
- materials, compounds, compositions, and components that can be used for, can be used in conjunction with, can be used in preparation for, or are products of the disclosed methods and compositions.
- These and other materials are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these materials are disclosed that while specific reference of each various individual and collective combinations and permutation of these compounds may not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a compound is disclosed and a number of modifications that can be made to a number of components of the compound are discussed, each and every combination and permutation that are possible are specifically contemplated unless specifically indicated to the contrary.
- each of the combinations A-E, A-F, B-D, B-E, B-F, C-D, C-E, and C-F are specifically contemplated and should be considered disclosed from disclosure of A, B, and C; D, E, and F; and the example combination A-D.
- any subset or combination of these is also specifically contemplated and disclosed.
- the sub-group of A-E, B-F, and C-E are specifically contemplated and should be considered disclosed from disclosure of A, B, and C; D, E, and F; and the example combination A-D.
- This concept applies to all aspects of this disclosure including, but not limited to, steps in methods of making and using the disclosed compositions.
- steps in methods of making and using the disclosed compositions are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific aspect or combination of aspects of the disclosed methods, and that each such combination is specifically contemplated and should be considered disclosed.
- a delivery device can contain a loading substance that is to be delivered to a subject upon eating/drinking the food article.
- the disclosed food articles can be any article that can be consumed (e.g., eaten, drank, or ingested) by a subject.
- the food article can be a composition for human and animal consumption, including foods/beverages for consumption by agricultural animals, pets and zoo animals. It can be desired that the food article be a palatable and popular food article.
- suitable food articles include, but are not limited to, fruit, vegetable, meat, a grain food, a starch food, a confectionery such as sweets (hard and soft candy, jelly, jam, candy bar, etc.), gum, a baked confectionery or molded confectionery (cookie, biscuit, etc.), a steamed confectionery, a cacao or cacao product (chocolate and cocoa), a frozen confectionery (ice cream, ices, etc.), a beverage (fruit juice, soft drink, carbonated beverage, health drink), a health or nutritional bar, baked good, pasta, a milk product, a cheese product, an egg product, a condiment, a soup mix, a snack food, a nut product, a plant protein product, a poultry product, a granulated sugar (e.g., white or brown), a sauce, a gravy, a syrup, a dry beverage powder, a fish product, or pet companion food.
- a confectionery such as sweets (hard and soft candy, jelly, jam, candy bar,
- a suitable food article can include, but is not limited to, bread, tortillas, cereal, sausage, chicken, ice cream, yogurt, milk, salad dressing, rice bran, fruit juice, a dry beverage powder, rolls, cookies, crackers, fruit pies, or cakes.
- the food article can be a chip (potato chip, corn chip, tortilla chip, etc.), pretzel, cracker, and the like.
- the food article can include, but is not limited to, frozen foods (e.g., frozen vegetables).
- the food article is a salty, savory snack food such as, for example, a rice cake or popcorn.
- food articles that can contain delivery devices can be the in the Wet Soup Category, the Dehydrated and Culinary Food Category, the Beverage Category, the Frozen Food Category, the Snack Food Category, and seasonings or seasoning blends.
- “Wet Soup Category” means wet/liquid soups regardless of concentration or container, including frozen soups.
- soup(s) means a food prepared from meat, poultry, fish, vegetables, grains, fruit and other ingredients, cooked in a liquid, which may include visible pieces of some or all of these ingredients. It may be clear (as a broth) or thick (as a chowder), smooth, pureed or chunky, ready-to-serve, semi-condensed or condensed and can be served hot or cold, as a first course or as the main course of a meal or as a between meal snack (sipped like a beverage). Soup can be used as an ingredient for preparing other meal components and can range from broths (consommé) to sauces (cream or cheese-based soups).
- “Dehydrated and Culinary Food Category” means: (i) Cooking aid products such as: powders, granules, pastes, concentrated liquid products, including concentrated bouillon, bouillon and bouillon like products in pressed cubes, tablets or powder or granulated form, which are sold separately as a finished product or as an ingredient within a product, sauces and recipe mixes (regardless of technology); (ii) Meal solutions products such as: dehydrated and freeze dried soups, including dehydrated soup mixes, dehydrated instant soups, dehydrated ready-to-cook soups, dehydrated or ambient preparations of ready-made dishes, meals and single serve entrees including pasta, potato and rice dishes; and (iii) Meal embellishment products such as: condiments, marinades, salad dressings, salad toppings, dips, breading, batter mixes, shelf stable spreads, barbecue sauces, liquid recipe mixes, concentrates, sauces or sauce mixes, including recipe mixes for salad, sold as a finished product or as an ingredient within a product, whether dehydrated, liquid
- “Beverage Category” means beverages, beverage mixes, and concentrates including, but not limited to, alcoholic and non-alcoholic beverages, ready to drink and dry powdered beverages, carbonated and non-carbonated beverages, e.g., sodas, fruit or vegetable juices.
- Also disclosed herein are methods for preparing a homogenized formulation that comprises providing a pre-homogenized composition comprising one or more delivery devices (e.g., microcapsules) and homogenizing the composition.
- the delivery devices are present in the pre-homogenized composition prior to homogenization.
- the homogenized formulations are further processed (e.g., pasteurized/sterilized).
- the disclosed homogenized formulations can also be pasteurized or sterilized formulations.
- the disclosed homogenized formulations can be incorporated into (e.g., used to prepare) many of the food articles disclosed herein.
- disclosed herein are combinations of food articles and homogenized formulations.
- the amount of delivery devices in a homogenized formulation can be at least 50% of the amount of delivery devices in a pre-homogenized composition. In other examples, the amount of delivery devices in a homogenized formulation can be at least about 55, 60, 65, 70, 75, 80, 85, 90, 95, 97, 98, or 99% of the amount of delivery devices in a pre-homogenized composition, where any of the stated values can form an upper or lower endpoint of a range.
- the amount of delivery devices in the disclosed homogenized formulations and pre-homogenized compositions can be determined by methods known in the art (for example, see the Examples disclosed herein).
- the disclosed homogenized formulations and methods have certain advantages over many existing compositions. For example, by having delivery devices present in the “crude” starting material (i.e., prior to homogenization and, in some cases, prior to other processing techniques such as pasteurization or sterilization), a plant's existing processing streams can be used, thus avoiding costly modifications to most existing designs where pasteurization is performed directly before or after homogenization. Another advantage is that the delivery devices are subjected to the homogenization process (and, in other examples, pasteurization and sterilization processes as well). This can avoid regulatory issues that surround methods where delivery devices (or other additives) are added after pasteurization/sterilization, which usually require that the product be re-pasteurized or re-sterilized.
- homogenized formulations e.g., dairy formulations
- methods disclosed herein can include a narrower particle size distribution of the delivery devices in the homogenized formulations as compared to formulations where the delivery devices were added after homogenization and thus not homogenized.
- milk proteins can assemble around the outer shell of the delivery devices during pasteurization. The degree and amount of assembly is believed to be dependent on the time and temperature of pasteurization.
- the assembly of the milk proteins e.g. whey proteins and caesins
- the associated milk proteins can provide further stability to the delivery devices and their contents.
- the pre-homogenized composition can be any fluid that is to be homogenized.
- the disclosed methods are not intended to be limited in any way by the particular pre-homogenized compositions.
- the pre-homogenized composition can be any comestible, cosmetic, pharmaceutical, nutritional, or health care product that is to be homogenized.
- the pre-homogenized composition can be a dairy product (e.g., milk).
- pre-homogenized compositions can have already been homogenized one or more times before. As long as these compositions are to be homogenized at least once again, they are acceptable pre-homogenized compositions for the disclosed methods.
- the pre-homogenized can also be either pasteurized or un-pasteurized.
- a dairy composition that is pasteurized, but has yet to be homogenized is a suitable pre-homogenized composition.
- a dairy composition that has yet to be either homogenized or pasteurized (in any order) is a suitable pre-homogenized composition.
- the disclosed pre-homogenized compositions can comprise one or more delivery devices, as described herein.
- the disclosed pre-homogenized compositions and resulting homogenized formulations can comprise the same type of delivery devices and, in other examples, different types of delivery devices (e.g., microcapsules containing different loading substances).
- homogenized formulations disclosed herein comprise microcapsules having about 130 mg of DHA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 5:25 oil derived from tuna and/or bonito) and the outer shell of the microcapsules comprises pork or fish gelatin.
- the homogenized formulations disclosed herein comprise a microcapsule having about 150 mg of DHA and EPA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 18:12 oil derived from sardine and/or anchovy) and the outer shell of the microcapsules comprises pork or fish gelatin. Any of these formulations can be infant formula, milk, or yogurt formulations for example.
- any of the disclosed delivery devices can be added to any of the disclosed pre-homogenized compositions.
- the particular method of addition will depend on the particular pre-homogenized composition, the particular delivery devices, the homogenized composition, including its end use and methods and apparatus of preparation, as well as preference.
- the disclosed methods are not intended to be limited by any particular method of adding microcapsules to the pre-homogenized composition.
- the delivery devices are manually added or poured into the pre-homogenized composition (or added to a homogenized composition that is to be homogenized again).
- the delivery devices or solutions thereof can be pumped into the pre-homogenized compositions or added via a hopper.
- Other suitable methods of adding the delivery devices into the pre-homogenized composition are known in the art.
- mixing can be also be desired in order to fully incorporate the delivery devices into the pre-homogenized compositions.
- Such mixing can also be accomplished by methods known in the art such as, but not limited to, mechanical stirrers, magnetic stirrers, shakers, bubbling gas, sonication, vortexing, and the like.
- the particular amount of delivery devices that can be present in the pre-homogenized compositions will depend on the preference and the particular end use of the homogenized formulations. For example, if one desires or requires a particular amount delivery devices in the homogenized formulations disclosed herein, then about the same amount can be present in or added to the pre-homogenized compositions.
- Specific examples of amounts of delivery devices in homogenized dairy formulations can be from about 0.005% to about 25%, from about 0.01% to about 20%, from about 0.05% to about 18%, from about 0.1% to about 16%, from about 1% to about 10%, by weight of the total composition.
- compositions containing from about 0.005 to about 5%, from about 0.01 to about 5%, or from about 0.1 to about 5% delivery devices by weight of the total composition.
- the disclosed homogenized formulations can contain about 0.005, 0.01, 0.05, 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25% delivery devices by weight of the total composition, where any of the stated values can form an upper or lower endpoint when appropriate.
- the pre-homogenized compositions are homogenized. Any homogenization technique and apparatus known in the art can be used in the disclosed methods. Such homogenization techniques and apparatuses are commonly used in, for example, the food, dairy, pharmaceutical, cosmetic, and fragrance industries. Many suitable homogenizers are commercially available. Homogenization can involve the use of sonication, pressure, and/or mechanical devices to homogenize the fluid.
- the homogenization can be a single stage homogenization, a multi-step or multi-stage homogenization (e.g., a two-stage homogenization), a high pressure homogenization (e.g., single or multi-stage high pressure homogenizations), a very-high pressure homogenization, a rotator-stator homogenization, a blade homogenization, and the like.
- the homogenization step can be a pressure-based homogenization technique operating at pressures of from about 200 to about 15,000 psi, from about 500 to about 12,000 psi, from about 1,000 to about 9,000 psi, or from about 3,000 to about 6,000 psi.
- the homogenization step can be performed at about 200, 500, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, 5000, 5500, 6000, 6500, 7000, 7500, 8000, 8500, 9000, 9500, 10000, 10500, 11000, 11500, or 12000, 12500, 13000, 13500, 14000, 14500, 15000, where any of the stated values can form an upper or lower endpoint. It is further contemplated that multiple passes of homogenization at any of these pressures can be used, including combinations thereof.
- the disclosed homogenized formulations can undergo further processing.
- the homogenized formulations can be sterilized or pasteurized. Examples of typically pasteurization conditions are high temperature short time pasteurization (HTST), ultra pasteurization (UP), and ultra high temperature (UHT) pasteurization.
- the homogenized formulations can also be further processed after homogenization by, e.g., the addition of additives, further formulation into the final product, packaged, spray dried, etc.
- the homogenized formulations can be steam injected. Steam injection is a known technique that is sometimes used in the dairy industry. Generally, steam is injected into the milk to remove odors produced when the moisture is flashed off during pasteurization. This process is typically used on milks that are UHT pasteurized.
- pre-homogenized compositions comprising one or more microcapsules can be processed prior to homogenization.
- pre-homogenized compositions comprising one or more microcapsules can first be sterilized or pasteurized and then homogenized.
- the pre-homogenized compositions comprising one or more microcapsules can be subject to other processing steps prior to homogenization (e.g., the addition of additives, etc.).
- the disclosed homogenized formulations have many and varied uses. Any current use of a homogenized fluid can also be suitable for the disclosed homogenized formulations.
- the homogenized formulations disclosed herein can generally be taken orally and can be in any form suitable for oral administration.
- the homogenized formulation can be spray dried and then formed into a tablet or provided in a sachet.
- the homogenized formulations can be incorporated into gel-caps, capsules, liquids, syrups, ointments, lotions, creams, gels, or drops.
- the homogenized formulations can also be designed for humans or animals, based on the recommended dietary intake for a given individual. Such considerations are generally based on various factors such as species, age, and sex as described above, which are known or can be determined by one of skill in the art.
- the disclosed formulations can be used as a component of feed for animals such as, but not limited to, livestock (e.g., pigs, chickens, cows, goats, horses, and the like), and domestic pets (e.g., cats, dogs, birds, and the like).
- the disclosed homogenized formulations can also include additional carriers, as well as flavorings, thickeners, diluents, buffers, preservatives, surface active agents, emulsifiers, dispersing aids, or binders and the like in addition to the microcapsules disclosed herein.
- homogenized formulations or products derived therefrom include fresh/pasteurized milk, full fat fresh/pasteurized milk, semi skimmed fresh/pasteurized milk, long-life/UHT milk, full fat long life/UHT milk, semi skimmed long life/UHT milk, fat-free long life/UHT milk, goat milk, condensed/evaporated milk, plain condensed/evaporated milk, flavored, functional and other condensed milk, flavored milk drinks, dairy only flavored milk drinks, flavored milk drinks with fruit juice, soy milk, sour milk drinks, fermented dairy drinks, coffee whiteners, powder milk, flavored powder milk drinks, cream, cheese, processed cheese, spreadable processed cheese, unspreadable processed cheese, unprocessed cheese, spreadable unprocessed cheese, hard cheese, packaged hard cheese, unpackaged hard cheese, yogurt, plain/natural yogurt, flavored yogurt, fruited yogurt, probiotic yogurt, drinking yogurt, regular drinking yogurt, probiotic drinking yogurt, chilled snacks, fromage
- the disclosed homogenized formulations can be prepared in a powdered form (e.g., via spray drying or dehydration) and contained in articles such as sachets or shakers, which can be used to pour or sprinkle the disclosed compositions onto and into food and beverages.
- articles such as sachets or shakers, which can be used to pour or sprinkle the disclosed compositions onto and into food and beverages.
- Still other examples include baked goods (e.g., breads, rolls, cookies, crackers, fruit pies, or cakes), pastas, condiments, salad dressings, soup mixes, snack foods, processed fruit juices, sauces, gravies, syrups, beverages, dry beverage powders, jams or jellies, or pet companion food that have been prepared with a homogenized formulation as disclosed herein.
- Examples of delivery devices that can be used in the disclosed food articles and methods include, but are not limited to, microcapsules, microspheres, nanospheres or nanoparticles, liposomes, noisome, emulsions, or powders.
- liposomes are generally derived from phospholipids or other lipid substances. Liposomes are formed by mono- or multi-lamellar hydrated liquid crystals that are dispersed in an aqueous medium. Any non-toxic, physiologically acceptable and metabolizable lipid capable of forming liposomes can be used. The liposome can also contain stabilizers, preservatives, excipients, and the like. Examples of suitable lipids are the phospholipids and the phosphatidyl cholines (lecithins), both natural and synthetic. Methods of forming liposomes are known in the art.
- the liposomes can be cationic liposomes (e.g., DOTMA, DOPE, DC cholesterol) or anionic liposomes.
- niosomes are delivery devices that can be used to deliver a loading substance as disclosed herein.
- noisysomes are multilamellar or unilamellar vesicles involving non-ionic surfactants.
- Solid-lipid nanoparticles as described herein, are other delivery devices that can be used to deliver a loading substance as disclosed herein.
- Solid-lipid nanoparticles are nanoparticles, which are dispersed in an aqueous surfactant solution. They are comprised of a solid hydrophobic core having a monolayer of a phospholipid coating and are usually prepared by high-pressure homogenization techniques.
- Microcapsules as described herein, are yet further examples of delivery devices that can be used in the disclosed food articles and methods as disclosed herein.
- microcapsules including microspheres
- These delivery devices are obtained by controlled precipitation of polymers, chemical cross-linking of soluble polymers, and interfacial polymerization of two monomers or high-pressure homogenization techniques.
- the encapsulated compound i.e., loading substance
- LHRH agonists like leuprorelin and triptoreline
- Poly(lactide co-glycolide) (PLGA) microspheres are currently used as monthly and three monthly dosage forms in the treatment of advanced prostrate cancer, endometriosis, and other hormone responsive conditions.
- Leuprolide an LHRH superagonist, was incorporated into a variety of PLGA matrices using a solvent extraction/evaporation method. As noted, all of these delivery devices can be used in the food articles and methods disclosed herein.
- microcapsules can protect certain compositions from oxidation and degradation, keeping the loading substance fresh. Also, because microcapsules can hide the unpleasant odor or taste of certain compositions, the food articles and methods disclosed herein can be particularly useful for delivering and supplementing unpleasant compositions. Still further, the use of microcapsules can allow various loading substances to be added to food articles which are otherwise not amenable to supplementation. For example, omega-3 fatty acids can degrade or oxidize in air and can be sensitive to food preparation techniques (e.g., baking). By the use microencapsulated omega-3 fatty acids, these compositions can be added to food without significant degradation during food preparation.
- Microcapsules that are suitable for use in the disclosed food articles are defined as small particles of solids, or droplets of liquids, inside a thin coating of a shell material such as beeswax, starch, gelatine, or polyacrylic acid. They are used, for example, to prepare liquids as free-flowing powders or compressed solids, to separate reactive materials, to reduce toxicity, to protect against oxidation and/or to control the rate of release of a substance such as an enzyme, a flavor, a nutrient, a drug, etc.
- a shell material such as beeswax, starch, gelatine, or polyacrylic acid. They are used, for example, to prepare liquids as free-flowing powders or compressed solids, to separate reactive materials, to reduce toxicity, to protect against oxidation and/or to control the rate of release of a substance such as an enzyme, a flavor, a nutrient, a drug, etc.
- microcapsules are formed by spray cooling an aqueous emulsion of oil or carotenoid particles such that the gelatine hardens around “cores” of the oil or carotenoid particles.
- Yoshida et al. discloses a complex coacervation process for the manufacture of microcapsules in which an emulsion of gelatine and paraffin wax is added to an arabic rubber solution and then mixed with a surfactant to form “multi-core” microcapsules. Ijichi et al. ( J. Chem. Eng. Jpn .
- microencapsulated large droplets of biphenyl using a complex coacervation process to form multi-layered microcapsules U.S. Pat. Nos. 4,219,439 and 4,222,891 disclose “multi-nucleus,” oil-containing microcapsules having an average diameter of about 3 to about 20 ⁇ m with an oil droplet size of about 1 to about 10 ⁇ m for use in pressure-sensitive copying papers and heat sensitive recording papers.
- microcapsules include those that are resistant to rupture during the preparation of the food article (including packaging, transportation, and storage of the food article).
- the microcapsules can be of a size and consistency that does not detract from the texture and constitution of the food article.
- Microcapsules suitable for use in the disclosed articles and methods can be any microcapsule as disclosed herein.
- the microcapsules can comprise an agglomeration of primary microcapsules and a loading substance.
- Each individual primary microcapsule has a primary shell.
- the loading substance is encapsulated by the primary shell and the agglomeration is encapsulated by an outer shell.
- These microcapsules are referred to herein as “multicore microcapsules.”
- described herein are microcapsules that comprise a loading substance, a primary shell, and a secondary shell, wherein the primary shell encapsulates the loading substance and the secondary shell encapsulates the composition and primary shell.
- microcapsules are referred to herein as “single-core microcapsules.” Unless stated otherwise, the term “microcapsule” is used herein to refer to multicore, single-core, or a mixture of multicore and single-core microcapsules. Particularly suitable microcapsules are disclosed in U.S. Pat. Nos. 6,974,592 and 6,969,530 and US Publication No. 2005-0019416-A1, which are all incorporated by reference herein in their entireties for at least their disclosures of microcapsules, their methods of preparation, and their methods of use.
- the microcapsules disclosed herein generally have a combination of high payload and structural strength.
- the disclosed microcapsules are strong enough to survive the homogenization process.
- the payloads of loading substances in the disclosed microcapsules can be from about 20% to about 90%, about 50% to about 70% by weight, or about 60% by weight of the microcapsule.
- the disclosed microcapsules can contain about 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, or 90% by weight of the microcapsule, where any of the stated values can form an upper or lower endpoint when appropriate.
- one or more additional shell layers can be placed on the outer shell of the microcapsules.
- the techniques described in International Publication No. WO 2004/041251 A1, which is incorporated by reference in its entirety, can be used to add additional shell layers to the microcapsules.
- the primary shell and/or outer shell material of the disclosed microcapsules can comprise a surfactant, gelatin, protein, polyphosphate, polysaccharide, or mixtures thereof.
- suitable materials for the primary shell and/or outer shell include, but are not limited to, gelatin type A, gelatin type B, polyphosphate, gum arabic, alginate, chitosan, carrageenan, pectin, starch, modified starch, alfa-lactalbumin, beta-lactoglobumin, ovalbumin, polysorbiton, maltodextrin, cyclodextrin, cellulose, methyl cellulose, ethyl cellulose, hydropropylmethylcellulose, carboxymethylcellulose, milk protein, whey protein, soy protein, canola protein, albumin, chitin, polylactides, poly-lactide-co-glycolides, derivatized chitin, poly-lysine, kosher gelatin, non-kosher gelatin, Halal gelatin, and non-Halal gelatin, including combinations and mixtures thereof. It is also contemplated that derivatives of these polymers can be used as well.
- the primary shell and/or outer shell material can have a Bloom number of from about 0 to about 350.
- the Bloom number describes the gel strength formed at 10° C. with a 6.67% solution gelled for 18 hours. Determining the Bloom number of a substance can be accomplished by methods known in the art.
- the primary shell and/or outer shell material can have a Bloom number of about 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 100, 101, 102, 103, 104, 105, 106, 107,
- the primary and/or outer shell material can have a Bloom number of from about 0 to about 50, and in other examples the primary and/or outer shell material can have a Bloom number of from about 51 to about 350. Still other specific examples include microcapsules comprising a primary shell and/or outer shell material having a Bloom number of about 0, about 210, about 220, or about 240. In one example, the microcapsule does not contain “low Bloom” gelatine, which is gelatin having a Bloom number less than 50.
- the shell material can be a two-component system made from a mixture of different types of polymer components.
- the shell material can be a complex coacervate between two or more polymer components (e.g., gelatine A and polyphosphate).
- Component A can be gelatine type A, although other polymers like those mentioned above for the shell materials are also contemplated as component A.
- Component B can be gelatine type B, polyphosphate, gum arabic, alginate, chitosan, carrageenan, pectin, carboxymethyl-cellulose or a mixture thereof. Again other polymers like those disclosed above for the shell materials are also contemplated as component B.
- the molar ratio of component A:component B that is used depends on the type of components but is typically from about 1:5 to about 15:1.
- the molar ratio of component A:component B can be about 8:1 to about 12:1; when gelatine type A and gelatine type B are used as components A and B respectively, the molar ratio of component A:component B can be about 2:1 to about 1:2; and when gelatine type A and alginate are used as components A and B respectively, the molar ratio of component A:component B can be about 3:1 to about 5:1.
- the primary shell and/or outer shell can comprise a complex coacervate.
- the primary shell and/or outer shell can comprise a complex coacervate of gelatin and polyphosphate.
- the outer shell can have an average diameter of from about 1 ⁇ m to about 2,000 ⁇ m, from about 20 ⁇ m to about 1,000 ⁇ m, or from about 30 ⁇ m to about 80 ⁇ m.
- the average diameter of the outer shell can be about 1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, or 2000 ⁇ m, where any of the stated values can form an upper or lower endpoint when appropriate.
- the primary shells of the disclosed microcapsules can have an average diameter of from about 40 nm to about 10 ⁇ m or from about 0.1 ⁇ m to about 5 ⁇ m.
- the average diameter of the primary shell can be about 40 nm, 50 nm, 60 nm, 70 nm, 80 nm, 90 nm, 100 nm, 200 nm, 300 nm, 400 nm, 500 nm, 600 nm, 700 nm, 800 nm, 900 nm, 1000 nm, 2 ⁇ m, 3 ⁇ m, 4 ⁇ m, 5 ⁇ m, 6 ⁇ m, 7 ⁇ m, 8 ⁇ m, 9 ⁇ m, 10 ⁇ m, where any of the stated values can form an upper or lower endpoint when appropriate.
- Particle size can be measured using any typical equipment known in the art, for example, a Coulter LS230 Particle Size Analyzer, Miami, Fla., USA.
- the loading substance can be any substance that one desires to be delivered to a subject.
- a suitable loading substance is not entirely soluble in an aqueous mixture.
- the loading substance can be a solid, a hydrophobic liquid, or a mixture of a solid and a hydrophobic liquid.
- the loading substance can comprise a long chain polyunsaturated fatty acid, specific examples of which are included below.
- the loading substance can comprise a biologically active substance, a nutrient such as a nutritional supplement, a flavoring substance, a polyunsaturated fatty acid like an omega-3 fatty acid, a vitamin, a mineral, a carbohydrate, a steroid, a trace element, and/or a protein, and the like including mixtures and combinations thereof.
- a biologically active substance such as a nutritional supplement, a flavoring substance, a polyunsaturated fatty acid like an omega-3 fatty acid, a vitamin, a mineral, a carbohydrate, a steroid, a trace element, and/or a protein, and the like including mixtures and combinations thereof.
- the loading substance can comprise microbial oil, algal oil (e.g., oil from a dinoflagellate such as Crypthecodinium cohnii ), fungal oil (e.g., oil from Thraustochytrium, Schizochytrium , or a mixture thereof), and/or plant oil (e.g., flax, vegetables), including mixtures and combinations thereof.
- the loading substance can be a pharmaceutical composition (e.g., a drug and/or an enzyme) or a flavor.
- the loading substance can also be a hydrophobic liquid, such as grease, oil or a mixture thereof.
- Typical oils can be fish oils, vegetable oils (e.g., canola, olive, corn, rapeseed), mineral oils, derivatives thereof or mixtures thereof.
- the loading substance can comprise a purified or partially purified oily substance such as a fatty acid, a triglyceride, or a mixture thereof.
- a suitable loading substance can comprise marine oil, such as natural and refined and concentrated fish oil.
- suitable fish oils include, but are not limited to, Atlantic fish oil, Pacific fish oil, Mediterranean fish oil, light pressed fish oil, alkaline treated fish oil, heat treated fish oil, light and heavy brown fish oil, bonito oil, pilchard oil, tuna oil, sea bass oil, halibut oil, spearfish oil, barracuda oil, cod oil, menhaden oil, sardine oil, anchovy oil, capelin oil, Atlantic cod oil, Atlantic herring oil, Atlantic mackerel oil, Atlantic menhaden oil, salmonid oil, and shark oil, including mixtures and combinations thereof.
- Non-alkaline treated fish oil is also a suitable loading substance.
- marine oils suitable for use herein include, but are not limited to, squid oil, cuttle fish oil, octopus oil, krill oil, seal oil, whale oil, and the like, including mixtures and combinations thereof. Any marine oil and combination of marine oil can be used in the disclosed delivery devices and in the disclosed food articles and methods.
- omega-3 fatty acids Many of the microbial, algal, fungal, plant, and marine oils disclosed herein contain omega-3 fatty acids.
- certain delivery devices disclosed herein can contain a loading substance that comprises an omega-3 fatty acid, an alkyl ester of an omega-3 fatty acid, a triglyceride ester of an omega-3 fatty acid, a phytosterol ester of an omega-3 fatty acid, and/or mixtures and combinations thereof.
- An omega-3 fatty acid is an unsaturated fatty acid that contains as its terminus CH 3 —CH 2 —CH ⁇ CH—.
- an omega-3 fatty acid has the following formula:
- R 1 is a C 3 -C 40 alkyl or alkenyl group comprising at least one double bond and R 2 is H or alkyl group.
- alkane or “alkyl” as used herein is a saturated hydrocarbon group (e.g., methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like).
- alkene or “alkenyl” as used herein is a hydrocarbon group containing at least one carbon-carbon double bond. Asymmetric structures such as (AB)C ⁇ C(CD) are intended to include both the E and Z isomers (cis and trans).
- R 1 can be a C 5 -C 38 , C 6 -C 36 , C 8 -C 34 , C 10 -C 32 , C 12 -C 30 , C 14 -C 28 , C 16 -C 26 , or C 18 -C 24 alkenyl group.
- the alkenyl group of R 1 can have from 2 to 6, from 3 to 6, from 4 to 6, or from 5 to 6 double bonds. Still further, the alkenyl group of R 1 can have from 1, 2, 3, 4, 5, or 6 double bonds, where any of the stated values can form an upper or lower endpoint as appropriate.
- omega-3 fatty acids that are suitable loading substances that can be used in the disclosed delivery devices include, but are not limited to, ⁇ -linolenic acid (18:3 ⁇ 3), octadecatetraenoic acid (18:4 ⁇ 3), eicosapentaenoic acid (20:5 ⁇ 3) (EPA), eicosatetraenoic acid (20:4 ⁇ 3), henicosapentaenoic acid (21:5 ⁇ 3), docosahexaenoic acid (22:6 ⁇ 3) (DHA), docosapentaenoic acid (22:5 ⁇ 3) (DPA), including derivatives and mixtures thereof.
- ⁇ -linolenic acid (18:3 ⁇ 3)
- octadecatetraenoic acid 18:4 ⁇ 3
- EPA eicosapentaenoic acid (20:5 ⁇ 3)
- EPA eicosatetraenoic acid
- henicosapentaenoic acid 21:5 ⁇ 3
- esters such as phytosterol esters, furanoid esters, branched or unbranched C 1 -C 30 alkyl esters, branched or unbranched C 2 -C 30 alkenyl esters or branched or unbranched C 3 -C 30 cycloalkyl esters, in particular phytosterol esters and C 1 -C 6 alkyl esters.
- the loading substance can be a phytosterol ester of docosahexaenoic acid and/or eicosapentaenoic acid, a C 1 -C 6 alkyl ester of docosahexaenoic acid and/or eicosapentaenoic acid, a triglyceride ester of docosahexaenoic acid and/or eicosapentaenoic acid, and/or a mixture thereof.
- suitable loading substances that can be present in the disclosed delivery devices comprise at least 4, at least 6, at least 8, at least 10, at least 12, at least 14, at least 16, at least 18, or at least 20 carbon atoms.
- the loading substance can contain about 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, or 45 carbon atoms, where any of the stated values can form an upper or lower endpoint when appropriate.
- the loading substance can comprise a mixture of fatty acids (including derivatives thereof) having a range of carbon atoms.
- the loading substance can comprise from about 8 to about 40, from about 10 to about 38, from about 12 to about 36, from about 14 to about 34, from about 16 to about 32, from about 18 to about 30, or from about 20 to about 28 carbon atoms.
- loading substances are those that contain at least one unsaturated bond (i.e., a carbon-carbon double or triple bond).
- the loading substance can contain at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, or at least 8 carbon-carbon double bonds, triple bonds, or any combination thereof.
- the loading substance can comprise 1, 2, 3, 4, 5, 6, 7, or 8 unsaturated bonds, where any of the stated values can form an upper or lower endpoint as appropriate.
- loading substances which are unsaturated fatty acids
- loading substances which are unsaturated fatty acids
- Unsaturated fatty acids that contain at least one pair of methylene interrupted unsaturated bonds are also suitable loading substances.
- methylene interrupted unsaturated bond is meant that one carbon-carbon double or triple bond is separated from another carbon-carbon double or triple bond by at least one methylene group (i.e., CH 2 ).
- such loading substances include, but are not limited to, the n-1 family derived from 9, 12, 15-16:3; n-2 family derived from 9, 12, 15-17:3, 15:3, 17:3, 17:4, 20:4; n-3 family derived from 9, 12, 15-18:3, 15:2, 15:3, 15:4, 16:3, 16:4, 18:3 ( ⁇ -linolenic), 18:4, 18:5, 20:2, 20:3, 20:4; 20:5 (EPA), 21:5, 22:3, 22:5 (DPA), 22:6 (DHA), 24:3, 24:4, 24:5, 24:6, 26:5, 26:6, 28:7, 30:5; n-4 family derived from 9, 12-16:2, 16:2, 16:3, 18:2, 18:3; n-5 family derived from 9, 12-17:2, 15:2, 17:2, 17:3, 19:2, 19:4, 20:3, 20:4 21:4, 21:5; n-6 family derived from 9, 12-18:2, 15:2, 16:2, 18:2 (linoleic), 18
- the compounds are identified by referring first to the “n-x family,” where x is the position in the fatty acid where the first double bond begins.
- the numbering scheme begins at the terminal end of the fatty acid, where, for example, the terminal CH 3 group is designated position 1.
- the n-3 family would be an omega-3 fatty acid, as described above.
- the next number identifies the total number of carbon atoms in the fatty acid.
- the third number which is after the colon, designates the total number of double bonds in the fatty acid.
- 16:3 refers to a 16 carbon long fatty acid with 3 double bonds, each separated by a methylene, wherein the first double bond begins at position 1, i.e., the terminal end of the fatty acid.
- 18:3 refers to an 18 carbon long fatty acid with 3 methylene separated double bonds beginning at position 6, i.e., the sixth carbon from the terminal end of the fatty acid, and so forth.
- conjugated unsaturated bonds include, but are not limited to, those in Table 3.
- conjugated unsaturated bond is meant that at least one pair of carbon-carbon double and/or triple bonds are bonded together, without a methylene (CH 2 ) group between them (e.g., CH ⁇ CH—CH ⁇ CH—).
- derivatives of the disclosed loading substances can also be used.
- derivatives is meant the ester of a fatty acid (e.g., methyl and ethyl esters), salts of the fatty acids (e.g., sodium and potassium salts), and triglycerides, diglycerides, and monoglycerides, sterol esters, antioxidant-oil conjugates (e.g., ascorbyl palmitate), and naturally derivatives such as furanoid fatty acid derivatives.
- the loading substances disclosed herein can also be crude oils, semi-refined (also called alkaline refined), or refined oils from such sources disclosed herein. Still further, the disclosed compositions and methods can use oils comprising re-esterified triglycerides.
- the disclosed delivery devices can contain two or more different loading substances.
- the loading substance can be present in an amount of from about 1% to about 50% by weight of a microcapsule.
- the loading substance can be present in an amount of from about 1% to about 40%, from about 1% to about 30%, from about 1% to about 20%, from about 1% to about 15%, or from about 1% to about 10% by weight of a microcapsule.
- the loading substance is not a fatty acid conjugate.
- a fatty acid conjugate is a fatty acid that has been coupled to (e.g., bonded to) another chemical moiety, such as a metal (e.g., chromium) or cofactor (CoQ 10 ).
- the loading substances can contain an antioxidant.
- Suitable examples of antioxidants include, but are not limited to, a phenolic compound, a plant extract, or a sulfur-containing compound.
- the antioxidant can be ascorbic acid or a salt thereof, e.g., sodium ascorbate.
- the antioxidant can be citric acid or a salt thereof.
- the antioxidant can be vitamin E, CoQ 10 , tocopherols, lipid soluble derivatives of more polar antioxidants such as ascobyl fatty acid esters (e.g., ascobyl palmitate), plant extracts (e.g., rosemary, sage and oregano oils), algal extracts, and synthetic antioxidants (e.g., BHT, TBHQ, ethoxyquin, alkyl gallates, hydroquinones, tocotrienols).
- polar antioxidants such as ascobyl fatty acid esters (e.g., ascobyl palmitate), plant extracts (e.g., rosemary, sage and oregano oils), algal extracts, and synthetic antioxidants (e.g., BHT, TBHQ, ethoxyquin, alkyl gallates, hydroquinones, tocotrienols).
- the disclosed loading substance can also contain other nutrient(s) such as vitamins other trace elements, minerals, and the like. Further, the loading substances can comprise other components such as preservatives, antimicrobials, anti-oxidants, chelating agents, thickeners, flavorings, diluents, emulsifiers, dispersing aids, or binders, including any mixture thereof.
- suitable delivery devices include microcapsules that contain any of the shell materials and any of the loading substances disclosed herein. Some specific examples include, but are not limited to, microcapsules where the shell materials are complex coacervates, e.g., coacervates of gelatin and polyphosphate.
- the shell material can, in certain examples, comprise gelatin with a Bloom number of from about 0 to about 50.
- Loading substances that can be used can, in many instances, include marine oils (e.g., fish oils and algal oils). Loading substances that comprise omega-3 fatty acids such as EPA and DHA can also be desirable.
- omega-3 fatty acids such as mono-, di-, and triglycerides, alkyl esters, sterol esters, antioxidant esters (e.g., ascorbyl and citryl esters), and furanoid esters, can also be suitable loading substances.
- microcapsules include microcapsules containing fish oils.
- fish oils include, but are not limited to, sardine, anchovy, bonito, and/or tuna oil.
- Fish oils can also be referred to herein by the approximate ratio of EPA and DHA, or derivatives thereof, found in the oil.
- 18:12 oils generally comprise a ratio of EPA to DHA (or their triglyceride esters for example) of about 18:12.
- 5:25 oils generally comprise a ratio of EPA to DHA of about 5:25. Any of these oils can be encapsulated in a complex coacervate comprising and fish or pork gelatin.
- microcapsules can be Generally Regarded as Safe (GRAS), kosher, and/or Halal. Also, such microcapsules can have at least about 130 mg of DHA or at least about 150 mg of EPA and DHA per gram of powder. Further, antioxidants such as ascorbic acid, citric acid, and/or phosphoric acid (or salts thereof) can be present in such microcapsules.
- GRAS Generally Regarded as Safe
- kosher kosher
- Halal can have at least about 130 mg of DHA or at least about 150 mg of EPA and DHA per gram of powder.
- antioxidants such as ascorbic acid, citric acid, and/or phosphoric acid (or salts thereof) can be present in such microcapsules.
- Some specific examples of food articles disclosed herein comprise microcapsules having about 130 mg of DHA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 5:25 oil derived from tuna and/or bonito) and the outer shell of the microcapsules comprises pork or fish gelatin.
- a food article disclosed herein can comprise a microcapsule having about 150 mg of DHA and EPA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 18:12 oil derived from sardine and/or anchovy) and the outer shell of the microcapsules comprises pork or fish gelatin.
- the loading substance is not a conjugated fatty acid.
- the microcapsule does not comprise a low Bloom gelatin.
- Microcapsules prepared by the processes disclosed herein typically have a combination of payload and structural strength that are suitable for the disclosed food articles and methods.
- the methods disclosed in U.S. Pat. Nos. 6,974,592 and 6,969,530, which are incorporated by reference in their entirety can be used to prepare microcapsules that can be incorporated into the food articles disclosed herein.
- one or more additional shell layers can be placed on the outer shell of the single-core or multicore microcapsules.
- the techniques described in International Publication No. WO 2004/041251 A1 which is incorporated by reference in its entirety, can be used to add additional shell layers to the single-core and multicore microcapsules.
- suitable microcapsules can be prepared by a process that comprises providing an emulsion comprising a first polymer component and a loading substance; adding a second polymer component to the emulsion; adjusting pH, temperature, concentration, mixing speed, or a combination thereof to form an aqueous mixture comprising a primary shell material, wherein the primary shell material comprises the first and second polymer components and surrounds the loading substance; cooling the aqueous mixture to a temperature above the gel point of the primary shell material until the primary shell material forms agglomerations; and further cooling the aqueous mixture to form an outer shell around the agglomeration.
- the first polymer component and second polymer component can be the same as any of the primary and outer shell materials described herein. That is, the first and second polymer components can become the primary and/or outer shell materials in the disclosed methods for preparing microcapsules. Furthermore, any of the loading substances described herein can be used in these methods for preparing microcapsules.
- an aqueous mixture of a loading substance, a first polymer component of the shell material, and a second polymer component of the shell material is formed.
- the aqueous mixture can be a mechanical mixture, a suspension, or an emulsion.
- a liquid loading substance is used, particularly a hydrophobic liquid
- the aqueous mixture can be an emulsion of the loading substance and the polymer components.
- a first polymer component is provided in aqueous solution, together with processing aids, such as antioxidants.
- a loading substance can then be dispersed into the aqueous mixture, for example, by using a homogenizer.
- the loading substance is a hydrophobic liquid
- an emulsion is formed in which a fraction of the first polymer component begins to deposit around individual droplets of loading substance to begin the formation of primary shells.
- the loading substance is a solid particle
- a suspension is formed in which a fraction of the first polymer component begins to deposit around individual particles to begin the formation of primary shells.
- another aqueous solution of a second polymer component can be added to the aqueous mixture.
- providing an emulsion of the first polymer component and the loading substance can be accomplished by methods and apparatus known in the art, e.g., homogenization and high pressure/high shear pumps.
- emulsification can take place by emulsifying at from about 1,000 to about 15,000 rpm.
- the emulsification step can be monitored by removing a sample of the mixture and analyzing it under such methods as microscopy, light scattering, turbidity, etc.
- emulsification can be performed until an average droplet size of less than about 1,000, 750, 500, 100, or 10 nm is obtained.
- the emulsification speed it is possible to produce single or multicore microcapsules.
- lower emulsification speeds e.g., 1,000 to 2,000 rpm
- the droplets of the loading substance are large enough to form a single particle, which upon encapsulation, produces a single core microcapsule.
- high emulsification speeds e.g., 5,000 to 15,000 rpm
- the resultant droplets of loading substance are usually small (e.g., from 1 to 10 ⁇ m).
- Particle size can be measured using any typical equipment known in the art, for example, a COULTERTM LS230 Particle Size Analyzer, Miami, Fla. USA.
- the emulsification step can be performed at greater than room temperature, greater than 30, 40, 50, 60, 70, or 80° C., where any of the stated values can form an upper or lower endpoint when appropriate. Specific examples include emulsifying the mixture at from about 30° C. to about 60° C. or from about 40° C. to about 50° C.
- antioxidants and/or surfactants which are also described herein, can be added to the aqueous mixture. Such antioxidants and/or surfactants can be added before, during, and/or after the emulsion is provided.
- the amount of the polymer components of the shell material provided in the aqueous mixture is typically sufficient to form both the primary shells and the outer shells of the loading agglomeration of microcapsules.
- the loading substance can be provided in an amount of from about 1% to about 15% by weight of the aqueous mixture, from about 3% to about 8% by weight, or about 6% by weight.
- the pH, temperature, concentration, mixing speed, or a combination thereof can be adjusted to form an aqueous mixture comprising a primary shell material, wherein the primary shell material comprises the first and second polymer components and surrounds the loading substance. If there is more than one type of polymer component, complex coacervation will occur between the components to form a coacervate, which further deposits around the loading substance to form primary shells of shell material.
- the pH adjustment depends on the type of shell material to be formed. For example, the pH may be adjusted to a value from 3.5 to 5.0, or from 4.0 to 5.0. If the pH of the mixture starts in the desired range, then little or no pH adjustment is required.
- the initial temperature of the aqueous mixture can be from about 20° C. to about 60° C., or about 30° C. to about 50° C.
- Mixing can be adjusted so that there is good mixing without breaking the microcapsules as they form.
- Particular mixing parameters depend on the type of equipment being used. Any of a variety of types of mixing equipment known in the art may be used.
- an axial flow impeller such as LIGHTNIN A310 or A510, can be used.
- the primary shell and the outer shell of the disclosed microcapsules can comprise a complex coacervate.
- the complex coacervate can be formed from the first and second polymer components.
- the primary shell and the outer shell can comprise a complex coacervate between gelatin and polyphosphate. All combinations of first and second polymer components are contemplated herein for the complex coacervate and the primary and outer shell.
- the aqueous mixture can then be cooled under controlled cooling rate and mixing parameters to permit agglomeration of the primary shells to form encapsulated agglomerations of primary shells.
- the encapsulated agglomerations are discrete particles themselves. It is advantageous to control the formation of the encapsulated agglomerations at a temperature above the gel point of the shell material, and to let excess shell material form a thicker outer shell. It is also possible at this stage to add more polymer, where the polymer is the same or different as the shell material being used, in order to thicken the outer shell and/or produce microcapsules having primary and outer shells of different composition.
- the outer shell encapsulates the agglomeration of primary shells to form a rigid encapsulated agglomeration of microcapsules.
- Cooling the aqueous mixture can be accomplished by methods known in the art (e.g., the use of a chiller).
- the rate of cooling can be about 1° C. per about 1 to about 100 minutes.
- the rate of cooling can be about 1° C. per about 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100 minutes, where any of the stated values can form an upper or lower endpoint when appropriate.
- the rate of cooling can be about 1° C./5 minutes. Cooling can take place until the mixture reaches a temperature of from about 5° C. to about 10° C., e.g., about 5° C.
- Processing aids can be included in the shell material (e.g., primary and/or outer shells). Processing aids can be used for a variety of reasons. For example, they may be used to promote agglomeration of the primary microcapsules, stabilize the emulsion system, improve the properties of the outer shells, control microcapsule size, and/or to act as an antioxidant.
- the processing aid can be an emulsifier, a fatty acid, a lipid, a wax, a microbial cell (e.g., yeast cell lines), a clay, or an inorganic compound (e.g., calcium carbonate). Not wishing to be bound by theory, these processing aids can improve the barrier properties of the microcapsules.
- one or more antioxidants can be added to the shell material. Antioxidant properties are useful both during the process (e.g., during coacervation and/or spray drying) and in the microcapsules after they are formed (i.e., to extend shelf-life, etc). Preferably a small number of processing aids that perform a large number of functions can be used.
- the antioxidant can be a phenolic compound, a plant extract, or a sulphur-containing amino acid.
- ascorbic acid or citric acid (or a salt thereof such as sodium or potassium ascorbate or sodium or potassium citrate) can be used to promote agglomeration of the primary microcapsules, to control microcapsule size and to act as an antioxidant.
- the antioxidant can be used in an amount of about 100 ppm to about 12,000 ppm, or from about 1,000 ppm to about 5,000 ppm.
- Other processing aids such as, for example, metal chelators, can be used as well.
- ethylene diamine tetraacetic acid can be used to bind metal ions, which can reduce the catalytic oxidation of the loading substance.
- the shell material can also be cross-linked.
- the disclosed methods can further involve the addition of a cross-linker.
- the cross-linker can be added to further increase the rigidity of the microcapsules by cross-linking the shell material in both the outer and primary shells and to make the shells insoluble in both aqueous and oily media.
- the cross-linker is added after the outer shell of the microcapsule is produced. Any suitable cross-linker can be used and the choice of cross-linker can vary depending upon the selection of the first and second polymer component.
- the cross-linkers can be enzymatic cross-linkers (e.g. transglutaminase), aldehydes (e.g.
- the cross-linker can be a plant extract or a phenolic. It is also contemplated that one or more loading substances (e.g., antioxidants) can be used with the cross-linker.
- the cross-linkers are preferably non-toxic or of sufficiently low toxicity. The amount of cross-linker used depends on the components selected and can be adjusted to provide more or less structural rigidity as desired.
- the amount of cross-linker that can be used is in the amount of about 0.1% to about 5.0%, about 0.5% to about 5.0%, about 1.0% to about 5.0%, about 2.0% to about 4.0%, or about 2.5%, by weight of the first polymer component.
- the cross-linker can be added at any stage of the process, however it, can typically be added after the cooling step.
- the disclosed microcapsules can be washed with water and/or dried to provide a free-flowing powder.
- the disclosed methods of preparing microcapsules can comprise a drying step for the microcapsules. Drying can be accomplished by a number of methods known in the art such as, for example, freeze drying, drying with ethanol, or spray drying. In one aspect, spray drying can be used for drying the microcapsules. Spray drying techniques are disclosed in “Spray Drying Handbook”, K. Masters, 5th edition, Longman Scientific Technical UK, 1991, the disclosure of which is hereby incorporated by reference at least for its teaching of spray drying methods.
- the food articles disclosed herein contain delivery devices, such as those disclosed herein, and can be used to deliver loading substances encapsulated within the delivery device (e.g., omega-3 fatty acids) to a subject for nutritional or medical purposes.
- the delivery device is a microcapsule.
- the microcapsules disclosed herein have good rupture strength to help reduce or prevent breaking of the microcapsules during incorporation into food or other formulations.
- the microcapsule's shells are insoluble in both aqueous and oily media, and help reduce or prevent oxidation and/or deterioration of the loading substance during preparation of the microcapsules, during long-term storage, and/or during incorporation of the microcapsules into a formulation vehicle, for example, into food articles.
- the delivery device e.g., microcapsules
- the delivery device can be mixed with the ingredients of the food article before the food article is prepared. Examples of this can include adding delivery devices to batter or breading for various food articles (e.g., fish, shrimp, poultry, vegetables) and then cooking the food.
- the delivery devices can be added to (e.g., contacted to or poured or sprinkled on) the food article after it is prepared, but before packaging. Typical examples of this method involve contacting the food article with the delivery device. Such contacting steps can be combined with other seasoning steps.
- the delivery device can be packaged separately from the food article (e.g., microcapsules can be packaged alone as a condiment pack or mixed into other seasonings) and then added to the food article prior to consumption (e.g., by the consumer or food preparation personnel).
- microcapsules can be packaged alone as a condiment pack or mixed into other seasonings
- delivery devices can be pulse sprayed or mist sprayed onto the surface of the food article.
- a drum can contain the delivery devices and the food article can be introduced into the drum and agitated (e.g., rolled around inside the drum).
- FIG. 1 depicts one example of this technique, where, for example, a seasoning and delivery device comprising omega-3 fatty acids are mixed in a horizontal mixer 1. The mixture is then placed in a sprayer 2, which then applies the mixture to the food article 4 present in drum 3. Drum 3 can be rotated while the mixture is sprayed onto the food article in order to ensure even distribution of the mixture to the food article.
- Suitable apparatus for introducing delivery devices can be obtained commercially from suppliers such as FMC Technologies (Chalfont, Pa.).
- the amount of delivery devices (and thus loading substance) that can be used with the disclosed food articles will depend on such factors as the type of food article, the type of loading substance, the presence of additional seasonings, the desired dietary intake, preference, and the like. Guidance can be found in the literature for appropriate amounts for given classes of loading substances and determining a particular amount is within the skill in art. Generally, an amount of delivery devices that will provide the desired amount of loading substance to a subject, but not detract from the taste and texture of the food article can be used.
- the disclosed food article comprises a snack food (e.g., a chip) and a microcapsules.
- the food article is a chip and the loading substance comprises an omega-3 fatty acid.
- Typical amounts of microcapsules that can be used for chips are about 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 2.9%, 3.0%, 3.5%, 4.0%, 1.5%, 5.0%, 5.5%, or 6.0% by weight, based on the total weight of the chip, where any of the stated values can form an upper or lower end point when appropriate.
- a chip can have about 0.5, 1.0, 1.5, 2.0, 2.5, 2.9, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, or 6.0 parts by weight microcapsules, where any of the stated values can form an upper or lower end point when appropriate.
- a chip can have less than or equal to about 6.0, less than or equal to about 5.0, less than or equal to about 4.0, less than or equal to about 3.0, less than or equal to about 2.0, or less than or equal to about 1.0 parts by weight microcapsule.
- a chip can have microcapsules at from about 1 to about 6, from about 2 to about 4, or about 3% by weight based on the total weight of the chip. Still further, a chip can have from about 1 to about 6, from about 2 to about 4, and about 3 parts by weight microcapsules.
- the disclosed food article can comprise seasonings in addition to the delivery devices.
- the seasonings can be blended with the microcapsules and then added to the food article (e.g., chip).
- a seasoning for a food article that comprises a microcapsule.
- the delivery device comprises a microcapsule.
- Exemplary amounts of microcapsules that can be blended with a seasoning are about 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, or 40% by weight, based on the total weight of the blend, where any of the stated values can form an upper or lower end point when appropriate.
- microcapsules can be blended with a seasoning at about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 parts by weight, where any of the stated values can form an upper or lower end point when appropriate.
- a seasoning blend can contain from about 20 to about 25, from about 15 to about 30, from about 10 to about 35, from about 5 to about 40, from about 5 to about 20, from about 20 to about 40 parts by weight microcapsules.
- the seasoning When the seasoning is a chip seasoning, it can be present in an amount of about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20% by weight based on the total amount of the chip, where any of the stated values can form an upper or lower endpoint when appropriate.
- a chip can contain about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 parts by weight seasoning, where any of the stated values can form an upper or lower endpoint when appropriate.
- the chip can also contain oil in an amount of about 1, 2, 3, 4, 5, 6, 7, or 8% by weight, where any of the stated values can form an upper or lower endpoint when appropriate.
- kits for mixing the delivery device (e.g., microcapsule) with one or more ingredients used to prepare the food article prior to preparing the food article.
- Alternative or additional methods involve contacting an already prepared food article with the delivery device.
- the delivery device can be blended with a seasoning for the food article.
- the delivery device can also be sprayed onto the food article. Further, the delivery device can be mixed with the food article.
- the amount of delivery device used to prepare a food article can vary depending on the type of food article, the type of delivery device, the amount of loading substance, the desired dosage, preference, and the like. In general, the amount of loading substance desired to be delivered will be a main consideration.
- a microcapsule containing EPA and DHA can be added in such an amount that the food article containing the microcapsule can have from about 10 to about 250 mg of EPA+DHA per serving.
- the food article can have about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, or 250 mg of the loading substance per serving, where any of the stated values can form an upper or lower endpoint when appropriate.
- a delivery device contains large amounts of loading substance, then less of the deliver device needs to be used in the food article to obtain a desired level of a loading substance.
- a deliver device contains small amounts of loading substance, then more of the deliver device will need to be used in the food article to obtain a desired level of a loading substance.
- more loading substance is desired, then more delivery device can be added, and when less loading substance is desired, then less delivery device can be added.
- the food articles can contain other additives and components.
- the food articles disclosed herein can also comprise a probiotic.
- Probiotics are live microorganisms that can be administered to a subject and which can confer a beneficial health effect on the subject.
- suitable probiotics include, but are not limited to, Lactobacillus species, Lactococcus species, and Pediococcus species.
- the probiotic can be one or more bacteria chosen from Lactobacillus acidophilus, Lactobacillus sakei, Lactococcus lactis , and Pediococcus acidilactici . These bacteria can be particularly useful in the methods and compositions disclosed herein because they are food safe (i.e., safe to use in, on, or near foods).
- disclosed herein are methods of delivering a loading substance to a subject by administering to the subject a food article as disclosed herein.
- the disclosed food articles can be used as a source of fatty acids (e.g., omega-3 fatty acids), lowering triglycerides and influencing diabetes related biochemistry.
- disclosed herein are methods of lowering cholesterol levels, triglyceride levels, or a combination thereof in a subject by administering an effective amount of a food article disclosed herein.
- Omega-3 fatty acids are vital to everyday life and function.
- omega-3 fatty acids like cis-5,8,11,14,17-eicosapentaenoic acid (EPA) and cis-4,7,10,13,16,19-docosahexaenoic acid (DHA) on lowering serum triglycerides are well established.
- EPA cis-5,8,11,14,17-eicosapentaenoic acid
- DHA cis-4,7,10,13,16,19-docosahexaenoic acid
- These compounds are also known for other cardioprotective benefits such as preventing cardiac arrhythmias, stabilizing atherosclerotic plaques, reducing platelet aggregation, and reducing blood pressure. See e.g., Dyrberg et al., In: Omega-3 Fatty Acids: Prevention and Treatment of Vascular Disease.
- omega-3 fatty acids can reduce cardiovascular and heart disease risk.
- Other benefits of omega-3 fatty acids are those related to the prevention and/or treatment of inflammation and neurodegenerative diseases, and to improved cognitive development. See e.g., Sugano and Michihiro, “Balanced intake of polyunsaturated fatty acids for health benefits.” J. Oleo Sci. 2001, 50(5):305-11.
- EPA and DHA can be synthesized in the human body from ⁇ -linolenic acid (18:3); however, the conversion rate from this precursor molecule is limited (Muskiet et al., “Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials.” J Nutr. 2004, 134(1):183-6). Accordingly, EPA and DHA in the body are primarily derived from dietary sources (e.g., oily fish). Diets rich in fish oils are known to have many beneficial effects for heart disease, cancer, arthritis, allergies, and other chronic diseases.
- omega-3 fatty acids like EPA and DHA in prevention of cardiovascular disease
- the average daily consumption of these fatty acids by North Americans is estimated to be between 0.1 to 0.2 grams, compared to a suggested daily intake of 0.65 grams to confer benefit
- Webb “Alternative sources of omega-3 fatty acids.” Natural Foods Merchandiser 2005, XXVI (8):40-4). Since altering dietary patterns of populations is difficult and many people do not like to eat fish, dietary supplementation with EPA and DHA is an important approach to addressing this problem.
- many supplements of omega-3 fatty acids are sensitive to oxidation and can be foul smelling and tasting. Further, compliance with dietary supplement regimens requires discipline, which is often wanting.
- the disclosed formulations comprising microcapsules can be used to deliver omega-3 fatty acids to a subject.
- the food articles that are administered can be any of the formulations disclosed herein.
- an “effective amount” of one of the disclosed food articles can be employed in pure form or, where such forms exist, in pharmaceutically acceptable salt form, foodstuff, or other form.
- the specific effective dose level for any particular subject will depend upon a variety of factors including the disorder being treated and the severity of the disorder; the identity and activity of the specific composition employed; the age, body weight, general health, sex and diet of the patient; the time of administration; the route of administration; the rate of excretion of the specific composition employed; the duration of the treatment; drugs used in combination or coincidental with the specific composition employed and like factors well known in the medical arts.
- the effective daily dose can be divided into multiple doses for purposes of administration. Consequently, single dose compositions can contain such amounts or submultiples thereof to make up the daily dose.
- the dosage can be adjusted by the individual physician or the subject in the event of any counterindications. Dosage can vary, and can be administered in one or more dose administrations daily, for one or several days. Guidance can be found in the literature for appropriate dosages for given classes of pharmaceutical products.
- gelatine 275 Bloom type A (isoelectric point of about 9) was mixed with 600 grams of deionized water containing 0.5% sodium ascorbate under agitation at 50° C. until completely dissolved. 5.45 grams of sodium polyphosphate was dissolved in 104 grams of deionized water containing 0.5% sodium ascorbate.
- the emulsion was diluted with 700 grams of deionized water containing 0.5% sodium ascorbate at 50° C.
- the sodium polyphosphate solution was then added into the emulsion and mixed with a Lightning agitator at 600 rpm.
- the pH was then adjusted to 4.5 with a 10% aqueous acetic acid solution.
- a coacervate formed from the gelatine and polyphosphate coated onto the oil droplets to form primary microcapsules. Cooling was carried out to above the gel point of the gelatine and polyphosphate and the primary microcapsules started to agglomerate to form lumps under agitation.
- polymer remaining in the aqueous phase further coated the lumps of primary microcapsules to form an encapsulated agglomeration of microcapsules having an outer shell and having an average size of 50 ⁇ m.
- polymer remaining in the aqueous phase further coated the lumps of primary microcapsules to form an encapsulated agglomeration of microcapsules having an outer shell and having an average size of 50 ⁇ m.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 0.25% sodium ascorbate was used. A payload of 50% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that no ascorbate was used. A payload of 60% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 105 grams of fish oil concentrate was used and a payload of 70% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that it was applied to triglyceride (TG) fish oil (available from Ocean Nutrition Canada Ltd.) rather than ethyl ester fish oil.
- TG triglyceride
- ethyl ester fish oil available from Ocean Nutrition Canada Ltd.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that gelatine (type A) and gum arabic were used as polymer components of the shell material.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 150 Bloom gelatine (type A) and polyphosphate were used as polymer components of the shell material and 105 grams of fish oil concentrate was used to obtain a payload of 70%.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that transglutaminase was used to cross-link the shell material.
- Microencapsulated omega-3 oil (MEG-3TM powder) was provided by Ocean Nutrition Canada (Dartmouth, Canada). Unseasoned potato chips and dry seasoning were provided by Kettle Chip Company (Salem, Oreg.).
- the dry seasoning (at ambient temperature) and microcapsules (at minus 18° C.) were placed in a plastic laboratory tub. The tub was covered and the contents were shaken vigorously by hand for about one minute until the mixture was homogeneous. A commercial blender at low speed for a short period of time can also be used. Since a dry blend can heat during the blending process, it can be desired to keep the mixture cool. See Table 4.
- the unseasoned chips were sprayed with oil (e.g., PAM; ConAgra Foods, Omaha, Nebr.), while tossing the chips with a spatula until about 4% by weight of the oil was sprayed on the chips. It is also possible to use freshly fried chips, since the residual oil can serve as an adhesive for the dry seasonings.
- oil e.g., PAM; ConAgra Foods, Omaha, Nebr.
- the dry seasoning was added to the PAM-sprayed chips while tossing was continued until at least 950% of the dry seasoning had adhered to the chips. In multiple trials, the amount of seasoning pick up was from about 95% to about 99%.
- a standard tumbling drum, where the chips are tossed with dry seasoning added at a pre-determined rate, can also be used. See Table 4.
- the chips were then placed in a gas-barrier pouch, which was flushed with ambient nitrogen gas and sealed.
- Applesauce containing microcapsules was prepared according to the formulation shown in Table 5. Specifically, applesauce was placed into a water-jacketed kettle preheated to 99.5° C. Microencapsulated omega-3 oil (MC601812TG or MC60DHA from Ocean Nutrition Canada; Dartmouth, Canada) was added to the applesauce. A high shear mixer with a rod attachment was positioned in mixture and the mix speed was set at 800 rpm for the batch. The mixture was covered to minimize evaporation and maintained at 90.5° C. for approximately 10 minutes. The hot mixture was then filled into glass containers (125 g serving size). Foil seals were ironed onto the containers and the containers were inverted for 2 minutes or more. The containers were then cooled in an ice water bath and stored refrigerated.
- Apples and banana baby food containing microcapsules was prepared by first blending bananas with citric acid to a target pH of about 4.20-4.30. Then, in a water-jacketed kettle, the bananas were combined with apples and the mixture was pureed to a desired consistency.
- Microencapsulated omega-3 oil (MEG-3TM powder from Ocean nutrition Canada; Dartmouth, Canada; 30-50 mg of EPA+DHA per serving) was blended into the mixture with a hand mixer. The mixture was covered to minimize evaporation and maintained at 91° C. The hot mixture was then filled into glass containers (125 g serving size). Foil seals were ironed onto the containers and the containers were inverted for 2 minutes or more. The containers were then cooled in an ice water bath and stored refrigerated. Taste test revealed that lower levels of EPA+DHA were preferred over higher levels.
- Micromp containing microcapsules were prepared according to the formulation shown in Table 6. Specifically, frozen shrimp were dipped into a predust containing microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada). The shrimp were shaken gently to remove the extra predust adhering to the shrimp. The shrimp were then dipped into the batter and coated with breadcrumbs. Each shrimp took up to about 0.3 g of predust, 0.4 g batter and 1 g breading. The shrimp were then fried in 177° C. oil for approximately 4 minutes. The shrimp were kept frozen in plastic bags until ready to test.
- MEG-3TM powder microencapsulated omega-3 oil
- the shrimp were then dipped into the batter and coated with breadcrumbs. Each shrimp took up to about 0.3 g of predust, 0.4 g batter and 1 g breading.
- the shrimp were then fried in 177° C. oil for approximately 4 minutes. The shrimp were kept frozen in plastic bags until ready to test.
- the shrimp had 175 mg EPA+DHA (350 mg before frying) per serving (about 18 shrimp). In taste test, the flavor was acceptable. Since the microcapsules may interfere with adherence of crust to the shrimp, care should be taken during battering and breading processes.
- Pasteurized process cheese containing microcapsules was prepared according to the formulation shown in Table 7. All dry ingredients were first blended. Then all wet ingredients were gradually blended into the dry ingredients with a whisk. The mixture was heated in a double boiler to about 60° C. Cheese was added to the mixture and melted by heating to about 79-82° C. with mixing. The mixture was vacuum packaged in plastic film pouches to form slices. The pouches were chilled to form and stored refrigerated.
- Microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada) was added with the dry ingredients or the wet ingredients. Both methods produced similar results; although, adding them with the dry ingredients was easier.
- the products had 32 mg of EPA+DHA oil per serving (30 g slice). At these loading levels of EPA+DHA, the products tasted acceptable. Products containing higher levels (50 mg EPA+DHA/serving and higher) had detectable fish flavors, but the fish flavor dissipated somewhat as the product aged.
- a chewy granola bar containing microcapsules was prepared according to the formulation shown in Table 8. Specifically, microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth, Canada) was pre-blended with honey. To account for loss during transfer, a larger amount than needed was prepared based on the following calculation (16.54% microcapsules and honey mixture). The mixture was stirred well and allowed to sit and hydrate. In a large mixing bowl, oats and crisp rice were combined and gently mixed. Oil was drizzled into the mixture while mixing continued. The microcapsules and honey mixture mixed into the mixture and gently stirred for 1 minute. The mixture was spread onto baking sheets coated with non-stick spray and baked at 121° C. in a convection oven for 20 minutes, tossing after 10 minutes. After cooling, the product was stored in an airtight foil package until ready to use.
- MEG-3TM powder from Ocean Nutrition Canada; Dartmouth, Canada
- the product contained 130 mg EPA+DHA per serving (40 g). Fishy flavors were at were least noticeable when the microencapsulated oil was baked with cereals. It appears that cinnamon may have accentuated the fishy flavors. However, the microcapsules baked and blended with honey (or syrup) produced an acceptable flavor.
- a chicken dinner baby food containing microcapsules was prepared according to the formulation shown in Table 9. Specifically, the dry ingredients were blended and set aside. Chicken was boiled, cooled, chopped into small pieces, and then finely ground in a food processor. Egg noodles were cooked, cooled, and set aside. Peas were cooked, cooled, pressed through a sieve, and set aside. Carrots, split peas, chicken fat, oil, and the noodles were blended in a food processor. While blending, the dry ingredients and water were slowly added. The ground chicken was then added and the mixture was blended until the mixture was completely combined and smooth. The product was then filled into to 8 oz glass jars and retorted at 15 psi for 40 minutes. The product was stored at ambient temperature.
- the product contained about 60 mg EPA+DHA per serving (125 g). To avoid shearing and damage of microcapsules, it was found that the baby food base needed to be prepared prior to the addition of microcapsules.
- a potato chip seasoning containing microcapsules was prepared according to the formulation shown in Table 10. Specifically, the ingredients were blended together. The flavors tested included BBQ, sour cream and green onion, and salt and pepper. Then the mixture was applied to potato chips at a level of 12.9%. If there was insufficient residual oil on the chips to allow for the seasoning to properly adhere, oil was sprayed (about 4% by weight) onto the chips to act as an adhesive. The chips were packaged in a nitrogen flushed, metallized film and stored at ambient temperature. The chips contained 130 g of EPA+DHA per serving (30 g of seasoned chips).
- An extruded cereal bar containing microcapsules was prepared according to the formulation shown in Table 11. Specifically, fat was creamed with sugar and liquids ingredients were added. Then the microcapsules were blended with the dry ingredients. All ingredients were combined and mixed to form dough. The dough was extruded with a fruit filling center. The product was baked at 163° C. for approximately 6-7 minutes.
- the product contained 50 mg of EPA+DHA per serving (40 g).
- the product had acceptable flavor at time of manufacture. Further the product flavor was acceptable after 4 months.
- Chicken nuggets containing microcapsules were prepared according to the formulation shown in Table 12. Four batches were prepared: a control, a batch containing 150 mg EPA+DHA per 100 g serving, a batch containing 175 mg EPA+DHA per 100 g serving, and a batch containing 300 mg EPA+DHA per 100 g serving.
- Microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada) was added to soy protein, which was then added to ground chicken meat. The mixture was stirred, formed into nugget shapes, coated with a pre-dust, and then a batter and breading was applied. The product was par-fried for 30 seconds at approximately 196° C. to set the coating and the color.
- the product was then transferred to the oven where it was fully cooked at 177° C. for approximately 3 minutes.
- the cider trim was reduced to compensate for the added microcapsules.
- the final weight of each batch was 400 kg.
- the final product was packaged in clear plastic bags and stored frozen until consumption.
- the preparation instructions for the product include reheating in the oven at 220° C. for 10-15 minutes, microwaved, or deep-fried.
- Cider trim 253.94 Skin and fat 14.50 Soy protein FX 213 20.25 Water 107.78 Salt 3.57 Total 400.00
- the samples were evaluated monthly for sensory attributes, color, and pH during a 12-month shelf life.
- the samples were evaluated initially for difference from control and at the end of shelf life for acceptability.
- the samples were also tested at the beginning and end of shelf life for EPA+DHA and moisture content.
- the EPA+DHA and moisture contents of the nuggets remained constant throughout the shelf life. No significant difference was found between the nuggets containing 300 mg of EPA+DHA per serving and the control, at the beginning of the shelf life. At the end of the 12-month shelf life, panelists indicated that they “liked very much” the nuggets containing 300 mg EPA+DHA per serving. The sample nuggets had similar stability to the control nuggets. High levels of EPA+DHA can be added per serving without affecting the sensory and physical attributes of the nuggets or the overall stability.
- Soymilk containing microcapsules was prepared using an automatic soymilk maker. Two batches of soymilk were produced, one control and one containing 250 mg EPA+DHA per 250 mL serving. Specifically, 85 g of dry soybeans were soaked in tap water overnight. The soaked beans were drained and rinsed. 1.5 L of water was poured into the soymilk maker and the beans were placed in the filter cup. The soymilk maker was then started. The soymilk was collected and the spent beans discarded. The soymilk was cooled. Microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada) was added and the soy milk was pasteurized at 85° C. for 5 sec. Pasteurization and addition of MEG-3TM powder to plain soymilk helped to reduce beany off-notes.
- MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada
- soymilk Three more batches of soymilk were produced as just described: pasteurized soymilk, pasteurized soymilk with 1 cm 3 salt and 30 cm 3 sugar, pasteurized soy milk with microencapsulated omega-3 oil, 1 cm 3 salt and 30 cm 3 sugar (the salt and sugar were added to the soymilk after pasteurization).
- Pasteurized soy milk containing salt and sugar tasted similar to commercial soymilks.
- the pasteurized soy milk containing microcapsules, salt and sugar was slightly less sweet but tasted better than the pasteurized soymilk containing no salt and sugar.
- Soymilk was an acceptable beverage for the addition of microcapsules. No off-flavors or odors attributable to the powder were observed, even at 250 mg EPA+DHA per serving. Some of the typical soy beany flavor was masked by the microcapsules.
- Frozen waffles containing microcapsules were prepared according to the formulation shown in Table 13. Specifically, the dry ingredients were blended together. Water, melted butter, and vanilla were then added to the dry mix. After mixing the ingredients together, the batter was placed onto oil brushed waffle maker and baked for 70 seconds. The waffles were removed from the waffle maker and placed into plastic pouches, separated by wax paper, and frozen.
- the waffles had about 130 mg of EPA+DHA per 85 g serving. Flavor in both levels were acceptable in first round tastings. Plain and blueberry waffles were also prepared. An apple cinnamon flavor was included in early development, but cinnamon seems to enhance off flavors. Cinnamon should not be used as a flavor for this type of product.
- Granola cereal containing microcapsules were prepared according to the formulation shown in Table 14.
- Microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth, Canada) was blended with honey. The mixture was stirred well and the mixture was allowed to hydrate. Vanilla was then added to the mixture and mixed well. Brown sugar, flour, cinnamon, and nonfat dry milk were slowly stirred for 1 minute. Oats, sunflower seeds, almonds, and sesame seeds were then added. Raisins were added at the end of baking to cooled granola. Oil was heated to 43° C. and drizzled into a bowl while continuing to stir for 1 minute. The microcapsules, vanilla, and honey mixture were heated to 60° C. and drizzled into the mixture.
- the mixture was spread onto uncoated baking sheets.
- the mixture was baked 121° C. in a convection oven on low fan for 30 minutes.
- the mixture was then tossed after 15 minutes. After cooling, the granola was stored in an airtight container until ready to use.
- the granola cereal contained about 50 mg EPA+DHA per serving (55 g). While fishy flavors were noticeable when the cereal was fresh, this dissipated over 10-12 days. The cinnamon may have accentuated the fishy flavors. Samples tasted in milk did not have any off flavors.
- Gummy Candies containing microcapsules were prepared according to the formulation shown in Table 15. Specifically, sugar, corn syrup, microencapsulated omega-3 oil (MEG-3TM powder from Ocean Nutrition Canada; Dartmouth Canada) and water were mixed together in a cooking vessel. The mixture was brought to a boil at 118° C. The mixture was removed from heat and cooled to 96° C. Gum mucilage was vigorously stirred into the syrup to create a homogenous blend. Gum mucilage was prepared by adding gelatin to water and holding in a water bath at 60° C. for one hour or until the solution was clear. The solution was kept warm (above 54° C.) until ready for use in gummy candies. Flavor, color and acid solution was added and the mixture was blended well.
- the mixture was then placed in starch molds and allowed to set for 48 hours at room temperature.
- the resulting gummy were removed from the molds and lightly oiled with a 1:3 blend of mineral/coconut oil.
- the product was allowed to age for 2 days before packaging in a nitrogen purged, metallized film.
- Gummy candies containing about 50, 100, and 130 mg EPA+DHA per serving (40 g) were tried. Lower levels gave favorable results.
- different methods of addition of the microcapsules were tried, such as soaking with gelatin in mucilage, boiling with syrup, and boiling in water for 5 minutes prior to addition of syrup. Addition of the microcapsules to the mucilage produced a grainy texture and soft gel. Boiling of the microcapsules in water prior to addition of syrup actually provided the best results.
- Pasta sauce containing microcapsules were prepared according to the formulation shown in Table 16. Specifically, the wet ingredients were mixed together and the dry ingredients were mixed together. The dry band wet mixtures were then combined. The mixture was heated to 88° C. and held at that temperature for 1 minute. The mixture was then poured into glass jars.
- Samples containing about 100 mg, 120 mg, and 130 mg EPA+DHA per serving (125 g) were prepared. No fishy flavors were detected at any levels initially or after 3 months of storage.
- a Strawberry Yogurt Smoothie (serving size of 8 fl oz; about 226 g) incorporating microencapsulated omega-3 fatty acids (1812TG Omega-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 17.
- the product had a 130 mg dosage of EPA+DHA per serving.
- a second smoothie was prepared according to the formulation in Table 6. Specifically, 1% milk, starch, gelatin, and whey protein were mixed together. The microcapsules were then sprinkled over the surface and allowed to hydrate for 5 minutes. The mixture was then heated to 55° C. and homogenized at a total pressure of 2,300 psi (first stage at 1,800 psi and second stage at 500 psi). The homogenized formulation was then pasteurized at 86° C. for 30 minutes and cooled to 38° C. Yogurt culture mixed with 2% milk was added to the homogenized/pasteurized formulation and incubated at 38° C. for approximately 10 hours, or until the mixture reached a pH of 4.5.
- the resulting mixture was then mixed with a fruit preparation and heated to 88° C. Then, the mixture was again homogenized at a total pressure of 2,500 psi (first stage at 2,000 psi and second stage at 500 psi). The mixture was chilled and stored refrigerated until ready to use.
- a batch of orange juice (18 servings; each serving size being 250 g) incorporating microencapsulated omega-3 fatty acids (1812TG Omega-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 19. Specifically, the microcapsules were sprinkled on the surface of orange juice in a blend tank equipped with an agitator providing a minimum of 30 rpm. The juice was blended for 5 minute. Afterwards, the juice was pasteurized at 91° C. for 17 seconds with a flow rate of 212 L/minute. The pasteurized juice was filled into gable top containers and stored refrigerated.
- the orange juice contained 100 mg of EPA+DHA (120 mg of total omega-3 fatty acids) per serving. In taste tests there was no perceptible difference in taste, texture, or quality between the omega-3 orange juice and the control.
- a chocolate frozen dairy dessert (serving size of 1 ⁇ 2 cup; about 118 mL) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 20.
- the product had a 100 mg dosage of EPA+DHA per serving.
- the ice cream had a start weight per 4 fl. oz of 150, end weight per 4 fl. oz of 90, and overrun of 67.00%.
- the ice cream had 100 mg of EPA+DHA per 118 mL serving. Further, each serving of the ice cream contained 200,000,000 colony forming units (CFU) of probiotic per serving.
- CFU colony forming units
- the nutritional facts of the ice cream are as follows: 150 calories (45 from fat); 5 g of total fats (3 g from saturated fat; 0 g from trans fat); 20 mg of cholesterol; 40 mg of sodium; 19 g of total carbohydrates (less than 1 g of dietary fiber; 18 g from sugar); and 7 g of protein.
- the ice cream also contained 6% vitamin A, 15% vitamin C, 15% calcium, and 4% iron, which are percent daily values based on a 2000 calorie diet.
- a strawberry frozen dairy dessert (serving size of 1 ⁇ 2 cup; about 118 mL) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 21.
- the product had a 100 mg dosage of EPA+DHA per serving.
- the ice cream had a start weight per 4 fl. oz of 150, end weight per 4 fl. oz of 95, and overrun of 65.00%.
- the ice cream had 100 mg of EPA+DHA per 118 mL serving. Further, each serving of the ice cream contained 200,000,000 colony forming units (CFU) of probiotic per serving.
- CFU colony forming units
- the nutritional facts of the ice cream are as follows: 150 calories (40 from fat); 4.5 g of total fats (2.5 g from saturated fat; 0 g from trans fat); 20 mg of cholesterol; 35 mg of sodium; 21 g of total carbohydrates (0 g of dietary fiber; 18 g from sugar); and 6 g of protein.
- the ice cream also contained 6% vitamin A, 20% vitamin C, 15% calcium, and 0% iron, which are percent daily values based on a 2000 calorie diet.
- Microwave popcorn serving size of 30 g
- microencapsulated omega-3 fatty acids MAG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada
- the product had a 32 mg dosage of EPA+DHA per serving.
- fat was melted at about 49° C. While stirring and maintaining heat, annatto color was then added to the melted fat. In a separate container, all dry ingredients were blended together. The dry ingredients were then added to the melted fat. Popcorn was then placed into a microwave popcorn bag. The fat-dry ingredient slurry, which contained the microencapsulated omega-3 oil, was deposited into the bag (30 g per bag). The bag was sealed and folded into thirds. The fat was allowed to harden.
- Country style baked beans serving size of 1 ⁇ 2 cup, about 130 g
- microencapsulated omega-3 fatty acids (1812TG powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Tables 23 and 24.
- the product had a 32 mg dosage of EPA+DHA (0.2133 g powder) per serving.
- beans were rinsed well and soaked at ambient temperature overnight in water (3 ⁇ volume of beans). Next, a large pot of water was brought to a boil. The beans were drained and then added to the boiling water. The beans were boiled for 5 minutes. The boiling water was drained and the beans were rinsed with cold water. The beans were then drained in a colander for 15 minutes before transferring to the cans.
- the country style sauce was prepared according to the formulation in Table 23.
- the dry ingredients were weighed and then pre-blended in a saucepan. Water was added to the dry ingredients in the saucepan and the mixture was blended well. Molasses and pork base was added next and the mixture was blended. The sauce was brought to a simmer (>91° C.) for 5 minutes to thicken the starch. The saucepan was cooled in an ice water bath and brought to a 100% yield. The sauce had a pH of 5.6 and brix of 22.5.
- the beans were then prepared according to the formulation in Table 24.
- the beans were weighed into a can.
- the sauce was also weighed into the can.
- the mixture was topped with a piece of salt pork and the can was sealed.
- Water was added to a retort and the cans were layered into the retort.
- the water was brought to a boil and the retort lid was sealed.
- the retort vented with steam escaping through a vent for 15 minutes and then a temperature gauge was placed on top. Once the temperature reached 121° C. (15 psi), the beans were retorted for 60 minutes. Heat was then removed and the gauge was vented until ambient pressure was reached.
- the lid was removed and the cans were transferred to an ice water bath. After samples were cold, they were dried and stored under refrigeration.
- Gummy bears serving size of 2 g per gummy bear
- microencapsulated omega-3 fatty acids MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada
- the product had a 15 mg dosage of EPA+DHA per 2 g serving.
- the omega-3 powder was dispersed in water and stirred until completely dissolved. Gelatin was added and melted in a water bath at 77° C. Next, sugar, corn syrup, and water were weighed together in a cooking vessel. The mixture was brought to a boil and the sides of the pot were washed of any crystals. Boiling was continued until 90% solids (118° C.). The pot was removed from the heat and cooled to 96° C. Gum mucilage was added to and blended with the cooked syrup. Flavor, color, and acid solution were added next and blended well. The resulting mixture was deposited into dry starch molds and allowed to set for 48 hours at room temperature. The gummies were removed from the molds and excess starch was brushed off. The gummies were brushed lightly with capol and allowed to age for 2 days before packaging. The cooked yield was 90.16%.
- a natural lemon chew (serving size of 5.6 g) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 26.
- the product had a 100 mg dosage of EPA+DHA per 5.6 g serving.
- egg protein was solubilized in the first measure of water.
- sugar and the first measure of corn syrup was brought to a boil.
- the boiled syrup was slowly added to the mixer bowl while mixing on low speed. After all syrup had been added, the speed was increased to maximum speed and the mixture was whipped until the volume was at maximum.
- palm oil was melted to clarity and combined with 80% of the omega-3 powder, until thickening began.
- the resulting paste was stirred until all dry ingredients were evenly coated with fat.
- An orange chew (serving size of 5.6 g) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 27.
- the product had a 100 mg dosage of EPA+DHA per 5.6 g serving.
- egg protein was solubilized in the first measure of water.
- sugar and the first measure of corn syrup was brought to a boil.
- the boiled syrup was slowly added to the mixer bowl while mixing on low speed. After all syrup had been added, the speed was increased to maximum speed and the mixture was whipped until the volume was at maximum.
- palm oil was melted to clarity and combined with 80% of the omega-3 powder, until thickening began.
- the resulting paste was stirred until all dry ingredients were evenly coated with fat.
- Pasta (serving size of 150 g) incorporating microencapsulated omega-3 fatty acids (1812 TG powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 28.
- the product had a 32 mg dosage of EPA+DHA per 140 g serving.
- Flour and omega-3 powder were mixed together in one container. Eggs and water were combined in a separate container. The wet ingredients were slowly poured into the dry ingredients as they were mixed in a mixer equipped with a dough hook. The resulting dough was kneaded for about 30 seconds. The dough was then covered with plastic wrap and allowed to stand for 45 minutes. The dough was then sheeted into fettuccini sized noodles and dried for from 20 minutes to 1 hour. To cook the noodles, water was brought to a rolling boil and the noodles were added. After 3.5 minutes, the water was drained and the cooked noodles were rinsed under cold water.
Abstract
Description
- This application claims the benefit of priority to U.S. Provisional Patent Application 60/697,092, filed Jul. 7, 2005, U.S. Provisional Patent Application 60/811,830, filed Jun. 8, 2006, U.S. Provisional Patent Application 60/811,503, filed Jun. 7, 2006, and U.S. Utility application Ser. No. 11/435,605, filed May 17, 2006, which are all incorporated by reference herein in their entireties.
- The disclosure generally relates to food articles comprising delivery devices. Methods of preparing such food articles are also disclosed.
- Polyunsaturated fatty acids, for example, omega-3 fatty acids, are vital to everyday life and function. Such compounds play critical roles in the structure of cell membranes and they form the foundation for the synthesis of many cell mediators (e.g., prostaglandins and leukotrienes). These cell mediators are an important part of human physiology and can affect, for example, cell proliferation, cell signaling, gene expression, coagulation, and inflammation.
- As an example, omega-3 fatty acids and their derivates are known to be primary components of brain and nerve tissue. Also, omega-3 fatty acids can reduce thrombogenisis and inflammation by altering certain pathways leading to the production of inflammatory mediators (e.g., prostaglandins, leukotrienes and thromboxanes). See e.g., Sugano, Michihiro. “Balanced intake of polyunsaturated fatty acids for health benefits.” Journal of Oleo Science (2001), 50(5):305-311. Further, omega-3 fatty acids are known to positively affect heart function, hemodynamics, and arterial endothelial function. The American Heart Association has reported that omega-3 fatty acids can reduce cardiovascular and heart disease risk.
- The primary source of such polyunsaturated fatty acids is through diet. Diets rich in polyunsaturated fatty acids like omega-3 fatty acids are known to have beneficial effects for heart disease, cancer, arthritis, allergies, and other chronic diseases. (See e.g., The American Heart Association, Scientific Statement, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease,” November 2002; Radack et al., “The effects of low doses of omega-3 fatty acid supplementation on blood pressure in hypertensive subjects: a randomized controlled trial.” Arch. Intern. Med. (1991) 151:1173-1180; Appel et al., “Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials. Arch. Intern. Med. (1993) 153(12): 1429-1438; GISSI-Prevenzione Investigators. “Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.” Lancet (1999) 354:447-455.)
- The American Heart Association has recommended that people may need 2 to 4 grams of omega-3 fatty acids per day. Unfortunately, most western diets are deficient in these beneficial fatty acids. Even a 1 gram/day dose may be more than can readily be achieved through diet alone. Thus, people who desire to increase their intake of such polyunsaturated fatty acids typically turn to dietary supplements. Such supplements, however, are usually sensitive to oxidation and can be foul smelling and tasting. Further, compliance with dietary supplement regimens requires discipline, which is often wanting.
- In light of the health benefits of polyunsaturated fatty acids and the problems associated with adequate intake of such compounds, what is needed in the art are food articles containing beneficial compounds such as, for example, polyunsaturated fatty acids and which are more palatable and pleasing to the consumer. The subject matter disclosed herein meets these and other needs.
- In accordance with the purposes of the disclosed materials, compounds, compositions, articles, and methods, as embodied and broadly described herein, the disclosed subject matter, in one aspect, relates to compounds and compositions and methods for preparing and using such compounds and compositions. In a further aspect, the disclosed subject matter relates to articles of food comprising delivery devices. In a still further aspect, the disclosed subject matter relates to methods of preparing such food articles. In yet a further aspect, the disclosed subject matter relates to homogenized formulations that comprise microcapsules, and to food articles prepared with or comprising homogenized formulations. In a still further aspect, the disclosed subject matter relates to methods of making and using the disclosed homogenized formulations and food articles prepared from and comprising them.
- Additional advantages will be set forth in part in the description that follows, and in part will be obvious from the description, or may be learned by practice of the aspects described below. The advantages described below will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive.
- The accompanying figures, which are incorporated in and constitute a part of this specification, illustrate several aspects described below.
-
FIG. 1 is a schematic of a process for applying the disclosed microencapsulated nutrients on to chips. - The materials, compounds, compositions, articles, and methods described herein can be understood more readily by reference to the following detailed description of specific aspects of the disclosed subject matter and the Examples included therein and to the FIGURE.
- Before the present materials, compounds, compositions, articles, and methods are disclosed and described, it is to be understood that the aspects described below are not limited to specific synthetic methods or specific reagents, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting.
- Also, throughout this specification, various publications are referenced. The disclosures of these publications in their entireties are hereby incorporated by reference into this application in order to more fully describe the state of the art to which the disclosed matter pertains. The references disclosed are also individually and specifically incorporated by reference herein for the material contained in them that is discussed in the sentence in which the reference is relied upon.
- In this specification and in the claims that follow, reference will be made to a number of terms, which shall be defined to have the following meanings:
- Throughout the description and claims of this specification the word “comprise” and other forms of the word, such as “comprising” and “comprises,” means including but not limited to, and is not intended to exclude, for example, other additives, components, integers, or steps.
- As used in the description and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to “a compound” includes mixtures of two or more such compounds, reference to “an omega-3 fatty acid” includes mixtures of two or more such omega-3 fatty acids, reference to “the microcapsule” includes mixtures of two or more such microcapsules, and the like.
- “Optional” or “optionally” means that the subsequently described event or circumstance can or cannot occur, and that the description includes instances where the event or circumstance occurs and instances where it does not.
- Ranges can be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint. It is also understood that there are a number of values disclosed herein, and that each value is also herein disclosed as “about” that particular value in addition to the value itself. For example, if the value “10” is disclosed, then “about 10” is also disclosed. It is also understood that when a value is disclosed that “less than or equal to” the value, “greater than or equal to the value” and possible ranges between values are also disclosed, as appropriately understood by the skilled artisan. For example, if the value “10” is disclosed, then “less than or equal to 10” as well as “greater than or equal to 10” is also disclosed. It is also understood that throughout the application data are provided in a number of different formats and that these data represent endpoints and starting points and ranges for any combination of the data points. For example, if a particular data point “10” and a particular data point “15” are disclosed, it is understood that greater than, greater than or equal to, less than, less than or equal to, and equal to 10 and 15 are considered disclosed as well as between 10 and 15. It is also understood that each unit between two particular units are also disclosed. For example, if 10 and 15 are disclosed, then 11, 12, 13, and 14 are also disclosed.
- References in the specification and concluding claims to parts by weight of a particular element or component in a composition denotes the weight relationship between the element or component and any other elements or components in the composition or article for which a part by weight is expressed. Thus, in a compound containing 2 parts by weight of component X and 5 parts by weight component Y, X and Y are present at a weight ratio of 2:5, and are present in such ratio regardless of whether additional components are contained in the compound.
- A weight percent of a component, unless specifically stated to the contrary, is based on the total weight of the formulation or composition in which the component is included.
- As used herein, by a “subject” is meant an individual. Thus, the “subject” can include domesticated animals (e.g., cats, dogs, etc.), livestock (e.g., cattle, horses, pigs, sheep, goats, etc.), laboratory animals (e.g., mouse, rabbit, rat, guinea pig, etc.), and birds. “Subject” can also include a mammal, such as a primate or a human.
- Reference will now be made in detail to specific aspects of the disclosed materials, compounds, compositions, articles, and methods, examples of which are illustrated in the accompanying Examples and FIGURE.
- Certain materials, compounds, compositions, and components disclosed herein can be obtained commercially or readily synthesized using techniques generally known to those of skill in the art. For example, the starting materials and reagents used in preparing the disclosed compounds and compositions are either available from commercial suppliers such as Ocean Nutrition Canada (Dartmouth, Nova Scotia), Aldrich Chemical Co., (Milwaukee, Wis.), Acros Organics (Morris Plains, N.J.), Fisher Scientific (Pittsburgh, Pa.), or Sigma (St. Louis, Mo.) or are prepared by methods known to those skilled in the art following procedures set forth in references such as Fieser and Fieser's Reagents for Organic Synthesis, Volumes 1-17 (John Wiley and Sons, 1991); Rodd's Chemistry of Carbon Compounds, Volumes 1-5 and Supplementals (Elsevier Science Publishers, 1989); Organic Reactions, Volumes 1-40 (John Wiley and Sons, 1991); March's Advanced Organic Chemistry, (John Wiley and Sons, 4th Edition); and Larock's Comprehensive Organic Transformations (VCH Publishers Inc., 1989).
- Also, disclosed herein are materials, compounds, compositions, and components that can be used for, can be used in conjunction with, can be used in preparation for, or are products of the disclosed methods and compositions. These and other materials are disclosed herein, and it is understood that when combinations, subsets, interactions, groups, etc. of these materials are disclosed that while specific reference of each various individual and collective combinations and permutation of these compounds may not be explicitly disclosed, each is specifically contemplated and described herein. For example, if a compound is disclosed and a number of modifications that can be made to a number of components of the compound are discussed, each and every combination and permutation that are possible are specifically contemplated unless specifically indicated to the contrary. Thus, if a class of components A, B, and C are disclosed as well as a class of components D, E, and F and an example of a combination compound A-D is disclosed, then even if each is not individually recited, each is individually and collectively contemplated. Thus, in this example, each of the combinations A-E, A-F, B-D, B-E, B-F, C-D, C-E, and C-F are specifically contemplated and should be considered disclosed from disclosure of A, B, and C; D, E, and F; and the example combination A-D. Likewise, any subset or combination of these is also specifically contemplated and disclosed. Thus, for example, the sub-group of A-E, B-F, and C-E are specifically contemplated and should be considered disclosed from disclosure of A, B, and C; D, E, and F; and the example combination A-D. This concept applies to all aspects of this disclosure including, but not limited to, steps in methods of making and using the disclosed compositions. Thus, if there are a variety of additional steps that can be performed it is understood that each of these additional steps can be performed with any specific aspect or combination of aspects of the disclosed methods, and that each such combination is specifically contemplated and should be considered disclosed.
- Disclosed herein are food articles that comprise one or more delivery devices. A delivery device, as is more fully described herein, can contain a loading substance that is to be delivered to a subject upon eating/drinking the food article. The disclosed food articles can be any article that can be consumed (e.g., eaten, drank, or ingested) by a subject. For example, the food article can be a composition for human and animal consumption, including foods/beverages for consumption by agricultural animals, pets and zoo animals. It can be desired that the food article be a palatable and popular food article. By using food articles that are widely accepted, compliance with dietary or dosage regimens for the loading substance can be increased.
- Those of ordinary skill in the art of preparing and selling food articles (i.e., edible foods or beverages, or precursors thereof) are well aware of a large variety of classes, subclasses, and species of food articles, and utilize well-known and recognized terms of art to refer to those articles while endeavoring to prepare and sell variations of those articles. Such a list of terms of art is enumerated below, and it is specifically contemplated hereby that the various delivery devices disclosed herein can be used to deliver a loading substance to a subject by incorporating the delivery device(s) into or on a food article as listed herein, either singly or in all reasonable combinations or mixtures thereof:
- One or more confectioneries, chocolate confectionery, tablets, countlines, bagged selflines/softlines, boxed assortments, standard boxed assortments, twist wrapped miniatures, seasonal chocolate, chocolate with toys, alfajores, other chocolate confectionery, mints, standard mints, power mints, boiled sweets, pastilles, gums, jellies and chews, toffees, caramels and nougat, medicated confectionery, lollipops, liquorice, other sugar confectionery, gum, chewing gum, sugarized gum, sugar-free gum, functional gum, bubble gum, bread, packaged/industrial bread, unpackaged/artisanal bread, pastries, cakes, packaged/industrial cakes, unpackaged/artisanal cakes, cookies, chocolate coated biscuits, sandwich biscuits, filled biscuits, savory biscuits and crackers, bread substitutes, breakfast cereals, RTE (ready-to-eat) cereals, family breakfast cereals, flakes, muesli, other RTE cereals, children's breakfast cereals, hot cereals, sweet and savory snacks, fruit snacks, chips/crisps, extruded snacks, tortilla/corn chips, popcorn, pretzels, nuts, other sweet and savory snacks, snack bars, granola bars, breakfast bars, energy bars, fruit bars, other snack bars, meal replacement products, slimming products, convalescence drinks, ready meals, canned ready meals, frozen ready meals, dried ready meals, chilled ready meals, dinner mixes, dessert mixes, frozen pizza, chilled pizza, soup, canned soup, dehydrated soup, instant soup, chilled soup, frozen soup, pasta, canned pasta, dried pasta, chilled/fresh pasta, noodles, plain noodles, instant noodles, frozen noodles, cups/bowl instant noodles, pouch instant noodles, chilled noodles, snack noodles, canned food, canned meat and meat products, canned fish/seafood, canned vegetables, canned tomatoes, canned beans, canned fruit, canned ready meals, canned pasta, other canned foods, frozen food, frozen processed red meat, frozen processed poultry, frozen processed fish/seafood, frozen processed vegetables, frozen meat substitutes, frozen potatoes, oven baked potato chips, other oven baked potato products, non-oven frozen potatoes, frozen bakery products, frozen desserts, other frozen food, dried food, chilled processed meats, chilled fish/seafood products, chilled processed fish, chilled coated fish, chilled smoked fish, chilled lunch kit, chilled/fresh pasta, chilled noodles, oils and fats, olive oil, vegetable and seed oil, cooking fats, butter, margarine, spreadable oils and fats, functional spreadable oils and fats, sauces, dressings and condiments, tomato pastes and purees, bouillon/stock cubes, stock cubes, gravy granules, liquid stocks and fonds, herbs and spices, fermented sauces, soy based sauces, pasta sauces, wet sauces, dry sauces/powder mixes, ketchup, mayonnaise, regular mayonnaise, mustard, salad dressings, regular salad dressings, low fat salad dressings, vinaigrettes, dips, pickled products, other sauces, dressings and condiments, spreads, jams and preserves, honey, chocolate spreads, nut-based spreads, and yeast-based spreads.
- Some other specific examples of suitable food articles include, but are not limited to, fruit, vegetable, meat, a grain food, a starch food, a confectionery such as sweets (hard and soft candy, jelly, jam, candy bar, etc.), gum, a baked confectionery or molded confectionery (cookie, biscuit, etc.), a steamed confectionery, a cacao or cacao product (chocolate and cocoa), a frozen confectionery (ice cream, ices, etc.), a beverage (fruit juice, soft drink, carbonated beverage, health drink), a health or nutritional bar, baked good, pasta, a milk product, a cheese product, an egg product, a condiment, a soup mix, a snack food, a nut product, a plant protein product, a poultry product, a granulated sugar (e.g., white or brown), a sauce, a gravy, a syrup, a dry beverage powder, a fish product, or pet companion food. In other examples, a suitable food article can include, but is not limited to, bread, tortillas, cereal, sausage, chicken, ice cream, yogurt, milk, salad dressing, rice bran, fruit juice, a dry beverage powder, rolls, cookies, crackers, fruit pies, or cakes. In some particular examples, the food article can be a chip (potato chip, corn chip, tortilla chip, etc.), pretzel, cracker, and the like. In still other examples, the food article can include, but is not limited to, frozen foods (e.g., frozen vegetables). In a further example, the food article is a salty, savory snack food such as, for example, a rice cake or popcorn.
- Further examples of food articles that can contain delivery devices, as disclosed herein, can be the in the Wet Soup Category, the Dehydrated and Culinary Food Category, the Beverage Category, the Frozen Food Category, the Snack Food Category, and seasonings or seasoning blends.
- “Wet Soup Category” means wet/liquid soups regardless of concentration or container, including frozen soups. For the purpose of this definition soup(s) means a food prepared from meat, poultry, fish, vegetables, grains, fruit and other ingredients, cooked in a liquid, which may include visible pieces of some or all of these ingredients. It may be clear (as a broth) or thick (as a chowder), smooth, pureed or chunky, ready-to-serve, semi-condensed or condensed and can be served hot or cold, as a first course or as the main course of a meal or as a between meal snack (sipped like a beverage). Soup can be used as an ingredient for preparing other meal components and can range from broths (consommé) to sauces (cream or cheese-based soups).
- “Dehydrated and Culinary Food Category” means: (i) Cooking aid products such as: powders, granules, pastes, concentrated liquid products, including concentrated bouillon, bouillon and bouillon like products in pressed cubes, tablets or powder or granulated form, which are sold separately as a finished product or as an ingredient within a product, sauces and recipe mixes (regardless of technology); (ii) Meal solutions products such as: dehydrated and freeze dried soups, including dehydrated soup mixes, dehydrated instant soups, dehydrated ready-to-cook soups, dehydrated or ambient preparations of ready-made dishes, meals and single serve entrees including pasta, potato and rice dishes; and (iii) Meal embellishment products such as: condiments, marinades, salad dressings, salad toppings, dips, breading, batter mixes, shelf stable spreads, barbecue sauces, liquid recipe mixes, concentrates, sauces or sauce mixes, including recipe mixes for salad, sold as a finished product or as an ingredient within a product, whether dehydrated, liquid or frozen.
- “Beverage Category” means beverages, beverage mixes, and concentrates including, but not limited to, alcoholic and non-alcoholic beverages, ready to drink and dry powdered beverages, carbonated and non-carbonated beverages, e.g., sodas, fruit or vegetable juices.
- Also disclosed herein are methods for preparing a homogenized formulation that comprises providing a pre-homogenized composition comprising one or more delivery devices (e.g., microcapsules) and homogenizing the composition. In these methods, the delivery devices are present in the pre-homogenized composition prior to homogenization. Thus, when the pre-homogenized composition undergoes homogenization, as disclosed herein, the delivery devices are present during and subjected to the homogenization process. Further, in many examples disclosed herein the homogenized formulations are further processed (e.g., pasteurized/sterilized). Thus, the disclosed homogenized formulations can also be pasteurized or sterilized formulations. In many examples, the disclosed homogenized formulations can be incorporated into (e.g., used to prepare) many of the food articles disclosed herein. For example, disclosed herein are combinations of food articles and homogenized formulations.
- In the disclosed homogenized formulations, the amount of delivery devices in a homogenized formulation can be at least 50% of the amount of delivery devices in a pre-homogenized composition. In other examples, the amount of delivery devices in a homogenized formulation can be at least about 55, 60, 65, 70, 75, 80, 85, 90, 95, 97, 98, or 99% of the amount of delivery devices in a pre-homogenized composition, where any of the stated values can form an upper or lower endpoint of a range. The amount of delivery devices in the disclosed homogenized formulations and pre-homogenized compositions can be determined by methods known in the art (for example, see the Examples disclosed herein).
- The disclosed homogenized formulations and methods have certain advantages over many existing compositions. For example, by having delivery devices present in the “crude” starting material (i.e., prior to homogenization and, in some cases, prior to other processing techniques such as pasteurization or sterilization), a plant's existing processing streams can be used, thus avoiding costly modifications to most existing designs where pasteurization is performed directly before or after homogenization. Another advantage is that the delivery devices are subjected to the homogenization process (and, in other examples, pasteurization and sterilization processes as well). This can avoid regulatory issues that surround methods where delivery devices (or other additives) are added after pasteurization/sterilization, which usually require that the product be re-pasteurized or re-sterilized.
- Further advantages of certain homogenized formulations (e.g., dairy formulations) and methods disclosed herein can include a narrower particle size distribution of the delivery devices in the homogenized formulations as compared to formulations where the delivery devices were added after homogenization and thus not homogenized. Also, when the homogenized formulations are pasteurized, as is typically done for dairy products, milk proteins can assemble around the outer shell of the delivery devices during pasteurization. The degree and amount of assembly is believed to be dependent on the time and temperature of pasteurization. The assembly of the milk proteins (e.g. whey proteins and caesins) can improve the flavor of the formulation, since such proteins are known to be good absorbers of certain flavors and odors. Also, the associated milk proteins can provide further stability to the delivery devices and their contents.
- In the disclosed methods, the pre-homogenized composition can be any fluid that is to be homogenized. Thus, the disclosed methods are not intended to be limited in any way by the particular pre-homogenized compositions. For example, the pre-homogenized composition can be any comestible, cosmetic, pharmaceutical, nutritional, or health care product that is to be homogenized. In certain specific examples, the pre-homogenized composition can be a dairy product (e.g., milk).
- It is understood that suitable pre-homogenized compositions can have already been homogenized one or more times before. As long as these compositions are to be homogenized at least once again, they are acceptable pre-homogenized compositions for the disclosed methods.
- The pre-homogenized can also be either pasteurized or un-pasteurized. For example, a dairy composition that is pasteurized, but has yet to be homogenized, is a suitable pre-homogenized composition. Also, a dairy composition that has yet to be either homogenized or pasteurized (in any order) is a suitable pre-homogenized composition.
- The disclosed pre-homogenized compositions, as well as the resulting homogenized formulations and food articles provided therefrom, can comprise one or more delivery devices, as described herein. In some examples the disclosed pre-homogenized compositions and resulting homogenized formulations can comprise the same type of delivery devices and, in other examples, different types of delivery devices (e.g., microcapsules containing different loading substances).
- Some specific examples of homogenized formulations disclosed herein comprise microcapsules having about 130 mg of DHA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 5:25 oil derived from tuna and/or bonito) and the outer shell of the microcapsules comprises pork or fish gelatin. In another specific example, the homogenized formulations disclosed herein comprise a microcapsule having about 150 mg of DHA and EPA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 18:12 oil derived from sardine and/or anchovy) and the outer shell of the microcapsules comprises pork or fish gelatin. Any of these formulations can be infant formula, milk, or yogurt formulations for example.
- Any of the disclosed delivery devices can be added to any of the disclosed pre-homogenized compositions. The particular method of addition will depend on the particular pre-homogenized composition, the particular delivery devices, the homogenized composition, including its end use and methods and apparatus of preparation, as well as preference. The disclosed methods are not intended to be limited by any particular method of adding microcapsules to the pre-homogenized composition. In some example, the delivery devices are manually added or poured into the pre-homogenized composition (or added to a homogenized composition that is to be homogenized again). In other example, the delivery devices or solutions thereof can be pumped into the pre-homogenized compositions or added via a hopper. Other suitable methods of adding the delivery devices into the pre-homogenized composition are known in the art. Further, mixing can be also be desired in order to fully incorporate the delivery devices into the pre-homogenized compositions. Such mixing can also be accomplished by methods known in the art such as, but not limited to, mechanical stirrers, magnetic stirrers, shakers, bubbling gas, sonication, vortexing, and the like.
- The particular amount of delivery devices that can be present in the pre-homogenized compositions will depend on the preference and the particular end use of the homogenized formulations. For example, if one desires or requires a particular amount delivery devices in the homogenized formulations disclosed herein, then about the same amount can be present in or added to the pre-homogenized compositions. Specific examples of amounts of delivery devices in homogenized dairy formulations, for example, can be from about 0.005% to about 25%, from about 0.01% to about 20%, from about 0.05% to about 18%, from about 0.1% to about 16%, from about 1% to about 10%, by weight of the total composition. Other examples can include formulations containing from about 0.005 to about 5%, from about 0.01 to about 5%, or from about 0.1 to about 5% delivery devices by weight of the total composition. In still other examples, the disclosed homogenized formulations can contain about 0.005, 0.01, 0.05, 0.1, 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, or 25% delivery devices by weight of the total composition, where any of the stated values can form an upper or lower endpoint when appropriate.
- In the disclosed methods, the pre-homogenized compositions are homogenized. Any homogenization technique and apparatus known in the art can be used in the disclosed methods. Such homogenization techniques and apparatuses are commonly used in, for example, the food, dairy, pharmaceutical, cosmetic, and fragrance industries. Many suitable homogenizers are commercially available. Homogenization can involve the use of sonication, pressure, and/or mechanical devices to homogenize the fluid. For example, the homogenization can be a single stage homogenization, a multi-step or multi-stage homogenization (e.g., a two-stage homogenization), a high pressure homogenization (e.g., single or multi-stage high pressure homogenizations), a very-high pressure homogenization, a rotator-stator homogenization, a blade homogenization, and the like.
- In some examples, the homogenization step can be a pressure-based homogenization technique operating at pressures of from about 200 to about 15,000 psi, from about 500 to about 12,000 psi, from about 1,000 to about 9,000 psi, or from about 3,000 to about 6,000 psi. In still other examples, the homogenization step can be performed at about 200, 500, 1000, 1500, 2000, 2500, 3000, 3500, 4000, 4500, 5000, 5500, 6000, 6500, 7000, 7500, 8000, 8500, 9000, 9500, 10000, 10500, 11000, 11500, or 12000, 12500, 13000, 13500, 14000, 14500, 15000, where any of the stated values can form an upper or lower endpoint. It is further contemplated that multiple passes of homogenization at any of these pressures can be used, including combinations thereof.
- After homogenization, the disclosed homogenized formulations can undergo further processing. For example, the homogenized formulations can be sterilized or pasteurized. Examples of typically pasteurization conditions are high temperature short time pasteurization (HTST), ultra pasteurization (UP), and ultra high temperature (UHT) pasteurization. The homogenized formulations can also be further processed after homogenization by, e.g., the addition of additives, further formulation into the final product, packaged, spray dried, etc. In some examples, the homogenized formulations can be steam injected. Steam injection is a known technique that is sometimes used in the dairy industry. Generally, steam is injected into the milk to remove odors produced when the moisture is flashed off during pasteurization. This process is typically used on milks that are UHT pasteurized.
- It is also contemplated that the pre-homogenized compositions comprising one or more microcapsules can be processed prior to homogenization. For example, such pre-homogenized compositions comprising one or more microcapsules can first be sterilized or pasteurized and then homogenized. Likewise, the pre-homogenized compositions comprising one or more microcapsules can be subject to other processing steps prior to homogenization (e.g., the addition of additives, etc.).
- The disclosed homogenized formulations have many and varied uses. Any current use of a homogenized fluid can also be suitable for the disclosed homogenized formulations. For comestible formulations, the homogenized formulations disclosed herein can generally be taken orally and can be in any form suitable for oral administration. For example, the homogenized formulation can be spray dried and then formed into a tablet or provided in a sachet. Alternatively, the homogenized formulations can be incorporated into gel-caps, capsules, liquids, syrups, ointments, lotions, creams, gels, or drops.
- The homogenized formulations can also be designed for humans or animals, based on the recommended dietary intake for a given individual. Such considerations are generally based on various factors such as species, age, and sex as described above, which are known or can be determined by one of skill in the art. In one example, the disclosed formulations can be used as a component of feed for animals such as, but not limited to, livestock (e.g., pigs, chickens, cows, goats, horses, and the like), and domestic pets (e.g., cats, dogs, birds, and the like).
- The disclosed homogenized formulations can also include additional carriers, as well as flavorings, thickeners, diluents, buffers, preservatives, surface active agents, emulsifiers, dispersing aids, or binders and the like in addition to the microcapsules disclosed herein.
- Other examples of homogenized formulations or products derived therefrom than can be prepared by the methods disclosed herein include fresh/pasteurized milk, full fat fresh/pasteurized milk, semi skimmed fresh/pasteurized milk, long-life/UHT milk, full fat long life/UHT milk, semi skimmed long life/UHT milk, fat-free long life/UHT milk, goat milk, condensed/evaporated milk, plain condensed/evaporated milk, flavored, functional and other condensed milk, flavored milk drinks, dairy only flavored milk drinks, flavored milk drinks with fruit juice, soy milk, sour milk drinks, fermented dairy drinks, coffee whiteners, powder milk, flavored powder milk drinks, cream, cheese, processed cheese, spreadable processed cheese, unspreadable processed cheese, unprocessed cheese, spreadable unprocessed cheese, hard cheese, packaged hard cheese, unpackaged hard cheese, yogurt, plain/natural yogurt, flavored yogurt, fruited yogurt, probiotic yogurt, drinking yogurt, regular drinking yogurt, probiotic drinking yogurt, chilled snacks, fromage frais and quark, plain fromage frais and quark, flavored fromage frais and quark, and kifer.
- Alternatively, the disclosed homogenized formulations can be prepared in a powdered form (e.g., via spray drying or dehydration) and contained in articles such as sachets or shakers, which can be used to pour or sprinkle the disclosed compositions onto and into food and beverages. Still other examples include baked goods (e.g., breads, rolls, cookies, crackers, fruit pies, or cakes), pastas, condiments, salad dressings, soup mixes, snack foods, processed fruit juices, sauces, gravies, syrups, beverages, dry beverage powders, jams or jellies, or pet companion food that have been prepared with a homogenized formulation as disclosed herein.
- Examples of delivery devices that can be used in the disclosed food articles and methods include, but are not limited to, microcapsules, microspheres, nanospheres or nanoparticles, liposomes, noisome, emulsions, or powders.
- Loading substances, as are described more fully herein, can be incorporated into liposomes. As is known in the art, liposomes are generally derived from phospholipids or other lipid substances. Liposomes are formed by mono- or multi-lamellar hydrated liquid crystals that are dispersed in an aqueous medium. Any non-toxic, physiologically acceptable and metabolizable lipid capable of forming liposomes can be used. The liposome can also contain stabilizers, preservatives, excipients, and the like. Examples of suitable lipids are the phospholipids and the phosphatidyl cholines (lecithins), both natural and synthetic. Methods of forming liposomes are known in the art. See e.g., Prescott, Ed., Methods in Cell Biology, Volume XIV, Academic Press, New York, p. 33 et seq., 1976, which is hereby incorporated by reference herein for its teachings of liposomes and their preparation. In other examples, the liposomes can be cationic liposomes (e.g., DOTMA, DOPE, DC cholesterol) or anionic liposomes.
- As described herein, niosomes are delivery devices that can be used to deliver a loading substance as disclosed herein. Noisomes are multilamellar or unilamellar vesicles involving non-ionic surfactants.
- Solid-lipid nanoparticles, as described herein, are other delivery devices that can be used to deliver a loading substance as disclosed herein. Solid-lipid nanoparticles are nanoparticles, which are dispersed in an aqueous surfactant solution. They are comprised of a solid hydrophobic core having a monolayer of a phospholipid coating and are usually prepared by high-pressure homogenization techniques.
- Microcapsules
- Microcapsules, as described herein, are yet further examples of delivery devices that can be used in the disclosed food articles and methods as disclosed herein. In contrast to liposomal delivery systems, microcapsules (including microspheres) typically do not have an aqueous core but a solid polymer matrix or membrane. These delivery devices are obtained by controlled precipitation of polymers, chemical cross-linking of soluble polymers, and interfacial polymerization of two monomers or high-pressure homogenization techniques. The encapsulated compound (i.e., loading substance) is gradually released from the depot by erosion or diffusion from the particles. Successful formulations of short acting peptides, such as LHRH agonists like leuprorelin and triptoreline, have been developed. Poly(lactide co-glycolide) (PLGA) microspheres are currently used as monthly and three monthly dosage forms in the treatment of advanced prostrate cancer, endometriosis, and other hormone responsive conditions. Leuprolide, an LHRH superagonist, was incorporated into a variety of PLGA matrices using a solvent extraction/evaporation method. As noted, all of these delivery devices can be used in the food articles and methods disclosed herein.
- The use of microcapsules can protect certain compositions from oxidation and degradation, keeping the loading substance fresh. Also, because microcapsules can hide the unpleasant odor or taste of certain compositions, the food articles and methods disclosed herein can be particularly useful for delivering and supplementing unpleasant compositions. Still further, the use of microcapsules can allow various loading substances to be added to food articles which are otherwise not amenable to supplementation. For example, omega-3 fatty acids can degrade or oxidize in air and can be sensitive to food preparation techniques (e.g., baking). By the use microencapsulated omega-3 fatty acids, these compositions can be added to food without significant degradation during food preparation.
- Microcapsules that are suitable for use in the disclosed food articles are defined as small particles of solids, or droplets of liquids, inside a thin coating of a shell material such as beeswax, starch, gelatine, or polyacrylic acid. They are used, for example, to prepare liquids as free-flowing powders or compressed solids, to separate reactive materials, to reduce toxicity, to protect against oxidation and/or to control the rate of release of a substance such as an enzyme, a flavor, a nutrient, a drug, etc.
- Over the past fifty years, much focus has been on so-called “single-core” microcapsules. However, one of the problems with single-core microcapsules is their susceptibility to rupture. To increase the strength of microcapsules, the thickness of the microcapsule wall can be increased. However, this can lead to a reduction in the loading capacity of the microcapsule. Another approach has been to create so-called “multi-core” microcapsules. For example, U.S. Pat. No. 5,780,056 discloses a “multi-core” microcapsule having gelatine as a shell material. These microcapsules are formed by spray cooling an aqueous emulsion of oil or carotenoid particles such that the gelatine hardens around “cores” of the oil or carotenoid particles. Yoshida et al. (Chemical Abstract 1990:140735 or Japanese Patent Publication JP 01-148338) discloses a complex coacervation process for the manufacture of microcapsules in which an emulsion of gelatine and paraffin wax is added to an arabic rubber solution and then mixed with a surfactant to form “multi-core” microcapsules. Ijichi et al. (J. Chem. Eng. Jpn. (1997) 30(5):793-798) microencapsulated large droplets of biphenyl using a complex coacervation process to form multi-layered microcapsules. U.S. Pat. Nos. 4,219,439 and 4,222,891 disclose “multi-nucleus,” oil-containing microcapsules having an average diameter of about 3 to about 20 μm with an oil droplet size of about 1 to about 10 μm for use in pressure-sensitive copying papers and heat sensitive recording papers.
- Particularly suitable microcapsules include those that are resistant to rupture during the preparation of the food article (including packaging, transportation, and storage of the food article). In some examples, the microcapsules can be of a size and consistency that does not detract from the texture and constitution of the food article.
- Microcapsules suitable for use in the disclosed articles and methods can be any microcapsule as disclosed herein. In specific examples, the microcapsules can comprise an agglomeration of primary microcapsules and a loading substance. Each individual primary microcapsule has a primary shell. The loading substance is encapsulated by the primary shell and the agglomeration is encapsulated by an outer shell. These microcapsules are referred to herein as “multicore microcapsules.” In another example, described herein are microcapsules that comprise a loading substance, a primary shell, and a secondary shell, wherein the primary shell encapsulates the loading substance and the secondary shell encapsulates the composition and primary shell. These microcapsules are referred to herein as “single-core microcapsules.” Unless stated otherwise, the term “microcapsule” is used herein to refer to multicore, single-core, or a mixture of multicore and single-core microcapsules. Particularly suitable microcapsules are disclosed in U.S. Pat. Nos. 6,974,592 and 6,969,530 and US Publication No. 2005-0019416-A1, which are all incorporated by reference herein in their entireties for at least their disclosures of microcapsules, their methods of preparation, and their methods of use.
- The microcapsules disclosed herein generally have a combination of high payload and structural strength. For example, the disclosed microcapsules are strong enough to survive the homogenization process. Further, the payloads of loading substances in the disclosed microcapsules can be from about 20% to about 90%, about 50% to about 70% by weight, or about 60% by weight of the microcapsule. In other examples, the disclosed microcapsules can contain about 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, or 90% by weight of the microcapsule, where any of the stated values can form an upper or lower endpoint when appropriate.
- It is also contemplated that one or more additional shell layers can be placed on the outer shell of the microcapsules. The techniques described in International Publication No. WO 2004/041251 A1, which is incorporated by reference in its entirety, can be used to add additional shell layers to the microcapsules.
- A number of different polymers can be used to produce the shell layers of the single-core and multicore microcapsules. For example, the primary shell and/or outer shell material of the disclosed microcapsules can comprise a surfactant, gelatin, protein, polyphosphate, polysaccharide, or mixtures thereof. Further examples of suitable materials for the primary shell and/or outer shell include, but are not limited to, gelatin type A, gelatin type B, polyphosphate, gum arabic, alginate, chitosan, carrageenan, pectin, starch, modified starch, alfa-lactalbumin, beta-lactoglobumin, ovalbumin, polysorbiton, maltodextrin, cyclodextrin, cellulose, methyl cellulose, ethyl cellulose, hydropropylmethylcellulose, carboxymethylcellulose, milk protein, whey protein, soy protein, canola protein, albumin, chitin, polylactides, poly-lactide-co-glycolides, derivatized chitin, poly-lysine, kosher gelatin, non-kosher gelatin, Halal gelatin, and non-Halal gelatin, including combinations and mixtures thereof. It is also contemplated that derivatives of these polymers can be used as well. One specific type of primary shell and/or outer shell material that can be used in the disclosed microcapsules is fish gelatin or pork gelatin.
- In many examples of suitable microcapsules, the primary shell and/or outer shell material can have a Bloom number of from about 0 to about 350. The Bloom number describes the gel strength formed at 10° C. with a 6.67% solution gelled for 18 hours. Determining the Bloom number of a substance can be accomplished by methods known in the art. It is contemplated that the primary shell and/or outer shell material can have a Bloom number of about 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139, 140, 140, 141, 142, 143, 144, 145, 146, 147, 148, 149, 150, 150, 151, 152, 153, 154, 155, 156, 157, 158, 159, 160, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 170, 171, 172, 173, 174, 175, 176, 177, 178, 179, 180, 180, 181, 182, 183, 184, 185, 186, 187, 188, 189, 190, 190, 191, 192, 193, 194, 195, 196, 197, 198, 199, 200, 200, 201, 202, 203, 204, 205, 206, 207, 208, 209, 210, 210, 211, 212, 213, 214, 215, 216, 217, 218, 219, 220, 220, 221, 222, 223, 224, 225, 226, 227, 228, 229, 230, 230, 231, 232, 233, 234, 235, 236, 237, 238, 239, 240, 240, 241, 242, 243, 244, 245, 246, 247, 248, 249, 250, 250, 251, 252, 253, 254, 255, 256, 257, 258, 259, 260, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 270, 271, 272, 273, 274, 275, 276, 277, 278, 279, 280, 280, 281, 282, 283, 284, 285, 286, 287, 288, 289, 290, 290, 291, 292, 293, 294, 295, 296, 297, 298, 299, 300, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 310, 310, 311, 312, 313, 314, 315, 316, 317, 318, 319, 320, 320, 321, 322, 323, 324, 325, 326, 327, 328, 329, 330, 330, 331, 332, 333, 334, 335, 336, 337, 338, 339, 340, 340, 341, 342, 343, 344, 345, 346, 347, 348, 349, or 350, where any of the stated values can form an upper or lower end point where appropriate. In some specific examples the primary and/or outer shell material can have a Bloom number of from about 0 to about 50, and in other examples the primary and/or outer shell material can have a Bloom number of from about 51 to about 350. Still other specific examples include microcapsules comprising a primary shell and/or outer shell material having a Bloom number of about 0, about 210, about 220, or about 240. In one example, the microcapsule does not contain “low Bloom” gelatine, which is gelatin having a Bloom number less than 50.
- The shell material can be a two-component system made from a mixture of different types of polymer components. In other examples, the shell material can be a complex coacervate between two or more polymer components (e.g., gelatine A and polyphosphate). Component A can be gelatine type A, although other polymers like those mentioned above for the shell materials are also contemplated as component A. Component B can be gelatine type B, polyphosphate, gum arabic, alginate, chitosan, carrageenan, pectin, carboxymethyl-cellulose or a mixture thereof. Again other polymers like those disclosed above for the shell materials are also contemplated as component B. The molar ratio of component A:component B that is used depends on the type of components but is typically from about 1:5 to about 15:1. For example, when gelatine type A and polyphosphate are used as components A and B respectively, the molar ratio of component A:component B can be about 8:1 to about 12:1; when gelatine type A and gelatine type B are used as components A and B respectively, the molar ratio of component A:component B can be about 2:1 to about 1:2; and when gelatine type A and alginate are used as components A and B respectively, the molar ratio of component A:component B can be about 3:1 to about 5:1. In many of the disclosed microcapsules the primary shell and/or outer shell can comprise a complex coacervate. For example, the primary shell and/or outer shell can comprise a complex coacervate of gelatin and polyphosphate.
- In the disclosed microcapsules the outer shell can have an average diameter of from about 1 μm to about 2,000 μm, from about 20 μm to about 1,000 μm, or from about 30 μm to about 80 μm. In further examples, the average diameter of the outer shell can be about 1, 10, 20, 30, 40, 50, 60, 70, 80, 90, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, or 2000 μm, where any of the stated values can form an upper or lower endpoint when appropriate.
- The primary shells of the disclosed microcapsules can have an average diameter of from about 40 nm to about 10 μm or from about 0.1 μm to about 5 μm. In further examples, the average diameter of the primary shell can be about 40 nm, 50 nm, 60 nm, 70 nm, 80 nm, 90 nm, 100 nm, 200 nm, 300 nm, 400 nm, 500 nm, 600 nm, 700 nm, 800 nm, 900 nm, 1000 nm, 2 μm, 3 μm, 4 μm, 5 μm, 6 μm, 7 μm, 8 μm, 9 μm, 10 μm, where any of the stated values can form an upper or lower endpoint when appropriate.
- Particle size can be measured using any typical equipment known in the art, for example, a Coulter LS230 Particle Size Analyzer, Miami, Fla., USA.
- Loading Substances
- In the disclosed delivery devices, the loading substance can be any substance that one desires to be delivered to a subject. In many examples, a suitable loading substance is not entirely soluble in an aqueous mixture. The loading substance can be a solid, a hydrophobic liquid, or a mixture of a solid and a hydrophobic liquid. In many of the examples herein, the loading substance can comprise a long chain polyunsaturated fatty acid, specific examples of which are included below. Further, the loading substance can comprise a biologically active substance, a nutrient such as a nutritional supplement, a flavoring substance, a polyunsaturated fatty acid like an omega-3 fatty acid, a vitamin, a mineral, a carbohydrate, a steroid, a trace element, and/or a protein, and the like including mixtures and combinations thereof. In other examples, the loading substance can comprise microbial oil, algal oil (e.g., oil from a dinoflagellate such as Crypthecodinium cohnii), fungal oil (e.g., oil from Thraustochytrium, Schizochytrium, or a mixture thereof), and/or plant oil (e.g., flax, vegetables), including mixtures and combinations thereof. In other examples, the loading substance can be a pharmaceutical composition (e.g., a drug and/or an enzyme) or a flavor. The loading substance can also be a hydrophobic liquid, such as grease, oil or a mixture thereof. Typical oils can be fish oils, vegetable oils (e.g., canola, olive, corn, rapeseed), mineral oils, derivatives thereof or mixtures thereof. The loading substance can comprise a purified or partially purified oily substance such as a fatty acid, a triglyceride, or a mixture thereof.
- In still other examples, a suitable loading substance can comprise marine oil, such as natural and refined and concentrated fish oil. Examples of suitable fish oils include, but are not limited to, Atlantic fish oil, Pacific fish oil, Mediterranean fish oil, light pressed fish oil, alkaline treated fish oil, heat treated fish oil, light and heavy brown fish oil, bonito oil, pilchard oil, tuna oil, sea bass oil, halibut oil, spearfish oil, barracuda oil, cod oil, menhaden oil, sardine oil, anchovy oil, capelin oil, Atlantic cod oil, Atlantic herring oil, Atlantic mackerel oil, Atlantic menhaden oil, salmonid oil, and shark oil, including mixtures and combinations thereof. Non-alkaline treated fish oil is also a suitable loading substance. Other marine oils suitable for use herein include, but are not limited to, squid oil, cuttle fish oil, octopus oil, krill oil, seal oil, whale oil, and the like, including mixtures and combinations thereof. Any marine oil and combination of marine oil can be used in the disclosed delivery devices and in the disclosed food articles and methods.
- Many of the microbial, algal, fungal, plant, and marine oils disclosed herein contain omega-3 fatty acids. As such, certain delivery devices disclosed herein can contain a loading substance that comprises an omega-3 fatty acid, an alkyl ester of an omega-3 fatty acid, a triglyceride ester of an omega-3 fatty acid, a phytosterol ester of an omega-3 fatty acid, and/or mixtures and combinations thereof. An omega-3 fatty acid is an unsaturated fatty acid that contains as its terminus CH3—CH2—CH═CH—. Generally, an omega-3 fatty acid has the following formula:
- wherein R1 is a C3-C40 alkyl or alkenyl group comprising at least one double bond and R2 is H or alkyl group. The term “alkane” or “alkyl” as used herein is a saturated hydrocarbon group (e.g., methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, n-pentyl, isopentyl, s-pentyl, neopentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, hexadecyl, eicosyl, tetracosyl, and the like). The term “alkene” or “alkenyl” as used herein is a hydrocarbon group containing at least one carbon-carbon double bond. Asymmetric structures such as (AB)C═C(CD) are intended to include both the E and Z isomers (cis and trans). In a further example, R1 can be a C5-C38, C6-C36, C8-C34, C10-C32, C12-C30, C14-C28, C16-C26, or C18-C24 alkenyl group. In yet another example, the alkenyl group of R1 can have from 2 to 6, from 3 to 6, from 4 to 6, or from 5 to 6 double bonds. Still further, the alkenyl group of R1 can have from 1, 2, 3, 4, 5, or 6 double bonds, where any of the stated values can form an upper or lower endpoint as appropriate.
- Specific examples of omega-3 fatty acids that are suitable loading substances that can be used in the disclosed delivery devices include, but are not limited to, α-linolenic acid (18:3ω3), octadecatetraenoic acid (18:4ω3), eicosapentaenoic acid (20:5ω3) (EPA), eicosatetraenoic acid (20:4ω3), henicosapentaenoic acid (21:5ω3), docosahexaenoic acid (22:6ω3) (DHA), docosapentaenoic acid (22:5ω3) (DPA), including derivatives and mixtures thereof. Many types of fatty acid derivatives are well known to one skilled in the art. Examples of suitable derivatives are esters, such as phytosterol esters, furanoid esters, branched or unbranched C1-C30 alkyl esters, branched or unbranched C2-C30 alkenyl esters or branched or unbranched C3-C30 cycloalkyl esters, in particular phytosterol esters and C1-C6 alkyl esters. In a further example, the loading substance can be a phytosterol ester of docosahexaenoic acid and/or eicosapentaenoic acid, a C1-C6 alkyl ester of docosahexaenoic acid and/or eicosapentaenoic acid, a triglyceride ester of docosahexaenoic acid and/or eicosapentaenoic acid, and/or a mixture thereof.
- Other examples of suitable loading substances that can be present in the disclosed delivery devices comprise at least 4, at least 6, at least 8, at least 10, at least 12, at least 14, at least 16, at least 18, or at least 20 carbon atoms. In some other examples, the loading substance can contain about 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, or 45 carbon atoms, where any of the stated values can form an upper or lower endpoint when appropriate. In still other examples, the loading substance can comprise a mixture of fatty acids (including derivatives thereof) having a range of carbon atoms. For example, the loading substance can comprise from about 8 to about 40, from about 10 to about 38, from about 12 to about 36, from about 14 to about 34, from about 16 to about 32, from about 18 to about 30, or from about 20 to about 28 carbon atoms.
- Some further examples of loading substances are those that contain at least one unsaturated bond (i.e., a carbon-carbon double or triple bond). For example, the loading substance can contain at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, or at least 8 carbon-carbon double bonds, triple bonds, or any combination thereof. In another example, the loading substance can comprise 1, 2, 3, 4, 5, 6, 7, or 8 unsaturated bonds, where any of the stated values can form an upper or lower endpoint as appropriate.
- Some specific examples of loading substances, which are unsaturated fatty acids, are shown in the following tables. Derivatives of these fatty acids are also suitable and are thus contemplated herein.
-
TABLE 1 Examples of Monoene Acids Total number of Carbon number where double bond begins. carbon atoms in the (“c” denotes a cis double bond; “t” denotes fatty acid chain a trans double bond) 10 4c 12 4c 14 4c and 9c 16 3t, 4c, 5t, 6c, 6t, 9c (palmitooleic), and 11c 18 3t, 5c, 5t, 6c (petroselinic), 6t, 9c (oleic), 10c, 11c (cis-vaccenic), 11t (vaccenic), and 13c 20 5c, 9c (gadolenic), 11c, 13c, and 15c 22 5c, 11c (cetoleic), 13c (erucic), and 15c 24 15c (selacholeic, nervonic) 26 9c, and 17c (ximenic) 28 9c, 19c (lumequic) 30 21c - Unsaturated fatty acids that contain at least one pair of methylene interrupted unsaturated bonds are also suitable loading substances. By “methylene interrupted unsaturated bond” is meant that one carbon-carbon double or triple bond is separated from another carbon-carbon double or triple bond by at least one methylene group (i.e., CH2). Specific examples of such loading substances include, but are not limited to, the n-1 family derived from 9, 12, 15-16:3; n-2 family derived from 9, 12, 15-17:3, 15:3, 17:3, 17:4, 20:4; n-3 family derived from 9, 12, 15-18:3, 15:2, 15:3, 15:4, 16:3, 16:4, 18:3 (α-linolenic), 18:4, 18:5, 20:2, 20:3, 20:4; 20:5 (EPA), 21:5, 22:3, 22:5 (DPA), 22:6 (DHA), 24:3, 24:4, 24:5, 24:6, 26:5, 26:6, 28:7, 30:5; n-4 family derived from 9, 12-16:2, 16:2, 16:3, 18:2, 18:3; n-5 family derived from 9, 12-17:2, 15:2, 17:2, 17:3, 19:2, 19:4, 20:3, 20:4 21:4, 21:5; n-6 family derived from 9, 12-18:2, 15:2, 16:2, 18:2 (linoleic acid), 18:3 (γ-linolenic acid); 20:2, 20:3, 20:4 (arachidonic acid), 22:2, 22:3, 22:4 (adrenic acid), 22:5, 24:2, 24:4, 25:2, 26:2, 30:4; n-7 family derived from 9-16:1, 15:2, 16:2, 17:2, 18:2, 19:2; n-8 family derived from 9-17:1, 15:2, 16:2, 17:2, 18:2, 19:2; n-9 family derived from 9-18:1, 17:2, 18:2, 20:2, 20:3, 22:3, 22:4; n-11 family 19:2, and the n-12 family 20:2. In one particular specific example, the loading substance can comprise arachidonic acid.
- In the above paragraph (and throughout) the compounds are identified by referring first to the “n-x family,” where x is the position in the fatty acid where the first double bond begins. The numbering scheme begins at the terminal end of the fatty acid, where, for example, the terminal CH3 group is designated
position 1. In this sense, the n-3 family would be an omega-3 fatty acid, as described above. The next number identifies the total number of carbon atoms in the fatty acid. The third number, which is after the colon, designates the total number of double bonds in the fatty acid. So, for example, in the n−1 family, 16:3, refers to a 16 carbon long fatty acid with 3 double bonds, each separated by a methylene, wherein the first double bond begins atposition 1, i.e., the terminal end of the fatty acid. In another example, in the n-6 family, 18:3, refers to an 18 carbon long fatty acid with 3 methylene separated double bonds beginning at position 6, i.e., the sixth carbon from the terminal end of the fatty acid, and so forth. - Further examples of loading substances that contain at least one pair of methylene interrupted unsaturated bonds are shown in Table 2.
-
TABLE 2 Examples of Polyene Acids Total number of Carbon number where double bond begins. carbon atoms in the (“c” denotes a cis double bond; “t” fatty acid chain denotes a trans double bond) 18 5, 9 5, 11 2t, 9, 12 3t, 9, 12 5t, 9, 12 5, 9, 12 5, 11, 14 3t, 9, 12, 15 5, 9, 12, 15 20 5, 11 5, 13 7, 11 7, 13 5, 11, 14 7, 11, 14 5, 11, 14, 17 22 5, 11 5, 13 7, 13 7, 15 7, 17 9, 13 9, 15 - Specific examples of suitable loading substances that contain conjugated unsaturated bonds include, but are not limited to, those in Table 3. By “conjugated unsaturated bond” is meant that at least one pair of carbon-carbon double and/or triple bonds are bonded together, without a methylene (CH2) group between them (e.g., CH═CH—CH═CH—).
-
TABLE 3 Examples of Conjugated Polyene Acids Total number of Carbon number where double bond begins. carbon atoms in the (“c” denotes a cis double bond; “t” fatty acid chain. denotes a trans double bond) 10 2t, 4t, 6c 2c, 4t, 6t 3t, 5t, 7c 3c, 5t, 7t 12 3, 5, 7, 9, 11 14 3, 5, 7, 9, 11 18 10t, 12t 8c, 10t, 12c (jacaric) 8t, 10t, 12c (calendic) 8t, 10t, 12t 9t, 11t, 13c (catalpic) 9c, 11t, 13t (α-eleostearic) 9c, 11t, 13c (punicic) 9t, 11t, 13t (β-eleostearic) 9c, 11t, 13t, 15c (α-parinaric) 9t, 11t, 13t, 15t (β-parinaric) - In the above examples of suitable loading substances, derivatives of the disclosed loading substances can also be used. By “derivatives” is meant the ester of a fatty acid (e.g., methyl and ethyl esters), salts of the fatty acids (e.g., sodium and potassium salts), and triglycerides, diglycerides, and monoglycerides, sterol esters, antioxidant-oil conjugates (e.g., ascorbyl palmitate), and naturally derivatives such as furanoid fatty acid derivatives.
- The loading substances disclosed herein can also be crude oils, semi-refined (also called alkaline refined), or refined oils from such sources disclosed herein. Still further, the disclosed compositions and methods can use oils comprising re-esterified triglycerides.
- It is contemplated herein that one or more of the disclosed loading substances can be used. For example the disclosed delivery devices can contain two or more different loading substances. Further, the loading substance can be present in an amount of from about 1% to about 50% by weight of a microcapsule. In specific examples, the loading substance can be present in an amount of from about 1% to about 40%, from about 1% to about 30%, from about 1% to about 20%, from about 1% to about 15%, or from about 1% to about 10% by weight of a microcapsule.
- In one example, the loading substance is not a fatty acid conjugate. A fatty acid conjugate is a fatty acid that has been coupled to (e.g., bonded to) another chemical moiety, such as a metal (e.g., chromium) or cofactor (CoQ10).
- In one example, the loading substances can contain an antioxidant. Suitable examples of antioxidants include, but are not limited to, a phenolic compound, a plant extract, or a sulfur-containing compound. In certain examples disclosed herein the antioxidant can be ascorbic acid or a salt thereof, e.g., sodium ascorbate. In other examples, the antioxidant can be citric acid or a salt thereof. In still other examples, the antioxidant can be vitamin E, CoQ10, tocopherols, lipid soluble derivatives of more polar antioxidants such as ascobyl fatty acid esters (e.g., ascobyl palmitate), plant extracts (e.g., rosemary, sage and oregano oils), algal extracts, and synthetic antioxidants (e.g., BHT, TBHQ, ethoxyquin, alkyl gallates, hydroquinones, tocotrienols).
- The disclosed loading substance can also contain other nutrient(s) such as vitamins other trace elements, minerals, and the like. Further, the loading substances can comprise other components such as preservatives, antimicrobials, anti-oxidants, chelating agents, thickeners, flavorings, diluents, emulsifiers, dispersing aids, or binders, including any mixture thereof.
- Specific examples of suitable delivery devices include microcapsules that contain any of the shell materials and any of the loading substances disclosed herein. Some specific examples include, but are not limited to, microcapsules where the shell materials are complex coacervates, e.g., coacervates of gelatin and polyphosphate. The shell material can, in certain examples, comprise gelatin with a Bloom number of from about 0 to about 50. Loading substances that can be used can, in many instances, include marine oils (e.g., fish oils and algal oils). Loading substances that comprise omega-3 fatty acids such as EPA and DHA can also be desirable. Further, derivatives of omega-3 fatty acids, such as mono-, di-, and triglycerides, alkyl esters, sterol esters, antioxidant esters (e.g., ascorbyl and citryl esters), and furanoid esters, can also be suitable loading substances.
- Some particularly suitable microcapsules include microcapsules containing fish oils. Examples of such fish oils include, but are not limited to, sardine, anchovy, bonito, and/or tuna oil. Fish oils can also be referred to herein by the approximate ratio of EPA and DHA, or derivatives thereof, found in the oil. For example, 18:12 oils generally comprise a ratio of EPA to DHA (or their triglyceride esters for example) of about 18:12. Likewise, 5:25 oils generally comprise a ratio of EPA to DHA of about 5:25. Any of these oils can be encapsulated in a complex coacervate comprising and fish or pork gelatin. Such microcapsules can be Generally Regarded as Safe (GRAS), kosher, and/or Halal. Also, such microcapsules can have at least about 130 mg of DHA or at least about 150 mg of EPA and DHA per gram of powder. Further, antioxidants such as ascorbic acid, citric acid, and/or phosphoric acid (or salts thereof) can be present in such microcapsules.
- Some specific examples of food articles disclosed herein comprise microcapsules having about 130 mg of DHA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 5:25 oil derived from tuna and/or bonito) and the outer shell of the microcapsules comprises pork or fish gelatin. In another specific example, a food article disclosed herein can comprise a microcapsule having about 150 mg of DHA and EPA per gram of microcapsule (e.g., a microcapsule wherein the loading substance comprises a 18:12 oil derived from sardine and/or anchovy) and the outer shell of the microcapsules comprises pork or fish gelatin.
- In one instance, the loading substance is not a conjugated fatty acid. In another instance, the microcapsule does not comprise a low Bloom gelatin.
- Method of Making Microcapsules
- Microcapsules prepared by the processes disclosed herein typically have a combination of payload and structural strength that are suitable for the disclosed food articles and methods. In one example, the methods disclosed in U.S. Pat. Nos. 6,974,592 and 6,969,530, which are incorporated by reference in their entirety, can be used to prepare microcapsules that can be incorporated into the food articles disclosed herein. It is also contemplated that one or more additional shell layers can be placed on the outer shell of the single-core or multicore microcapsules. In one example, the techniques described in International Publication No. WO 2004/041251 A1, which is incorporated by reference in its entirety, can be used to add additional shell layers to the single-core and multicore microcapsules.
- In general, suitable microcapsules can be prepared by a process that comprises providing an emulsion comprising a first polymer component and a loading substance; adding a second polymer component to the emulsion; adjusting pH, temperature, concentration, mixing speed, or a combination thereof to form an aqueous mixture comprising a primary shell material, wherein the primary shell material comprises the first and second polymer components and surrounds the loading substance; cooling the aqueous mixture to a temperature above the gel point of the primary shell material until the primary shell material forms agglomerations; and further cooling the aqueous mixture to form an outer shell around the agglomeration.
- In these methods, the first polymer component and second polymer component can be the same as any of the primary and outer shell materials described herein. That is, the first and second polymer components can become the primary and/or outer shell materials in the disclosed methods for preparing microcapsules. Furthermore, any of the loading substances described herein can be used in these methods for preparing microcapsules.
- In the disclosed methods, an aqueous mixture of a loading substance, a first polymer component of the shell material, and a second polymer component of the shell material is formed. The aqueous mixture can be a mechanical mixture, a suspension, or an emulsion. When a liquid loading substance is used, particularly a hydrophobic liquid, the aqueous mixture can be an emulsion of the loading substance and the polymer components. In another example, a first polymer component is provided in aqueous solution, together with processing aids, such as antioxidants. A loading substance can then be dispersed into the aqueous mixture, for example, by using a homogenizer. If the loading substance is a hydrophobic liquid, an emulsion is formed in which a fraction of the first polymer component begins to deposit around individual droplets of loading substance to begin the formation of primary shells. If the loading substance is a solid particle, a suspension is formed in which a fraction of the first polymer component begins to deposit around individual particles to begin the formation of primary shells. At this point, another aqueous solution of a second polymer component can be added to the aqueous mixture.
- In the processes for preparing microcapsules disclosed herein, providing an emulsion of the first polymer component and the loading substance can be accomplished by methods and apparatus known in the art, e.g., homogenization and high pressure/high shear pumps. For example, emulsification can take place by emulsifying at from about 1,000 to about 15,000 rpm. The emulsification step can be monitored by removing a sample of the mixture and analyzing it under such methods as microscopy, light scattering, turbidity, etc. Generally, emulsification can be performed until an average droplet size of less than about 1,000, 750, 500, 100, or 10 nm is obtained. Not wishing to be bound by theory but it is believed that by varying the emulsification speed it is possible to produce single or multicore microcapsules. For example, when lower emulsification speeds are used (e.g., 1,000 to 2,000 rpm), the droplets of the loading substance are large enough to form a single particle, which upon encapsulation, produces a single core microcapsule. Conversely, if high emulsification speeds are used (e.g., 5,000 to 15,000 rpm), the resultant droplets of loading substance are usually small (e.g., from 1 to 10 μm). These tiny droplets can have higher surface energy and can readily form agglomerations when pH and/or temperature is adjusted accordingly, which results in the formation of multicore microcapsules upon encapsulation. Particle size can be measured using any typical equipment known in the art, for example, a COULTER™ LS230 Particle Size Analyzer, Miami, Fla. USA.
- The emulsification step can be performed at greater than room temperature, greater than 30, 40, 50, 60, 70, or 80° C., where any of the stated values can form an upper or lower endpoint when appropriate. Specific examples include emulsifying the mixture at from about 30° C. to about 60° C. or from about 40° C. to about 50° C.
- It is further contemplated that antioxidants and/or surfactants, which are also described herein, can be added to the aqueous mixture. Such antioxidants and/or surfactants can be added before, during, and/or after the emulsion is provided.
- The amount of the polymer components of the shell material provided in the aqueous mixture is typically sufficient to form both the primary shells and the outer shells of the loading agglomeration of microcapsules. The loading substance can be provided in an amount of from about 1% to about 15% by weight of the aqueous mixture, from about 3% to about 8% by weight, or about 6% by weight.
- The pH, temperature, concentration, mixing speed, or a combination thereof can be adjusted to form an aqueous mixture comprising a primary shell material, wherein the primary shell material comprises the first and second polymer components and surrounds the loading substance. If there is more than one type of polymer component, complex coacervation will occur between the components to form a coacervate, which further deposits around the loading substance to form primary shells of shell material. The pH adjustment depends on the type of shell material to be formed. For example, the pH may be adjusted to a value from 3.5 to 5.0, or from 4.0 to 5.0. If the pH of the mixture starts in the desired range, then little or no pH adjustment is required.
- The initial temperature of the aqueous mixture can be from about 20° C. to about 60° C., or about 30° C. to about 50° C.
- Mixing can be adjusted so that there is good mixing without breaking the microcapsules as they form. Particular mixing parameters depend on the type of equipment being used. Any of a variety of types of mixing equipment known in the art may be used. In one example, an axial flow impeller, such as LIGHTNIN A310 or A510, can be used.
- In many examples disclosed herein, the primary shell and the outer shell of the disclosed microcapsules can comprise a complex coacervate. The complex coacervate can be formed from the first and second polymer components. For example, the primary shell and the outer shell can comprise a complex coacervate between gelatin and polyphosphate. All combinations of first and second polymer components are contemplated herein for the complex coacervate and the primary and outer shell.
- The aqueous mixture can then be cooled under controlled cooling rate and mixing parameters to permit agglomeration of the primary shells to form encapsulated agglomerations of primary shells. Not wishing to be bound by theory, the encapsulated agglomerations are discrete particles themselves. It is advantageous to control the formation of the encapsulated agglomerations at a temperature above the gel point of the shell material, and to let excess shell material form a thicker outer shell. It is also possible at this stage to add more polymer, where the polymer is the same or different as the shell material being used, in order to thicken the outer shell and/or produce microcapsules having primary and outer shells of different composition. The outer shell encapsulates the agglomeration of primary shells to form a rigid encapsulated agglomeration of microcapsules.
- Cooling the aqueous mixture can be accomplished by methods known in the art (e.g., the use of a chiller). The rate of cooling can be about 1° C. per about 1 to about 100 minutes. For example, the rate of cooling can be about 1° C. per about 1, 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 55, 60, 65, 70, 75, 80, 85, 90, 95, or 100 minutes, where any of the stated values can form an upper or lower endpoint when appropriate. In specific examples the rate of cooling can be about 1° C./5 minutes. Cooling can take place until the mixture reaches a temperature of from about 5° C. to about 10° C., e.g., about 5° C.
- Processing aids can be included in the shell material (e.g., primary and/or outer shells). Processing aids can be used for a variety of reasons. For example, they may be used to promote agglomeration of the primary microcapsules, stabilize the emulsion system, improve the properties of the outer shells, control microcapsule size, and/or to act as an antioxidant. In one aspect, the processing aid can be an emulsifier, a fatty acid, a lipid, a wax, a microbial cell (e.g., yeast cell lines), a clay, or an inorganic compound (e.g., calcium carbonate). Not wishing to be bound by theory, these processing aids can improve the barrier properties of the microcapsules. In one aspect, one or more antioxidants can be added to the shell material. Antioxidant properties are useful both during the process (e.g., during coacervation and/or spray drying) and in the microcapsules after they are formed (i.e., to extend shelf-life, etc). Preferably a small number of processing aids that perform a large number of functions can be used. In one aspect, the antioxidant can be a phenolic compound, a plant extract, or a sulphur-containing amino acid. In one aspect, ascorbic acid or citric acid (or a salt thereof such as sodium or potassium ascorbate or sodium or potassium citrate) can be used to promote agglomeration of the primary microcapsules, to control microcapsule size and to act as an antioxidant. The antioxidant can be used in an amount of about 100 ppm to about 12,000 ppm, or from about 1,000 ppm to about 5,000 ppm. Other processing aids such as, for example, metal chelators, can be used as well. For example, ethylene diamine tetraacetic acid can be used to bind metal ions, which can reduce the catalytic oxidation of the loading substance.
- In the disclosed microcapsules, the shell material can also be cross-linked. Thus, the disclosed methods can further involve the addition of a cross-linker. The cross-linker can be added to further increase the rigidity of the microcapsules by cross-linking the shell material in both the outer and primary shells and to make the shells insoluble in both aqueous and oily media. In one example, the cross-linker is added after the outer shell of the microcapsule is produced. Any suitable cross-linker can be used and the choice of cross-linker can vary depending upon the selection of the first and second polymer component. In another example, the cross-linkers can be enzymatic cross-linkers (e.g. transglutaminase), aldehydes (e.g. formaldehyde or gluteraldehyde), tannic acid, alum or a mixture thereof. In another aspect, the cross-linker can be a plant extract or a phenolic. It is also contemplated that one or more loading substances (e.g., antioxidants) can be used with the cross-linker. When the microcapsules are to be used in a formulation that is to be delivered to an organism, the cross-linkers are preferably non-toxic or of sufficiently low toxicity. The amount of cross-linker used depends on the components selected and can be adjusted to provide more or less structural rigidity as desired. In one aspect, the amount of cross-linker that can be used is in the amount of about 0.1% to about 5.0%, about 0.5% to about 5.0%, about 1.0% to about 5.0%, about 2.0% to about 4.0%, or about 2.5%, by weight of the first polymer component. In general, one skilled in the art can routinely determine the desired amount in any given case by simple experimentation. The cross-linker can be added at any stage of the process, however it, can typically be added after the cooling step.
- Further, the disclosed microcapsules can be washed with water and/or dried to provide a free-flowing powder. Thus, the disclosed methods of preparing microcapsules can comprise a drying step for the microcapsules. Drying can be accomplished by a number of methods known in the art such as, for example, freeze drying, drying with ethanol, or spray drying. In one aspect, spray drying can be used for drying the microcapsules. Spray drying techniques are disclosed in “Spray Drying Handbook”, K. Masters, 5th edition, Longman Scientific Technical UK, 1991, the disclosure of which is hereby incorporated by reference at least for its teaching of spray drying methods.
- The food articles disclosed herein contain delivery devices, such as those disclosed herein, and can be used to deliver loading substances encapsulated within the delivery device (e.g., omega-3 fatty acids) to a subject for nutritional or medical purposes. In one example, the delivery device is a microcapsule. The microcapsules disclosed herein have good rupture strength to help reduce or prevent breaking of the microcapsules during incorporation into food or other formulations. Furthermore, the microcapsule's shells are insoluble in both aqueous and oily media, and help reduce or prevent oxidation and/or deterioration of the loading substance during preparation of the microcapsules, during long-term storage, and/or during incorporation of the microcapsules into a formulation vehicle, for example, into food articles.
- The particular method of preparing the disclosed food articles will depend on such factors as the particular food article, the delivery device, and the loading substance. In some examples, the delivery device (e.g., microcapsules) can be mixed with the ingredients of the food article before the food article is prepared. Examples of this can include adding delivery devices to batter or breading for various food articles (e.g., fish, shrimp, poultry, vegetables) and then cooking the food. In other examples, the delivery devices can be added to (e.g., contacted to or poured or sprinkled on) the food article after it is prepared, but before packaging. Typical examples of this method involve contacting the food article with the delivery device. Such contacting steps can be combined with other seasoning steps. In still another example, the delivery device can be packaged separately from the food article (e.g., microcapsules can be packaged alone as a condiment pack or mixed into other seasonings) and then added to the food article prior to consumption (e.g., by the consumer or food preparation personnel).
- In one example, delivery devices, along with other optional seasonings, can be pulse sprayed or mist sprayed onto the surface of the food article. Alternatively, a drum can contain the delivery devices and the food article can be introduced into the drum and agitated (e.g., rolled around inside the drum).
FIG. 1 depicts one example of this technique, where, for example, a seasoning and delivery device comprising omega-3 fatty acids are mixed in ahorizontal mixer 1. The mixture is then placed in asprayer 2, which then applies the mixture to the food article 4 present indrum 3.Drum 3 can be rotated while the mixture is sprayed onto the food article in order to ensure even distribution of the mixture to the food article. Suitable apparatus for introducing delivery devices can be obtained commercially from suppliers such as FMC Technologies (Chalfont, Pa.). - The amount of delivery devices (and thus loading substance) that can be used with the disclosed food articles will depend on such factors as the type of food article, the type of loading substance, the presence of additional seasonings, the desired dietary intake, preference, and the like. Guidance can be found in the literature for appropriate amounts for given classes of loading substances and determining a particular amount is within the skill in art. Generally, an amount of delivery devices that will provide the desired amount of loading substance to a subject, but not detract from the taste and texture of the food article can be used.
- In one example, the disclosed food article comprises a snack food (e.g., a chip) and a microcapsules. In a further example, the food article is a chip and the loading substance comprises an omega-3 fatty acid. Typical amounts of microcapsules that can be used for chips are about 0.5%, 1.0%, 1.5%, 2.0%, 2.5%, 2.9%, 3.0%, 3.5%, 4.0%, 1.5%, 5.0%, 5.5%, or 6.0% by weight, based on the total weight of the chip, where any of the stated values can form an upper or lower end point when appropriate. In other examples, less than or equal to about 6.0%, less than or equal to about 5.0%, less than or equal to about 4.0%, less than or equal to about 3.0%, less than or equal to about 2.0%, or less than or equal to about 1.0% by weight, based on the total weight of the chip can be used. In other examples, a chip can have about 0.5, 1.0, 1.5, 2.0, 2.5, 2.9, 3.0, 3.5, 4.0, 4.5, 5.0, 5.5, or 6.0 parts by weight microcapsules, where any of the stated values can form an upper or lower end point when appropriate. In other examples, a chip can have less than or equal to about 6.0, less than or equal to about 5.0, less than or equal to about 4.0, less than or equal to about 3.0, less than or equal to about 2.0, or less than or equal to about 1.0 parts by weight microcapsule. In another example, a chip can have microcapsules at from about 1 to about 6, from about 2 to about 4, or about 3% by weight based on the total weight of the chip. Still further, a chip can have from about 1 to about 6, from about 2 to about 4, and about 3 parts by weight microcapsules.
- In another example, the disclosed food article can comprise seasonings in addition to the delivery devices. The seasonings can be blended with the microcapsules and then added to the food article (e.g., chip). As such, disclosed herein is a seasoning for a food article that comprises a microcapsule. In one example, the delivery device comprises a microcapsule. Exemplary amounts of microcapsules that can be blended with a seasoning are about 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, or 40% by weight, based on the total weight of the blend, where any of the stated values can form an upper or lower end point when appropriate. In other examples, from about 20 to about 25%, from about 15 to about 30%, from about 10 to about 35%, from about 5 to about 40%, from about 5 to about 20%, from about 20 to about 40% by weight, based on the total weight of the blend can be used. Also, microcapsules can be blended with a seasoning at about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 parts by weight, where any of the stated values can form an upper or lower end point when appropriate. In other examples, a seasoning blend can contain from about 20 to about 25, from about 15 to about 30, from about 10 to about 35, from about 5 to about 40, from about 5 to about 20, from about 20 to about 40 parts by weight microcapsules.
- When the seasoning is a chip seasoning, it can be present in an amount of about 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20% by weight based on the total amount of the chip, where any of the stated values can form an upper or lower endpoint when appropriate. In other examples, a chip can contain about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 parts by weight seasoning, where any of the stated values can form an upper or lower endpoint when appropriate.
- When preparing chips, the chip can also contain oil in an amount of about 1, 2, 3, 4, 5, 6, 7, or 8% by weight, where any of the stated values can form an upper or lower endpoint when appropriate.
- Other methods disclosed herein involve mixing the delivery device (e.g., microcapsule) with one or more ingredients used to prepare the food article prior to preparing the food article. Alternative or additional methods involve contacting an already prepared food article with the delivery device. For example, the delivery device can be blended with a seasoning for the food article. The delivery device can also be sprayed onto the food article. Further, the delivery device can be mixed with the food article.
- The amount of delivery device used to prepare a food article can vary depending on the type of food article, the type of delivery device, the amount of loading substance, the desired dosage, preference, and the like. In general, the amount of loading substance desired to be delivered will be a main consideration. As an example, a microcapsule containing EPA and DHA can be added in such an amount that the food article containing the microcapsule can have from about 10 to about 250 mg of EPA+DHA per serving. For example the food article can have about 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, or 250 mg of the loading substance per serving, where any of the stated values can form an upper or lower endpoint when appropriate. When a delivery device contains large amounts of loading substance, then less of the deliver device needs to be used in the food article to obtain a desired level of a loading substance. When a deliver device contains small amounts of loading substance, then more of the deliver device will need to be used in the food article to obtain a desired level of a loading substance. Also, when more loading substance is desired, then more delivery device can be added, and when less loading substance is desired, then less delivery device can be added.
- In other examples, the food articles can contain other additives and components. For example, the food articles disclosed herein can also comprise a probiotic. Probiotics are live microorganisms that can be administered to a subject and which can confer a beneficial health effect on the subject. Examples of suitable probiotics include, but are not limited to, Lactobacillus species, Lactococcus species, and Pediococcus species. In one example the probiotic can be one or more bacteria chosen from Lactobacillus acidophilus, Lactobacillus sakei, Lactococcus lactis, and Pediococcus acidilactici. These bacteria can be particularly useful in the methods and compositions disclosed herein because they are food safe (i.e., safe to use in, on, or near foods).
- In one aspect, disclosed herein are methods of delivering a loading substance to a subject by administering to the subject a food article as disclosed herein. In a particular example, the disclosed food articles can be used as a source of fatty acids (e.g., omega-3 fatty acids), lowering triglycerides and influencing diabetes related biochemistry. In another particular example, disclosed herein are methods of supplementing omega-3 fatty acids in a subject by administering an effective amount of a food article disclosed herein, wherein the loading substance comprises an omega-3 fatty acid. In another example, disclosed herein are methods of lowering cholesterol levels, triglyceride levels, or a combination thereof in a subject by administering an effective amount of a food article disclosed herein.
- Omega-3 fatty acids are vital to everyday life and function. For example, the beneficial effects of omega-3 fatty acids like cis-5,8,11,14,17-eicosapentaenoic acid (EPA) and cis-4,7,10,13,16,19-docosahexaenoic acid (DHA) on lowering serum triglycerides are well established. These compounds are also known for other cardioprotective benefits such as preventing cardiac arrhythmias, stabilizing atherosclerotic plaques, reducing platelet aggregation, and reducing blood pressure. See e.g., Dyrberg et al., In: Omega-3 Fatty Acids: Prevention and Treatment of Vascular Disease. Kristensen et al., eds., Bi & Gi Publ., Verona-Springer-Verlag, London, pp. 217-26, 1995; O'Keefe and Harris, Am. J. Cardiology 2000, 85:1239-41; Radack et al., “The effects of low doses of omega-3 fatty acid supplementation on blood pressure in hypertensive subjects: a randomized controlled trial.” Arch. Intern. Med. 1991, 151:1173-80; Harris, “Extending the cardiovascular benefits of omega-3 fatty acids.” Curr Atheroscler Rep 2005, 7:375-80; Holub, “Clinical nutrition: 4 omega-3 fatty acids in cardiovascular care.” CMAJ2002, 166(5):608-15. Indeed, the American Heart Association has also reported that omega-3 fatty acids can reduce cardiovascular and heart disease risk. Other benefits of omega-3 fatty acids are those related to the prevention and/or treatment of inflammation and neurodegenerative diseases, and to improved cognitive development. See e.g., Sugano and Michihiro, “Balanced intake of polyunsaturated fatty acids for health benefits.” J. Oleo Sci. 2001, 50(5):305-11.
- The fatty acids EPA and DHA can be synthesized in the human body from α-linolenic acid (18:3); however, the conversion rate from this precursor molecule is limited (Muskiet et al., “Is docosahexaenoic acid (DHA) essential? Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials.” J Nutr. 2004, 134(1):183-6). Accordingly, EPA and DHA in the body are primarily derived from dietary sources (e.g., oily fish). Diets rich in fish oils are known to have many beneficial effects for heart disease, cancer, arthritis, allergies, and other chronic diseases. Epidemiological clinical trials have shown that increasing the dietary intake of omega-3 fatty acids, in the form of fish or of fish oil supplements, may reduce various risk factors associated with cardiovascular disease. See e.g., The American Heart Association, Scientific Statement, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids and Cardiovascular Disease,” November 2002; Appel et al., “Does supplementation of diet with ‘fish oil’ reduce blood pressure? A meta-analysis of controlled clinical trials.” Arch. Intern. Med. 1993, 153(12):1429-1438; GISSI-Prevenzione Investigators. “Dietary supplementation with omega-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial.” Lancet 1999, 354:447-55.
- Despite the strong evidence for the benefit of omega-3 fatty acids like EPA and DHA in prevention of cardiovascular disease, the average daily consumption of these fatty acids by North Americans is estimated to be between 0.1 to 0.2 grams, compared to a suggested daily intake of 0.65 grams to confer benefit (Webb, “Alternative sources of omega-3 fatty acids.” Natural Foods Merchandiser 2005, XXVI (8):40-4). Since altering dietary patterns of populations is difficult and many people do not like to eat fish, dietary supplementation with EPA and DHA is an important approach to addressing this problem. Unfortunately, many supplements of omega-3 fatty acids are sensitive to oxidation and can be foul smelling and tasting. Further, compliance with dietary supplement regimens requires discipline, which is often wanting. In light of the health benefits of omega-3 fatty acids, the disclosed formulations comprising microcapsules can be used to deliver omega-3 fatty acids to a subject. In the disclosed methods of use, the food articles that are administered can be any of the formulations disclosed herein.
- When used in the above described methods or other treatments, an “effective amount” of one of the disclosed food articles (or one of the loading substances therein) can be employed in pure form or, where such forms exist, in pharmaceutically acceptable salt form, foodstuff, or other form.
- The specific effective dose level for any particular subject will depend upon a variety of factors including the disorder being treated and the severity of the disorder; the identity and activity of the specific composition employed; the age, body weight, general health, sex and diet of the patient; the time of administration; the route of administration; the rate of excretion of the specific composition employed; the duration of the treatment; drugs used in combination or coincidental with the specific composition employed and like factors well known in the medical arts. For example, it is well within the skill of the art to start doses of a composition at levels lower than those required to achieve the desired therapeutic effect and to gradually increase the dosage until the desired effect is achieved. If desired, the effective daily dose can be divided into multiple doses for purposes of administration. Consequently, single dose compositions can contain such amounts or submultiples thereof to make up the daily dose.
- The dosage can be adjusted by the individual physician or the subject in the event of any counterindications. Dosage can vary, and can be administered in one or more dose administrations daily, for one or several days. Guidance can be found in the literature for appropriate dosages for given classes of pharmaceutical products.
- Further, disclosed are methods for delivering a disclosed composition to a subject by administering to the subject any of the food articles disclosed herein.
- The following examples are set forth below to illustrate the methods and results according to the disclosed subject matter. These examples are not intended to be inclusive of all aspects of the subject matter disclosed herein, but rather to illustrate representative methods and results. These examples are not intended to exclude equivalents and variations of the present invention which are apparent to one skilled in the art.
- Efforts have been made to ensure accuracy with respect to numbers (e.g., amounts, temperature, etc.) but some errors and deviations should be accounted for. Unless indicated otherwise, parts are parts by weight, temperature is in ° C. or is at ambient temperature, and pressure is at or near atmospheric. There are numerous variations and combinations of reaction conditions, e.g., component concentrations, desired solvents, solvent mixtures, temperatures, pressures and other reaction ranges and conditions that can be used to optimize the product purity and yield obtained from the described process. Only reasonable and routine experimentation will be required to optimize such process conditions.
- 54.5 grams gelatine 275 Bloom type A (isoelectric point of about 9) was mixed with 600 grams of deionized water containing 0.5% sodium ascorbate under agitation at 50° C. until completely dissolved. 5.45 grams of sodium polyphosphate was dissolved in 104 grams of deionized water containing 0.5% sodium ascorbate. 90 grams of a fish oil concentrate containing 30% eicosapentaenoic acid ethyl ester (EPA) and 20% docosahexaenoic acid ethyl ester (DHA) (available from Ocean Nutrition Canada, Dartmouth, Nova Scotia) was dispersed with 1.0% of an antioxidant (blend of natural flavour, tocopherols and citric acid available as DURALOX™ from KALSEC™) into the gelatine solution with a high speed POLYTRON™ homogenizer. An oil-in-water emulsion was formed. The oil droplet size had a narrow distribution with an average size of about 1 μm measured by COULTER™ LS230 Particle Size Analyzer. The emulsion was diluted with 700 grams of deionized water containing 0.5% sodium ascorbate at 50° C. The sodium polyphosphate solution was then added into the emulsion and mixed with a Lightning agitator at 600 rpm. The pH was then adjusted to 4.5 with a 10% aqueous acetic acid solution. During pH adjustment and the cooling step that followed pH adjustment, a coacervate formed from the gelatine and polyphosphate coated onto the oil droplets to form primary microcapsules. Cooling was carried out to above the gel point of the gelatine and polyphosphate and the primary microcapsules started to agglomerate to form lumps under agitation. Upon further cooling of the mixture, polymer remaining in the aqueous phase further coated the lumps of primary microcapsules to form an encapsulated agglomeration of microcapsules having an outer shell and having an average size of 50 μm. Once the temperature had been cooled to 5° C., 2.7 grams of 50% gluteraldehyde was added into the mixture to further strengthen the shell. The mixture was then warmed to room temperature and kept stirring for 12 hours. Finally, the microcapsule suspension washed with water. The washed suspension was then spray dried to obtain a free-flowing powder. A payload of 60% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 0.25% sodium ascorbate was used. A payload of 50% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that no ascorbate was used. A payload of 60% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 105 grams of fish oil concentrate was used and a payload of 70% was obtained.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that it was applied to triglyceride (TG) fish oil (available from Ocean Nutrition Canada Ltd.) rather than ethyl ester fish oil.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that gelatine (type A) and gum arabic were used as polymer components of the shell material.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that 150 Bloom gelatine (type A) and polyphosphate were used as polymer components of the shell material and 105 grams of fish oil concentrate was used to obtain a payload of 70%.
- Encapsulated agglomerations of microcapsules were formed in accordance with the method of Example 1 except that transglutaminase was used to cross-link the shell material.
- Microencapsulated omega-3 oil (MEG-3™ powder) was provided by Ocean Nutrition Canada (Dartmouth, Canada). Unseasoned potato chips and dry seasoning were provided by Kettle Chip Company (Salem, Oreg.).
- The dry seasoning (at ambient temperature) and microcapsules (at minus 18° C.) were placed in a plastic laboratory tub. The tub was covered and the contents were shaken vigorously by hand for about one minute until the mixture was homogeneous. A commercial blender at low speed for a short period of time can also be used. Since a dry blend can heat during the blending process, it can be desired to keep the mixture cool. See Table 4.
- In a stainless steel bowl, the unseasoned chips were sprayed with oil (e.g., PAM; ConAgra Foods, Omaha, Nebr.), while tossing the chips with a spatula until about 4% by weight of the oil was sprayed on the chips. It is also possible to use freshly fried chips, since the residual oil can serve as an adhesive for the dry seasonings.
- The dry seasoning was added to the PAM-sprayed chips while tossing was continued until at least 950% of the dry seasoning had adhered to the chips. In multiple trials, the amount of seasoning pick up was from about 95% to about 99%. A standard tumbling drum, where the chips are tossed with dry seasoning added at a pre-determined rate, can also be used. See Table 4.
- It can also be desired to minimize the time between dry seasoning blending and application to the chips.
- The chips were then placed in a gas-barrier pouch, which was flushed with ambient nitrogen gas and sealed.
-
TABLE 4 Component 100 grams Weight (g) Percent Seasoning Blend Classic Barbeque 77.52 10.00 77.52% Seasoning Microencapsulated 22.48 2.90 22.48% Omega-3 Fatty Acid 100.00 12.90 100.00% Chip Unsalted Chip 283.70 83.10 83.10% Seasoning Blend 44.04 12.90 12.90% Oil 13.66 4.00 4.00% 341.40 100.00 100.00% - Applesauce containing microcapsules was prepared according to the formulation shown in Table 5. Specifically, applesauce was placed into a water-jacketed kettle preheated to 99.5° C. Microencapsulated omega-3 oil (MC601812TG or MC60DHA from Ocean Nutrition Canada; Dartmouth, Canada) was added to the applesauce. A high shear mixer with a rod attachment was positioned in mixture and the mix speed was set at 800 rpm for the batch. The mixture was covered to minimize evaporation and maintained at 90.5° C. for approximately 10 minutes. The hot mixture was then filled into glass containers (125 g serving size). Foil seals were ironed onto the containers and the containers were inverted for 2 minutes or more. The containers were then cooled in an ice water bath and stored refrigerated.
-
TABLE 5 Ingredients Weight (g) Real % Applesauce with Vitamin 1000.00 99.68 C, 100% DV, aseptic Omega-3 microcapsules 3.210 0.32 Total 1003.210 100.00 - No off-flavors were detected in the applesauce stored under accelerated or ambient conditions. The samples had about 60 mg EPA+DHA per 125 g serving.
- Apples and banana baby food containing microcapsules was prepared by first blending bananas with citric acid to a target pH of about 4.20-4.30. Then, in a water-jacketed kettle, the bananas were combined with apples and the mixture was pureed to a desired consistency. Microencapsulated omega-3 oil (MEG-3™ powder from Ocean nutrition Canada; Dartmouth, Canada; 30-50 mg of EPA+DHA per serving) was blended into the mixture with a hand mixer. The mixture was covered to minimize evaporation and maintained at 91° C. The hot mixture was then filled into glass containers (125 g serving size). Foil seals were ironed onto the containers and the containers were inverted for 2 minutes or more. The containers were then cooled in an ice water bath and stored refrigerated. Taste test revealed that lower levels of EPA+DHA were preferred over higher levels.
- Shrimp containing microcapsules were prepared according to the formulation shown in Table 6. Specifically, frozen shrimp were dipped into a predust containing microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth Canada). The shrimp were shaken gently to remove the extra predust adhering to the shrimp. The shrimp were then dipped into the batter and coated with breadcrumbs. Each shrimp took up to about 0.3 g of predust, 0.4 g batter and 1 g breading. The shrimp were then fried in 177° C. oil for approximately 4 minutes. The shrimp were kept frozen in plastic bags until ready to test.
-
TABLE 6 Ingredients Weight (g) Real % Shrimp, frozen 81.00 72.58 Predust* 5.40 4.83 Batter Mix* 7.20 6.45 Bread Crumbs 18.00 16.12 Total: 111.60 100.00 Predust Batter Mix 56.67 56.67 Omega 3 powder43.33 43.33 Total: 100.00 100.00 Batter Mix Batter Mix 80.00 34.78 Water, filtered 150.00 65.22 Total: 230.00 100.00 *see formula below - The shrimp had 175 mg EPA+DHA (350 mg before frying) per serving (about 18 shrimp). In taste test, the flavor was acceptable. Since the microcapsules may interfere with adherence of crust to the shrimp, care should be taken during battering and breading processes.
- Pasteurized process cheese containing microcapsules was prepared according to the formulation shown in Table 7. All dry ingredients were first blended. Then all wet ingredients were gradually blended into the dry ingredients with a whisk. The mixture was heated in a double boiler to about 60° C. Cheese was added to the mixture and melted by heating to about 79-82° C. with mixing. The mixture was vacuum packaged in plastic film pouches to form slices. The pouches were chilled to form and stored refrigerated.
-
TABLE 7 Ingredients Weight (g) Weight % Cheese 257.50 52.34 Water 118.41 24.07 Corn oil 50.00 10.16 Starch, Mira Clear 340 (Staley) 26.25 5.34 Starch, Tenderfil 8 (Staley) 21.25 4.32 Sodium citrate 10.00 2.03 Disodium Phosphate 5.00 1.02 Annatto color 0.04 0.008 Omega-3 3.56 0.72 Total 492.01 100.00 - Microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth Canada) was added with the dry ingredients or the wet ingredients. Both methods produced similar results; although, adding them with the dry ingredients was easier. The products had 32 mg of EPA+DHA oil per serving (30 g slice). At these loading levels of EPA+DHA, the products tasted acceptable. Products containing higher levels (50 mg EPA+DHA/serving and higher) had detectable fish flavors, but the fish flavor dissipated somewhat as the product aged.
- A chewy granola bar containing microcapsules was prepared according to the formulation shown in Table 8. Specifically, microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth, Canada) was pre-blended with honey. To account for loss during transfer, a larger amount than needed was prepared based on the following calculation (16.54% microcapsules and honey mixture). The mixture was stirred well and allowed to sit and hydrate. In a large mixing bowl, oats and crisp rice were combined and gently mixed. Oil was drizzled into the mixture while mixing continued. The microcapsules and honey mixture mixed into the mixture and gently stirred for 1 minute. The mixture was spread onto baking sheets coated with non-stick spray and baked at 121° C. in a convection oven for 20 minutes, tossing after 10 minutes. After cooling, the product was stored in an airtight foil package until ready to use.
-
TABLE 8 Ingredients Weight (g) Real % Rolled Oats 186.76 46.69 Honey, Clover (60° C.) 92.95 23.24 Crisp Rice 84.89 21.22 Omega 318.42 4.61 Canola Oil 16.98 4.24 Total 400.00 100.00 - The product contained 130 mg EPA+DHA per serving (40 g). Fishy flavors were at were least noticeable when the microencapsulated oil was baked with cereals. It appears that cinnamon may have accentuated the fishy flavors. However, the microcapsules baked and blended with honey (or syrup) produced an acceptable flavor.
- A chicken dinner baby food containing microcapsules was prepared according to the formulation shown in Table 9. Specifically, the dry ingredients were blended and set aside. Chicken was boiled, cooled, chopped into small pieces, and then finely ground in a food processor. Egg noodles were cooked, cooled, and set aside. Peas were cooked, cooled, pressed through a sieve, and set aside. Carrots, split peas, chicken fat, oil, and the noodles were blended in a food processor. While blending, the dry ingredients and water were slowly added. The ground chicken was then added and the mixture was blended until the mixture was completely combined and smooth. The product was then filled into to 8 oz glass jars and retorted at 15 psi for 40 minutes. The product was stored at ambient temperature.
-
TABLE 9 Ingredients Weight (g) Weight % Water 250.00 48.13 Carrots, IQF diced 205.00 39.45 Chicken breast 26.00 5.01 Peas, IQF 11.00 2.12 Egg noodles, cooked 10.00 1.93 Rice flour 9.00 1.73 Chicken fat 3.50 0.67 Onion powder 2.00 0.39 Soybean oil 1.50 0.29 Celery powder 0.05 0.01 Omega-3 1.40 0.27 Total 519.45 100.00 - No off-flavors or odors were detected in the product. The product contained about 60 mg EPA+DHA per serving (125 g). To avoid shearing and damage of microcapsules, it was found that the baby food base needed to be prepared prior to the addition of microcapsules.
- A potato chip seasoning containing microcapsules was prepared according to the formulation shown in Table 10. Specifically, the ingredients were blended together. The flavors tested included BBQ, sour cream and green onion, and salt and pepper. Then the mixture was applied to potato chips at a level of 12.9%. If there was insufficient residual oil on the chips to allow for the seasoning to properly adhere, oil was sprayed (about 4% by weight) onto the chips to act as an adhesive. The chips were packaged in a nitrogen flushed, metallized film and stored at ambient temperature. The chips contained 130 g of EPA+DHA per serving (30 g of seasoned chips).
-
TABLE 10 Ingredient Weight (g) Weight % Dry Seasoning 75.00 77.52 Omega-3 Powder 21.75 22.48 Total 96.75 100.00 - Under accelerated conditions (37.8° C.) some off-flavors were detected after 4 weeks. Under ambient conditions (21.1° C.), the flavors of the products were slightly muted but similar to the controls at 6 weeks of storage
- An extruded cereal bar containing microcapsules was prepared according to the formulation shown in Table 11. Specifically, fat was creamed with sugar and liquids ingredients were added. Then the microcapsules were blended with the dry ingredients. All ingredients were combined and mixed to form dough. The dough was extruded with a fruit filling center. The product was baked at 163° C. for approximately 6-7 minutes.
-
TABLE 11 Ingredients Weight (g) Real % Fruit Filling Granulated sugar 35.45 17.72 Strawberry puree, seedless 20.86 10.43 Water 18.25 9.12 Strawberry juice concentrate 17.73 8.86 Starch (Rezista) 6.26 3.13 lemon juice 1.04 0.52 Salt 0.42 0.21 Dough Pastry flour 43.86 21.93 Fructose 11.10 5.55 Unsalted butter 10.63 5.31 Molasses 5.13 2.56 Non fat milk 11.73 5.86 Egg white powder 4.35 2.17 Canola oil 3.54 1.77 Sugar 3.54 1.77 Salt 0.59 0.29 Lecithin 0.59 0.29 Baking powder 0.52 0.26 Baking soda 0.47 0.23 Emulsifier 0.24 0.12 Xanthan gum 0.18 0.09 Strawberry flavor 0.12 0.06 Vanilla flavor 0.08 0.04 Omega-3 Powder 3.33 1.66 Total 200.01 100.00 - The product contained 50 mg of EPA+DHA per serving (40 g). The product had acceptable flavor at time of manufacture. Further the product flavor was acceptable after 4 months.
- Chicken nuggets containing microcapsules were prepared according to the formulation shown in Table 12. Four batches were prepared: a control, a batch containing 150 mg EPA+DHA per 100 g serving, a batch containing 175 mg EPA+DHA per 100 g serving, and a batch containing 300 mg EPA+DHA per 100 g serving. Microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth Canada) was added to soy protein, which was then added to ground chicken meat. The mixture was stirred, formed into nugget shapes, coated with a pre-dust, and then a batter and breading was applied. The product was par-fried for 30 seconds at approximately 196° C. to set the coating and the color. The product was then transferred to the oven where it was fully cooked at 177° C. for approximately 3 minutes. For the chicken nuggets containing the microcapsules the cider trim was reduced to compensate for the added microcapsules. The final weight of each batch was 400 kg. The final product was packaged in clear plastic bags and stored frozen until consumption. The preparation instructions for the product include reheating in the oven at 220° C. for 10-15 minutes, microwaved, or deep-fried.
-
TABLE 12 Ingredients Quantity (kg) Cider trim 253.94 Skin and fat 14.50 Soy protein FX 213 20.25 Water 107.78 Salt 3.57 Total 400.00 - The samples were evaluated monthly for sensory attributes, color, and pH during a 12-month shelf life. The samples were evaluated initially for difference from control and at the end of shelf life for acceptability. The samples were also tested at the beginning and end of shelf life for EPA+DHA and moisture content.
- The EPA+DHA and moisture contents of the nuggets remained constant throughout the shelf life. No significant difference was found between the nuggets containing 300 mg of EPA+DHA per serving and the control, at the beginning of the shelf life. At the end of the 12-month shelf life, panelists indicated that they “liked very much” the nuggets containing 300 mg EPA+DHA per serving. The sample nuggets had similar stability to the control nuggets. High levels of EPA+DHA can be added per serving without affecting the sensory and physical attributes of the nuggets or the overall stability.
- Soymilk containing microcapsules was prepared using an automatic soymilk maker. Two batches of soymilk were produced, one control and one containing 250 mg EPA+DHA per 250 mL serving. Specifically, 85 g of dry soybeans were soaked in tap water overnight. The soaked beans were drained and rinsed. 1.5 L of water was poured into the soymilk maker and the beans were placed in the filter cup. The soymilk maker was then started. The soymilk was collected and the spent beans discarded. The soymilk was cooled. Microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth Canada) was added and the soy milk was pasteurized at 85° C. for 5 sec. Pasteurization and addition of MEG-3™ powder to plain soymilk helped to reduce beany off-notes.
- Three more batches of soymilk were produced as just described: pasteurized soymilk, pasteurized soymilk with 1 cm3 salt and 30 cm3 sugar, pasteurized soy milk with microencapsulated omega-3 oil, 1 cm3 salt and 30 cm3 sugar (the salt and sugar were added to the soymilk after pasteurization). Pasteurized soy milk containing salt and sugar tasted similar to commercial soymilks. The pasteurized soy milk containing microcapsules, salt and sugar was slightly less sweet but tasted better than the pasteurized soymilk containing no salt and sugar.
- Soymilk was an acceptable beverage for the addition of microcapsules. No off-flavors or odors attributable to the powder were observed, even at 250 mg EPA+DHA per serving. Some of the typical soy beany flavor was masked by the microcapsules.
- Frozen waffles containing microcapsules were prepared according to the formulation shown in Table 13. Specifically, the dry ingredients were blended together. Water, melted butter, and vanilla were then added to the dry mix. After mixing the ingredients together, the batter was placed onto oil brushed waffle maker and baked for 70 seconds. The waffles were removed from the waffle maker and placed into plastic pouches, separated by wax paper, and frozen.
-
TABLE 13 Ingredients Weight (g) Real % Water 187.40 34.1965 All Purpose Flour 163.90 29.9082 Blueberry, low moisture 60.00 10.9487 Sugar 50.00 9.1239 Eggs, Fresh Liquid 47.00 8.5765 Butter, Unsalted 25.00 4.5620 Omega 34.36 0.7956 Vanilla Extract 3.35 0.6113 Blueberry Flavor, Natural 2.00 0.3650 Salt 2.00 0.3650 Baking Soda 2.00 0.3650 Sodium Aluminum 1.00 0.1825 Phosphate Total 1000.00 100.0000 - The waffles had about 130 mg of EPA+DHA per 85 g serving. Flavor in both levels were acceptable in first round tastings. Plain and blueberry waffles were also prepared. An apple cinnamon flavor was included in early development, but cinnamon seems to enhance off flavors. Cinnamon should not be used as a flavor for this type of product.
- Granola cereal containing microcapsules were prepared according to the formulation shown in Table 14. Microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth, Canada) was blended with honey. The mixture was stirred well and the mixture was allowed to hydrate. Vanilla was then added to the mixture and mixed well. Brown sugar, flour, cinnamon, and nonfat dry milk were slowly stirred for 1 minute. Oats, sunflower seeds, almonds, and sesame seeds were then added. Raisins were added at the end of baking to cooled granola. Oil was heated to 43° C. and drizzled into a bowl while continuing to stir for 1 minute. The microcapsules, vanilla, and honey mixture were heated to 60° C. and drizzled into the mixture. After mixing for 2 minutes, the mixture was spread onto uncoated baking sheets. The mixture was baked 121° C. in a convection oven on low fan for 30 minutes. The mixture was then tossed after 15 minutes. After cooling, the granola was stored in an airtight container until ready to use.
-
TABLE 14 Ingredients Weight (g) Real % Rolled Oats 240.97 48.19 Honey, Clover (60° C.) 75.00 15.00 Canola Oil (43° C.) 40.00 8.00 Brown Sugar, granulated 30.00 6.00 Sunflower seeds 25.00 5.00 Whole Wheat flour 21.25 4.25 Almonds, raw, sliced 20.00 4.00 Non fat dry milk 15.00 3.00 Sesame Seeds 12.50 2.50 Raisins, midgets 10.00 2.00 Vanilla Extract, 2X 3.75 0.75 Cinnamon, ground 3.75 0.75 Omega 32.78 0.56 Total 500.00 100.00 - The granola cereal contained about 50 mg EPA+DHA per serving (55 g). While fishy flavors were noticeable when the cereal was fresh, this dissipated over 10-12 days. The cinnamon may have accentuated the fishy flavors. Samples tasted in milk did not have any off flavors.
- Gummy Candies containing microcapsules were prepared according to the formulation shown in Table 15. Specifically, sugar, corn syrup, microencapsulated omega-3 oil (MEG-3™ powder from Ocean Nutrition Canada; Dartmouth Canada) and water were mixed together in a cooking vessel. The mixture was brought to a boil at 118° C. The mixture was removed from heat and cooled to 96° C. Gum mucilage was vigorously stirred into the syrup to create a homogenous blend. Gum mucilage was prepared by adding gelatin to water and holding in a water bath at 60° C. for one hour or until the solution was clear. The solution was kept warm (above 54° C.) until ready for use in gummy candies. Flavor, color and acid solution was added and the mixture was blended well. The mixture was then placed in starch molds and allowed to set for 48 hours at room temperature. The resulting gummy were removed from the molds and lightly oiled with a 1:3 blend of mineral/coconut oil. The product was allowed to age for 2 days before packaging in a nitrogen purged, metallized film.
-
TABLE 15 Ingredient Quantity (g) Weight % Corn syrup 390.00 40.50 Sugar 300.00 31.15 Water 80.00 8.31 *Gum mucilage Gelatin, 225 Bloom 55.00 5.71 Water 100.00 10.38 Apple flavor 5.00 0.52 Malic acid, 50% solution 25.00 2.60 Green food color 0.43 0.04 Omega-3 Powder 7.50 0.78 Total 962.93 99.99 *prepare separately - Gummy candies containing about 50, 100, and 130 mg EPA+DHA per serving (40 g) were tried. Lower levels gave favorable results. Also, different methods of addition of the microcapsules were tried, such as soaking with gelatin in mucilage, boiling with syrup, and boiling in water for 5 minutes prior to addition of syrup. Addition of the microcapsules to the mucilage produced a grainy texture and soft gel. Boiling of the microcapsules in water prior to addition of syrup actually provided the best results.
- Pasta sauce containing microcapsules were prepared according to the formulation shown in Table 16. Specifically, the wet ingredients were mixed together and the dry ingredients were mixed together. The dry band wet mixtures were then combined. The mixture was heated to 88° C. and held at that temperature for 1 minute. The mixture was then poured into glass jars.
-
TABLE 16 Ingredients Weight (g) Weight % Tomatoes, ⅜″ diced 196.28 28.28 Water 230.00 33.13 Tomato puree 160.00 23.05 Sugar 39.00 5.62 Extra virgin olive oil 17.00 2.45 Onions, diced 14.00 2.02 Beef base 8.00 1.15 Modified food starch 6.85 0.99 Basil, IQF 4.30 0.62 Salt 6.50 0.94 Onion powder 3.00 0.43 Garlic puree 4.00 0.58 Citric acid, anhydrous 1.00 0.14 Black pepper 0.40 0.06 Omega-3 3.72 0.54 Total 694.05 100.00 - Samples containing about 100 mg, 120 mg, and 130 mg EPA+DHA per serving (125 g) were prepared. No fishy flavors were detected at any levels initially or after 3 months of storage.
- A Strawberry Yogurt Smoothie (serving size of 8 fl oz; about 226 g) incorporating microencapsulated omega-3 fatty acids (1812TG Omega-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 17. The product had a 130 mg dosage of EPA+DHA per serving.
-
TABLE 17 Ingredients Weight (g) Weight % Plain Yogurt 438.24 43.82 Strawberry Puree, Seedless 110.62 11.06 Water 299.78 29.98 Liquid Fructose 143.81 14.38 Strawberry Flavor 0.93 0.093 Red Color 0.02 0.002 Dipotassium Phosphate 1.33 0.133 Omega-3 3.83 0.383 Pectin 1.44 0.144 Total 1000.00 100.00 - Specifically, strawberry puree, water, liquid fructose, strawberry flavor, and red color were mixed together in a pot. Dipotassium phosphate, pectin, and the microcapsules were then added to the wet ingredients. The mixture was heated to 88° C. and then cooled to room temperature. Yogurt was added next and the mixture was again heated to 88° C. The mixture was then homogenized at a total pressure of 2,500 psi (first stage at 2,000 psi and second stage at 500 psi). The formulation was then placed into bottles and stored refrigerated until use.
- A second smoothie was prepared according to the formulation in Table 6. Specifically, 1% milk, starch, gelatin, and whey protein were mixed together. The microcapsules were then sprinkled over the surface and allowed to hydrate for 5 minutes. The mixture was then heated to 55° C. and homogenized at a total pressure of 2,300 psi (first stage at 1,800 psi and second stage at 500 psi). The homogenized formulation was then pasteurized at 86° C. for 30 minutes and cooled to 38° C. Yogurt culture mixed with 2% milk was added to the homogenized/pasteurized formulation and incubated at 38° C. for approximately 10 hours, or until the mixture reached a pH of 4.5. The resulting mixture was then mixed with a fruit preparation and heated to 88° C. Then, the mixture was again homogenized at a total pressure of 2,500 psi (first stage at 2,000 psi and second stage at 500 psi). The mixture was chilled and stored refrigerated until ready to use.
-
TABLE 18 Ingredients Weight (g) Weight % Milk, 1% milk fat 428.87 42.89 Starch 5.71 0.57 Whey Protein Isolate 1.99 0.20 Milk, 2% milk fat 1.64 0.16 Gelatin 1.19 0.12 Yo-Fast 17, yogurt culture 0.13 0.01 Strawberry fruit prep 556.64 55.66 Omega-3 3.83 0.383 Total 1000.00 100.00 - Both processes produced smoothies with acceptable flavor, odor, and texture.
- A batch of orange juice (18 servings; each serving size being 250 g) incorporating microencapsulated omega-3 fatty acids (1812TG Omega-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 19. Specifically, the microcapsules were sprinkled on the surface of orange juice in a blend tank equipped with an agitator providing a minimum of 30 rpm. The juice was blended for 5 minute. Afterwards, the juice was pasteurized at 91° C. for 17 seconds with a flow rate of 212 L/minute. The pasteurized juice was filled into gable top containers and stored refrigerated.
-
TABLE 19 Ingredients Weight (g) Weight % Orange Juice 4500.00 99.74 Omega-3 Powder 11.88 0.26 Total 4511.88 100.00 - The orange juice contained 100 mg of EPA+DHA (120 mg of total omega-3 fatty acids) per serving. In taste tests there was no perceptible difference in taste, texture, or quality between the omega-3 orange juice and the control.
- A chocolate frozen dairy dessert (serving size of ½ cup; about 118 mL) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 20. The product had a 100 mg dosage of EPA+DHA per serving.
-
TABLE 20 Ingredients Weight (g) Percent Chocolate Ice Cream Non Fat Milk 750.00 59.88% Sugar 200.00 15.97% Heavy Cream 150.00 11.98% MPC 80 70.000 5.59% Corn Syrup, Regular 42 DE 40.000 3.19% Cocoa Powder 24.000 1.92% Omega-3 Powder 7.00 0.56% Chocolate Flavor 3.410 0.27% Stabilizer 3.00 0.24% Tricalcium Phosphate 2.000 0.16% Probiotic Blend, 150 B/gm (from 3.000 0.24% DSM; L10/L26 (50/50 Ratio)) Total 1252.41 100.00% - Specifically, all dry ingredients were blended except the calcium phosphate and probiotic blend. The mixture of dry ingredients was then combined with milk, cream, and corn syrup. The mixture was stirred until smooth. Next, the mixture was heated to 72° C. for 30 seconds. After cooling to about 4° C., the mixture was aged for 24 hours under refrigeration. Chocolate flavor and the remaining ingredients were then added and the resulting mixture was placed in an ice cream freezer to the desired overrun (target 70%). The ice cream was ejected from the freezer and packed into individual containers, which were hard frozen overnight.
- The ice cream had a start weight per 4 fl. oz of 150, end weight per 4 fl. oz of 90, and overrun of 67.00%. The ice cream had 100 mg of EPA+DHA per 118 mL serving. Further, each serving of the ice cream contained 200,000,000 colony forming units (CFU) of probiotic per serving.
- The nutritional facts of the ice cream are as follows: 150 calories (45 from fat); 5 g of total fats (3 g from saturated fat; 0 g from trans fat); 20 mg of cholesterol; 40 mg of sodium; 19 g of total carbohydrates (less than 1 g of dietary fiber; 18 g from sugar); and 7 g of protein. The ice cream also contained 6% vitamin A, 15% vitamin C, 15% calcium, and 4% iron, which are percent daily values based on a 2000 calorie diet.
- A strawberry frozen dairy dessert (serving size of ½ cup; about 118 mL) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 21. The product had a 100 mg dosage of EPA+DHA per serving.
-
TABLE 21 Ingredient Weight (g) Percent Non Fat Milk 750.00 54.21% Sugar 200.00 14.46% Strawberry, Sliced, Sweetened 155.000 11.20% Heavy Cream 150.00 10.84% MPC 80 70.000 5.06% Strawberry Syrup 42.000 3.04% Omega-3 Powder 8.00 0.58% Stabilizer 3.00 0.22% Tricalcium Phosphate 2.000 0.14% Probiotic Blend, 150 B/gm (from 3.500 0.25% DSM; L10/L26 (50/50 Ratio) Total 1383.50 100.00% - Specifically, all dry ingredients were blended except the calcium phosphate and probiotic blend. The mixture of dry ingredients was then combined with milk and cream. The mixture was stirred until smooth. Next, the mixture was heated to 72° C. for 30 seconds. After cooling to about 4° C., the mixture was aged for 24 hours under refrigeration. Strawberry syrup and the remaining ingredients were then added and the resulting mixture was placed in an ice cream freezer to the desired overrun (target 70%). The ice cream was ejected from the freezer and packed into individual containers, which were hard frozen overnight.
- The ice cream had a start weight per 4 fl. oz of 150, end weight per 4 fl. oz of 95, and overrun of 65.00%. The ice cream had 100 mg of EPA+DHA per 118 mL serving. Further, each serving of the ice cream contained 200,000,000 colony forming units (CFU) of probiotic per serving.
- The nutritional facts of the ice cream are as follows: 150 calories (40 from fat); 4.5 g of total fats (2.5 g from saturated fat; 0 g from trans fat); 20 mg of cholesterol; 35 mg of sodium; 21 g of total carbohydrates (0 g of dietary fiber; 18 g from sugar); and 6 g of protein. The ice cream also contained 6% vitamin A, 20% vitamin C, 15% calcium, and 0% iron, which are percent daily values based on a 2000 calorie diet.
- Microwave popcorn (serving size of 30 g) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 22. The product had a 32 mg dosage of EPA+DHA per serving.
-
TABLE 22 Ingredient Weight (g) Percent Popcorn 70.11 70.11% Hydrogenated Soybean Oil 25.50 25.50% Salt 3.00 3.00 % Omega 3 Powder 0.75 0.75% Butter Flavor 0.60 0.60% Annatto 0.04 0.04% Total 100.00 100.00% - Specifically, fat was melted at about 49° C. While stirring and maintaining heat, annatto color was then added to the melted fat. In a separate container, all dry ingredients were blended together. The dry ingredients were then added to the melted fat. Popcorn was then placed into a microwave popcorn bag. The fat-dry ingredient slurry, which contained the microencapsulated omega-3 oil, was deposited into the bag (30 g per bag). The bag was sealed and folded into thirds. The fat was allowed to harden.
- Country style baked beans (serving size of ½ cup, about 130 g) incorporating microencapsulated omega-3 fatty acids (1812TG powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Tables 23 and 24. The product had a 32 mg dosage of EPA+DHA (0.2133 g powder) per serving.
- Basically, beans were rinsed well and soaked at ambient temperature overnight in water (3× volume of beans). Next, a large pot of water was brought to a boil. The beans were drained and then added to the boiling water. The beans were boiled for 5 minutes. The boiling water was drained and the beans were rinsed with cold water. The beans were then drained in a colander for 15 minutes before transferring to the cans.
- The country style sauce was prepared according to the formulation in Table 23.
-
TABLE 23 Ingredient Weight (g) Percent Water 721.00 75.700% Sugar 162.00 17.009% Modified Food Starch 20.00 2.100% Salt 15.00 1.575% Molasses 16.00 1.680% Pork Base 8.00 0.840% Onion Powder 4.00 0.420 % Omega 3 Powder 2.90 0.304% Caramel Color 1.50 0.157% Yellow Mustard Flour 1.00 0.105% Garlic Powder 1.00 0.105% Cloves, ground 0.04 0.004% Yield: 100% 952.44 99.999% - The dry ingredients were weighed and then pre-blended in a saucepan. Water was added to the dry ingredients in the saucepan and the mixture was blended well. Molasses and pork base was added next and the mixture was blended. The sauce was brought to a simmer (>91° C.) for 5 minutes to thicken the starch. The saucepan was cooled in an ice water bath and brought to a 100% yield. The sauce had a pH of 5.6 and brix of 22.5.
- The beans were then prepared according to the formulation in Table 24.
-
TABLE 24 Ingredient Weight (g) Percent County Style Sauce (described in Table 23) 121.80 53.70% Navy Beans, soaked, 6 min blanch 92.00 40.56% Salt Pork, ½″ × 1″ chunk 13.00 5.73% Total 226.80 99.99% - Specifically, the beans were weighed into a can. The sauce was also weighed into the can. The mixture was topped with a piece of salt pork and the can was sealed. Water was added to a retort and the cans were layered into the retort. The water was brought to a boil and the retort lid was sealed. The retort vented with steam escaping through a vent for 15 minutes and then a temperature gauge was placed on top. Once the temperature reached 121° C. (15 psi), the beans were retorted for 60 minutes. Heat was then removed and the gauge was vented until ambient pressure was reached. The lid was removed and the cans were transferred to an ice water bath. After samples were cold, they were dried and stored under refrigeration.
- Gummy bears (serving size of 2 g per gummy bear) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 25. The product had a 15 mg dosage of EPA+DHA per 2 g serving.
-
TABLE 25 Ingredient Weight (g) At Deposit Percent At Deposit Corn Syrup 30.000 24.300 31.14% 27.97% Sugar 26.000 26.000 26.98% 29.93% Water 10.000 6.217 10.38% 7.16% Gelatin - Gum Mucilage 4.500 4.500 4.67% 5.18% (250 Bloom) Sorbitol 1.000 1.000 1.04% 1.15% Water - Gum Mucilage 16.000 16.000 16.61% 18.42 % Omega 3 Fish Oil 4.650 4.650 4.83% 5.35% Blood Orange Flavor 0.800 0.800 0.83% 0.92% Blood Orange Oil Flavor 0.200 0.200 0.21% 0.23% Citric Acid, 50% 1.800 1.800 1.87% 2.07% Solution Lactic Acid, 88% 1.200 1.200 1.25% 1.38% Orange Color 0.150 0.150 0.16% 0.17% Red Color 0.050 0.050 0.05% 0.06% Total 96.35 86.87 100.00% 100.00% - Specifically, the omega-3 powder was dispersed in water and stirred until completely dissolved. Gelatin was added and melted in a water bath at 77° C. Next, sugar, corn syrup, and water were weighed together in a cooking vessel. The mixture was brought to a boil and the sides of the pot were washed of any crystals. Boiling was continued until 90% solids (118° C.). The pot was removed from the heat and cooled to 96° C. Gum mucilage was added to and blended with the cooked syrup. Flavor, color, and acid solution were added next and blended well. The resulting mixture was deposited into dry starch molds and allowed to set for 48 hours at room temperature. The gummies were removed from the molds and excess starch was brushed off. The gummies were brushed lightly with capol and allowed to age for 2 days before packaging. The cooked yield was 90.16%.
- A natural lemon chew (serving size of 5.6 g) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 26. The product had a 100 mg dosage of EPA+DHA per 5.6 g serving.
-
TABLE 26 Start End Finished Ingredients Wt (g) Wt (g) Starting % % Dried Whipping Egg Whites 33.00 33.00 1.54% 1.61% Water 55.50 55.50 2.59% 2.71% Invert Sugar 150.00 150.00 7.01% 7.33% Corn Syrup, 42 DE 75.00 75.00 3.51% 3.67% Sugar 690.00 690.00 32.25% 33.74% Corn Syrup, 42 DE 500.00 410.00 23.37% 20.05% Water 100.00 95.65 4.67% 4.68% Palm Oil, 102 mp 225.00 225.00 10.52% 11.00 % Omega 3 Oil 250.00 250.00 11.69% 12.22% Malic Acid, Fine Powder 24.00 24.00 1.12% 1.17% Citric Acid, Fine Powder 6.00 6.00 0.28% 0.29% Nat Lemon/Lime Flavor 18.00 18.00 0.84% 0.88% Lemon Oil 9.00 9.00 0.42% 0.44% Tumeric Powder 3.90 3.90 0.18% 0.19% Total 2139.40 2045.05 100.00% 100.00% - Specifically, in a mixer bowl with a whip attachment, egg protein was solubilized in the first measure of water. In a separate container, sugar and the first measure of corn syrup was brought to a boil. The boiled syrup was slowly added to the mixer bowl while mixing on low speed. After all syrup had been added, the speed was increased to maximum speed and the mixture was whipped until the volume was at maximum.
- In another container, palm oil was melted to clarity and combined with 80% of the omega-3 powder, until thickening began. The resulting paste was stirred until all dry ingredients were evenly coated with fat.
- Sugar, the second measure of corn syrup, and water were brought to a boil (126° C.). Syrup was slowly poured into the mixer bowl while mixing slowly. The omega-3 paste was added and mixed until even. Acid, the remaining dry omega-3 powder, and flavors were added next and mixed until even. The resulting mixture was poured and formed as a slab on a cool surface. The product was cut and wrapped. The product had a cooked yield of 95.59%.
- An orange chew (serving size of 5.6 g) incorporating microencapsulated omega-3 fatty acids (MEG-3 powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 27. The product had a 100 mg dosage of EPA+DHA per 5.6 g serving.
-
TABLE 27 Start End Finished Ingredient Wt (g) Wt (g) Starting % % Dried Whipping Egg Whites 33.00 33.00 1.53% 1.60% Water 55.50 55.50 2.57% 2.69% Invert Sugar 150.00 150.00 6.96% 7.27% Corn Syrup, 42 DE 75.00 75.00 3.48% 3.64% Sugar 690.00 690.00 32.00% 33.46% Corn Syrup, 42 DE 500.00 410.00 23.19% 19.88% Water 100.00 95.65 4.64% 4.64% Hydrogenated Palm Kernel 225.00 225.00 10.43% 10.91% Oil, 100 mp Omega 3 powder 250.00 250.00 11.59% 12.12% Malic Acid, Fine Powder 24.00 24.00 1.11% 1.16% Citric Acid, Fine Powder 6.00 6.00 0.28% 0.29% Orange Flavor 27.00 27.00 1.25% 1.31% Oil of Orange Water Soluble 9.00 9.00 0.42% 0.44% Orange Color, Liquid 12.00 12.00 0.56% 0.58% Total 2156.50 2062.15 100.00% 100.00% - Specifically, in a mixer bowl with a whip attachment, egg protein was solubilized in the first measure of water. In a separate container, sugar and the first measure of corn syrup was brought to a boil. The boiled syrup was slowly added to the mixer bowl while mixing on low speed. After all syrup had been added, the speed was increased to maximum speed and the mixture was whipped until the volume was at maximum.
- In another container, palm oil was melted to clarity and combined with 80% of the omega-3 powder, until thickening began. The resulting paste was stirred until all dry ingredients were evenly coated with fat.
- Sugar, the second measure of corn syrup, and water were brought to a boil (126° C.). Syrup was slowly poured into the mixer bowl while mixing slowly. The omega-3 paste was added and mixed until even. Acid, the remaining dry omega-3 powder, and flavors were added next and mixed until even. The resulting mixture was poured and formed as a slab on a cool surface. The product was cut and wrapped. The product had a cooked yield of 95.62%.
- Pasta (serving size of 150 g) incorporating microencapsulated omega-3 fatty acids (1812 TG powder from Ocean Nutrition Canada, Ltd., Dartmouth, Canada) was prepared according to the formulation in Table 28. The product had a 32 mg dosage of EPA+DHA per 140 g serving.
-
TABLE 28 Ingredient Weight (g) Percent Durham Wheat Flour 453.60 69.70% Whole Eggs 120.00 18.44% Water 75.00 11.52 % Omega 3 2.20 0.34% Total 650.80 100.00% - Flour and omega-3 powder were mixed together in one container. Eggs and water were combined in a separate container. The wet ingredients were slowly poured into the dry ingredients as they were mixed in a mixer equipped with a dough hook. The resulting dough was kneaded for about 30 seconds. The dough was then covered with plastic wrap and allowed to stand for 45 minutes. The dough was then sheeted into fettuccini sized noodles and dried for from 20 minutes to 1 hour. To cook the noodles, water was brought to a rolling boil and the noodles were added. After 3.5 minutes, the water was drained and the cooked noodles were rinsed under cold water.
- Other advantages which are obvious and which are inherent to the invention will be evident to one skilled in the art. It will be understood that certain features and sub-combinations are of utility and may be employed without reference to other features and sub-combinations. This is contemplated by and is within the scope of the claims. Since many possible embodiments may be made of the invention without departing from the scope thereof, it is to be understood that all matter herein set forth or shown in the accompanying drawings is to be interpreted as illustrative and not in a limiting sense.
Claims (48)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/988,320 US20090274791A1 (en) | 2005-07-07 | 2006-06-23 | Food Articles With Delivery Devices and Methods for the Preparation Thereof |
US14/198,079 US20140186503A1 (en) | 2005-07-07 | 2014-03-05 | Food articles with delivery devices and methods for the preparation thereof |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69709205P | 2005-07-07 | 2005-07-07 | |
US11/435,605 US9968120B2 (en) | 2006-05-17 | 2006-05-17 | Homogenized formulations containing microcapsules and methods of making and using thereof |
US81150306P | 2006-06-07 | 2006-06-07 | |
US81183006P | 2006-06-08 | 2006-06-08 | |
US11/988,320 US20090274791A1 (en) | 2005-07-07 | 2006-06-23 | Food Articles With Delivery Devices and Methods for the Preparation Thereof |
PCT/US2006/024735 WO2007008384A2 (en) | 2005-07-07 | 2006-06-23 | Food articles with delivery devices and methods for the preparation thereof |
Related Parent Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/435,605 Continuation US9968120B2 (en) | 2005-07-07 | 2006-05-17 | Homogenized formulations containing microcapsules and methods of making and using thereof |
PCT/US2006/024735 A-371-Of-International WO2007008384A2 (en) | 2005-07-07 | 2006-06-23 | Food articles with delivery devices and methods for the preparation thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/198,079 Continuation US20140186503A1 (en) | 2005-07-07 | 2014-03-05 | Food articles with delivery devices and methods for the preparation thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
US20090274791A1 true US20090274791A1 (en) | 2009-11-05 |
Family
ID=38712274
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/435,605 Active 2033-02-19 US9968120B2 (en) | 2005-07-07 | 2006-05-17 | Homogenized formulations containing microcapsules and methods of making and using thereof |
US11/988,320 Abandoned US20090274791A1 (en) | 2005-07-07 | 2006-06-23 | Food Articles With Delivery Devices and Methods for the Preparation Thereof |
US14/198,079 Abandoned US20140186503A1 (en) | 2005-07-07 | 2014-03-05 | Food articles with delivery devices and methods for the preparation thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/435,605 Active 2033-02-19 US9968120B2 (en) | 2005-07-07 | 2006-05-17 | Homogenized formulations containing microcapsules and methods of making and using thereof |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/198,079 Abandoned US20140186503A1 (en) | 2005-07-07 | 2014-03-05 | Food articles with delivery devices and methods for the preparation thereof |
Country Status (1)
Country | Link |
---|---|
US (3) | US9968120B2 (en) |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100055281A1 (en) * | 2006-04-07 | 2010-03-04 | Ocean Nutrition Canada Limited | Emulsions and Microcapsules With Substances Having Low Interfacial Tension, Methods of Making and Using Thereof |
US20100173002A1 (en) * | 2006-06-05 | 2010-07-08 | Jin Yulai | Microcapsules with improved shells |
US20100209524A1 (en) * | 2002-04-11 | 2010-08-19 | Ocean Nutrition Canada Ltd. | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
WO2011044193A1 (en) * | 2009-10-07 | 2011-04-14 | Diamond Foods, Inc. | Delivery of flavors in microwave popcorn bags |
US20110111020A1 (en) * | 2002-11-04 | 2011-05-12 | Ocean Nutrition Canada Limited | Microcapsules Having Multiple Shells and Method for the Preparation Thereof |
US20110217275A1 (en) * | 2010-03-04 | 2011-09-08 | Joar Opheim | Compositions comprising probiotic bacteria of the strain bacillus coagulans and omega-3 polyunsaturated fatty acids or derivatives thereof |
US20110293813A1 (en) * | 2008-07-18 | 2011-12-01 | Cargill, Incorporated | Frozen pellets made with juice |
US20120109842A1 (en) * | 2010-10-29 | 2012-05-03 | International Business Machines Corporation | Conversion traceability for product supply network |
WO2012129528A2 (en) * | 2011-03-23 | 2012-09-27 | Feregrino Quezada Juan Carlos | Low-calorie milk product |
US8283338B2 (en) | 2007-11-30 | 2012-10-09 | Kao Corporation | GIP secretion inhibitor |
US8338389B2 (en) | 2009-06-17 | 2012-12-25 | Kao Corporation | Agent for preventing or ameliorating obesity |
US20130259933A1 (en) * | 2012-03-30 | 2013-10-03 | Morishita Jintan Co., Ltd. | Capsule which disintegrates specifically in the large intestine |
US20140023775A1 (en) * | 2012-07-18 | 2014-01-23 | Paulette Suzanne Fox | Bite-sized ices composed of natural ingredients and method for processing and apparatus for packaging the same |
US20140148532A1 (en) * | 2012-11-29 | 2014-05-29 | Omura Consulting Gmbh | Adhesive composition |
US8865244B2 (en) | 2003-04-11 | 2014-10-21 | Cargill, Incorporated | Pellet systems for preparing beverages |
US20150030718A1 (en) * | 2012-03-12 | 2015-01-29 | Aker Biomarine Antarctic As | Oxidixable fatty acid composition delivery form |
CN105083792A (en) * | 2015-07-08 | 2015-11-25 | 巢湖学院 | Preparation method for instant noodle flavoring packaging bag |
US9968120B2 (en) | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
US10166196B2 (en) | 2007-01-10 | 2019-01-01 | Dsm Nutritional Products Ag | Vegetarian microcapsules |
US10292413B2 (en) * | 2013-10-18 | 2019-05-21 | Innovachildfood Ab | Nutritionally balanced composite meal for infants and small children and a method of producing said meal |
US11350657B2 (en) | 2018-08-06 | 2022-06-07 | Pharmavite, Llc | Protein gummy composition |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080098900A1 (en) * | 2006-11-01 | 2008-05-01 | Babatunde Aremu | Beverage manufacture using a static mixer |
US9445975B2 (en) | 2008-10-03 | 2016-09-20 | Access Business Group International, Llc | Composition and method for preparing stable unilamellar liposomal suspension |
EP2292102A1 (en) * | 2009-09-02 | 2011-03-09 | Lipofoods, S.L. | Microcapsules containing salts for food products |
EP3072510B1 (en) | 2012-03-30 | 2019-05-08 | Micelle BioPharma, Inc. | Omega-3 fatty acid ester compositions |
US10898458B2 (en) | 2012-03-30 | 2021-01-26 | Micelle Biopharma, Inc. | Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states |
US9480651B2 (en) | 2012-03-30 | 2016-11-01 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms |
US20160228397A1 (en) | 2012-03-30 | 2016-08-11 | Sancilio & Company, Inc. | Omega-3 fatty acid ester compositions |
US8617610B2 (en) * | 2012-05-21 | 2013-12-31 | Dsm Nutritional Products Ag | Compositions and methods for increasing the stability of food product additives |
CA2874379C (en) | 2012-05-21 | 2019-09-10 | Dsm Nutritional Products Ag | Compositions and methods for increasing the stability of food product additives |
ES2641451T3 (en) | 2012-07-31 | 2017-11-10 | Dsm Nutritional Products Ag | Oil refining using green tea extract antioxidants |
FR2996466B1 (en) * | 2012-10-09 | 2015-06-05 | Seppic Sa | METHOD OF ENCAPSULATION BY COACERVATION NOT IMPLEMENTING TOXIC RETICULANT |
US9404065B2 (en) | 2013-01-02 | 2016-08-02 | International Business Machines Corporation | Renewable self-healing capsule system |
US20170208825A1 (en) * | 2016-01-21 | 2017-07-27 | Alan Backus | Gaseous transfer device |
WO2020037020A1 (en) * | 2018-08-14 | 2020-02-20 | Thermaco, Inc. | Gelling f.o.g. for landfill disposal |
Citations (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US317960A (en) * | 1885-05-19 | Sylyia a | ||
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US3041289A (en) * | 1959-01-02 | 1962-06-26 | Ncr Co | Method of making walled clusters of capsules |
US3190837A (en) * | 1958-12-31 | 1965-06-22 | Ncr Co | Making individual capsules by dual deposition |
US3526682A (en) * | 1966-08-23 | 1970-09-01 | Pfizer & Co C | Microencapsulation of pharmaceuticals |
US3697437A (en) * | 1970-05-27 | 1972-10-10 | Ncr Co | Encapsulation process by complex coacervation using inorganic polyphosphates and organic hydrophilic polymeric material |
US4010038A (en) * | 1974-04-10 | 1977-03-01 | Kanzaki Paper Manufacturing Co., Ltd. | Process for producing microcapsules |
US4217370A (en) * | 1977-08-25 | 1980-08-12 | Blue Wing Corporation | Lipid-containing feed supplements and foodstuffs |
US4219439A (en) * | 1977-01-28 | 1980-08-26 | Kanzaki Paper Manufacturing Co., Ltd. | Method of making oil-containing microcapsules |
US4222891A (en) * | 1977-08-17 | 1980-09-16 | Kanzaki Paper Mfg. Co., Ltd. | Method of making oil-containing microcapsules |
US4232084A (en) * | 1978-01-25 | 1980-11-04 | Thalatta, Inc. | Sheets containing microencapsulated color-coded micromagnets |
US4273672A (en) * | 1971-08-23 | 1981-06-16 | Champion International Corporation | Microencapsulation process |
US4485172A (en) * | 1981-01-19 | 1984-11-27 | Cpc International Inc. | Multistage process for the preparation of fats and oils |
US4670247A (en) * | 1983-07-05 | 1987-06-02 | Hoffman-Laroche Inc. | Process for preparing fat-soluble vitamin active beadlets |
US4695466A (en) * | 1983-01-17 | 1987-09-22 | Morishita Jintan Co., Ltd. | Multiple soft capsules and production thereof |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US4749620A (en) * | 1984-02-15 | 1988-06-07 | Massachusetts Institute Of Technology | Encapsulated active material system |
US4808408A (en) * | 1983-05-11 | 1989-02-28 | Bend Research, Inc. | Microcapsules prepared by coacervation |
US4851339A (en) * | 1986-04-01 | 1989-07-25 | Hills Christopher B | Extraction of anti-mutagenic pigments from algae and vegetables |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US4867986A (en) * | 1987-07-17 | 1989-09-19 | Pharmachem Laboratories, Inc. | Dry stabilized microemulsified omega-three acid-containing oils |
US4891172A (en) * | 1979-10-15 | 1990-01-02 | Mitsubishi Paper Mills, Ltd. | Process for producing double-capsules |
US4895725A (en) * | 1987-08-24 | 1990-01-23 | Clinical Technologies Associates, Inc. | Microencapsulation of fish oil |
US4923855A (en) * | 1983-07-08 | 1990-05-08 | The William Seroy Group | Synthetic GTF chromium material and process therefor |
US4946624A (en) * | 1989-02-27 | 1990-08-07 | The Procter & Gamble Company | Microcapsules containing hydrophobic liquid core |
US4954492A (en) * | 1983-07-08 | 1990-09-04 | The William Seroy Group | Synthetic GTF chromium material for decreasing blood lipid levels and process therefor |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
US5035896A (en) * | 1988-06-15 | 1991-07-30 | Warner-Lambert Company | Water insoluble drugs coated by coacervated fish gelatin |
US5051304A (en) * | 1986-12-18 | 1991-09-24 | Societe Anonyme: Mero Rousselot Satia | Microcapsules based on gelatin and polysaccharides and process for obtaining same |
US5059622A (en) * | 1989-08-29 | 1991-10-22 | Biosyn, Inc. | Method for reducing blood pressure levels in hypertensive persons |
US5130061A (en) * | 1987-05-28 | 1992-07-14 | Innova Di Ridolfi Flora & C. S.A.S. | Process for the extraction of polyunsaturated fatty acid esters from fish oils |
US5156956A (en) * | 1987-03-04 | 1992-10-20 | Ajinomoto Co., Inc. | Transgultaminase |
US5194615A (en) * | 1983-07-08 | 1993-03-16 | The William Seroy Group | Synthetic GTF chromium nicotinate material and its preparation |
US5204029A (en) * | 1989-09-25 | 1993-04-20 | Morgan Food Products, Inc. | Methods of encapsulating liquids in fatty matrices, and products thereof |
US5324626A (en) * | 1991-07-09 | 1994-06-28 | Fuji Photo Film Co., Ltd. | Silver halide color photographic material |
US5330778A (en) * | 1988-09-19 | 1994-07-19 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles |
US5356636A (en) * | 1991-12-14 | 1994-10-18 | Basf Aktiengesellschaft | Stable vitamin and/or carotenoid products in powder form, and the preparation thereof |
US5378413A (en) * | 1993-01-21 | 1995-01-03 | The United States Of America As Represented By The Secretary Of The Navy | Process for preparing microcapsules having gelatin walls crosslinked with quinone |
US5428014A (en) * | 1993-08-13 | 1995-06-27 | Zymogenetics, Inc. | Transglutaminase cross-linkable polypeptides and methods relating thereto |
US5456985A (en) * | 1990-06-13 | 1995-10-10 | Zgoulli; Slim | Microcapsules of oily liquid |
US5482433A (en) * | 1993-11-19 | 1996-01-09 | United Technologies Corporation | Integral inner and outer shrouds and vanes |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5603961A (en) * | 1992-10-01 | 1997-02-18 | Tanabe Seiyaku Co., Ltd. | Sustained release multi-core microsphere preparation and method for producing the same |
US5603952A (en) * | 1994-12-30 | 1997-02-18 | Tastemaker | Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom |
US5670209A (en) * | 1995-04-24 | 1997-09-23 | Brite-Line Technologies, Inc. | High brightness durable retro-reflecting microspheres and method of making the same |
US5700397A (en) * | 1992-06-16 | 1997-12-23 | Fuji Oil Co., Ltd. | Emulsifier, emulsion composition, and powder composition |
US5759599A (en) * | 1992-03-30 | 1998-06-02 | Givaudan Roure Flavors Corporation | Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils |
US5766637A (en) * | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
US5780056A (en) * | 1996-05-10 | 1998-07-14 | Lion Corporation | Microcapsules of the multi-core structure containing natural carotenoid |
US5788991A (en) * | 1993-04-01 | 1998-08-04 | Novartis Corporation | Coated microparticle agglomerates |
US5827531A (en) * | 1994-12-02 | 1998-10-27 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microcapsules and methods for making |
US5855826A (en) * | 1996-09-17 | 1999-01-05 | Pacific Corporation | Matrix-double encapsulation method and a cosmetic composition containing matrix-double capsules |
US5872140A (en) * | 1993-07-23 | 1999-02-16 | Research Institute For Medicine And Chemistry, Inc. | Vitamin D analogues |
US5993851A (en) * | 1993-07-28 | 1999-11-30 | Pharmaderm Laboratories, Ltd. | Method for preparing biphasic multilamellar lipid vesicles |
US5997863A (en) * | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
US6019988A (en) * | 1996-11-18 | 2000-02-01 | Bristol-Myers Squibb Company | Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage |
US6020200A (en) * | 1995-03-03 | 2000-02-01 | Metabolex, Inc. | Encapsulation compositions and methods |
US6039901A (en) * | 1997-01-31 | 2000-03-21 | Givaudan Roure Flavors Corporation | Enzymatically protein encapsulating oil particles by complex coacervation |
US6063378A (en) * | 1997-08-22 | 2000-05-16 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
US6106875A (en) * | 1997-10-08 | 2000-08-22 | Givaudan Roure (International) Sa | Method of encapsulating flavors and fragrances by controlled water transport into microcapsules |
US6221401B1 (en) * | 1996-12-02 | 2001-04-24 | The Regents Of The University Of California | Bilayer structure which encapsulates multiple containment units and uses thereof |
US6235951B1 (en) * | 1996-01-17 | 2001-05-22 | Central Glass Company, Limited | Method for producing 1,1,1,3,3-pentafluoropropane |
US6234464B1 (en) * | 1998-07-08 | 2001-05-22 | K.D. Pharma Bexbech Gmbh | Microencapsulated unsaturated fatty acid or fatty acid compound or mixture of fatty acids and/fatty acid compounds |
US6274174B1 (en) * | 1997-10-31 | 2001-08-14 | Nisshinbo Industries, Inc. | Aggregates of spherical multivalent metal alginate microparticles and methods of making them |
US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
US6328176B1 (en) * | 1996-11-11 | 2001-12-11 | Keko-Varicon | Multifunctional protective component |
US6417233B1 (en) * | 1998-10-21 | 2002-07-09 | Sigma-Tau Healthscience S.P.A. | Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiguinones and methods of using same |
US6441050B1 (en) * | 2000-08-29 | 2002-08-27 | Raj K. Chopra | Palatable oral coenzyme Q liquid |
US6500463B1 (en) * | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US20030004438A1 (en) * | 2000-01-10 | 2003-01-02 | Eric Berthonnaud | Device for evaluating a position of balance for the human body |
US6528165B2 (en) * | 1999-08-17 | 2003-03-04 | Luminex Corporation | Encapsulation of discrete quanta of fluorescent particles |
US6534091B1 (en) * | 1999-07-02 | 2003-03-18 | Cognis Iberia S. L. | Microcapsules |
US6534094B2 (en) * | 2000-05-03 | 2003-03-18 | Eriochem S.A. | Manufacturing process of microcapsules for sustained release of water soluble peptides |
US6544926B1 (en) * | 2001-10-11 | 2003-04-08 | Appleton Papers Inc. | Microcapsules having improved printing and efficiency |
US20030091654A1 (en) * | 2000-09-21 | 2003-05-15 | Katz David P. | Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
US6630157B1 (en) * | 1997-07-22 | 2003-10-07 | Viatris Gmbh & Co. Kg. | Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
US20030193102A1 (en) * | 2002-04-11 | 2003-10-16 | Nianxi Yan | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US6652891B2 (en) * | 2001-12-12 | 2003-11-25 | Herbasway Laboratories, Llc | Co-enzyme Q10 dietary supplement |
US20040106591A1 (en) * | 2002-11-22 | 2004-06-03 | Pacioretty Linda M. | Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
US6794592B1 (en) * | 2003-09-16 | 2004-09-21 | Solteam Electronics Co., Ltd. | Dustproof and waterproof switch |
US6861458B2 (en) * | 2001-11-15 | 2005-03-01 | Xerox Corporation | Photoprotective and lightfastness-enhancing siloxanes |
US6867471B2 (en) * | 2002-08-29 | 2005-03-15 | Infineon Technologies Ag | Universal package for an electronic component with a semiconductor chip and method for producing the universal package |
US20050067726A1 (en) * | 2002-11-04 | 2005-03-31 | Nianxi Yan | Microcapsules having multiple shells and method for the preparation thereof |
US20050118285A1 (en) * | 2003-10-23 | 2005-06-02 | L'oreal | O/W emulsion containing aloe vera, uses thereof, method for making |
US6969530B1 (en) * | 2005-01-21 | 2005-11-29 | Ocean Nutrition Canada Ltd. | Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
US6972592B2 (en) * | 2003-11-24 | 2005-12-06 | Lsi Logic Corporation | Self-timed scan circuit for ASIC fault testing |
US20070027028A1 (en) * | 2003-08-14 | 2007-02-01 | Pears David A | Microencapsulated catalyst-ligand system, methods of preparation and methods of use thereof |
US20070059340A1 (en) * | 2005-09-09 | 2007-03-15 | Anthony Bello | Omega-3 Fatty Acids Encapsulated In Zein Coatings and Food Products Incorporating the Same |
US20070078071A1 (en) * | 2005-09-30 | 2007-04-05 | Kaiping Lee | Spray dry capsule products and methods for preparing and using same |
US20070141211A1 (en) * | 2005-12-16 | 2007-06-21 | Solae, Llc | Encapsulated Phospholipid-Stabilized Oxidizable Material |
US20070224216A1 (en) * | 2004-05-04 | 2007-09-27 | Jane Teas | Methods and Compositions Related to Antiviral Therapy Using Algae and Cyanobacteria |
US20100055281A1 (en) * | 2006-04-07 | 2010-03-04 | Ocean Nutrition Canada Limited | Emulsions and Microcapsules With Substances Having Low Interfacial Tension, Methods of Making and Using Thereof |
US7727692B2 (en) * | 2006-07-06 | 2010-06-01 | Fuji Xerox Co., Ltd. | Electrophotographic photoreceptor, image forming apparatus, and process cartridge |
Family Cites Families (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1035319B (en) | 1952-05-07 | 1958-07-31 | Hoffmann La Roche | Process for the production of a powder containing vitamins |
US2897119A (en) * | 1957-11-12 | 1959-07-28 | Camp Sea Food Company Inc Van | Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins |
NL262194A (en) | 1960-03-10 | 1900-01-01 | ||
US3317434A (en) | 1963-07-10 | 1967-05-02 | Armour & Co | Method of encapsulating particulate matter by coacervation using gelatins of opposite isoionic ph |
SE344686B (en) | 1968-01-29 | 1972-05-02 | Ncr | |
NZ199218A (en) | 1981-01-19 | 1985-03-20 | Cpc International Inc | Production of fats and oils by cultivating yeast cells |
JPS5828234A (en) | 1981-08-08 | 1983-02-19 | Snow Brand Milk Prod Co Ltd | Preparation of protein raw ingredient |
GB2115768A (en) | 1982-02-11 | 1983-09-14 | Kms Fusion Inc | Containment of hazardous fluids |
JPS58149645A (en) | 1982-03-01 | 1983-09-06 | Ajinomoto Co Inc | Preparation of gelatinized material |
US4568559A (en) * | 1984-02-06 | 1986-02-04 | Biotek, Inc. | Composite core coated microparticles and process of preparing same |
US4623588A (en) * | 1984-02-06 | 1986-11-18 | Biotek, Inc. | Controlled release composite core coated microparticles |
EP0301777A1 (en) | 1987-07-28 | 1989-02-01 | Queen's University At Kingston | Multiple membrane microencapsulation |
WO1992011083A1 (en) | 1987-09-28 | 1992-07-09 | Redding Bruce K Jr | Apparatus and method for making microcapsules |
US5175156A (en) | 1987-11-30 | 1992-12-29 | Nutrition 21 | Chromic picolinate treatment |
US5087623A (en) | 1988-05-31 | 1992-02-11 | Nitrition 21 | Chromic picolinate treatment |
JPH01148338A (en) | 1987-12-04 | 1989-06-09 | Nkk Corp | Production of microcapsule |
EP0434760B1 (en) | 1988-09-19 | 1994-01-12 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles and preparation thereof |
US5087624A (en) | 1989-03-21 | 1992-02-11 | Nutrition 21 | Chromic picolinate treatment |
JP2811470B2 (en) * | 1989-06-23 | 1998-10-15 | 株式会社サクラクレパス | Microcapsule surface modification method |
NO903844L (en) | 1989-09-05 | 1991-03-06 | Neophore Tech Inc | MEDICINAL DELIVERY MIXTURES BASED ON BIOLOGICAL CELLS OR COMPONENTS THEREOF AND PROCEDURES. |
FI905333A0 (en) | 1989-10-31 | 1990-10-29 | Warner Lambert Co | FOERKAPSLAT BRUKSSYSTEM FOER SOETNINGS- OCH AROMMEDEL OCH FOERFARANDE FOER DESS FRAMSTAELLNING. |
JP2571874B2 (en) | 1989-11-06 | 1997-01-16 | アルカーメス コントロールド セラピューティクス,インコーポレイテッド | Protein microsphere composition |
US5413804A (en) * | 1991-04-23 | 1995-05-09 | Cacique, Inc. | Process for making whey-derived fat substitute product and products thereof |
JPH05292899A (en) | 1991-06-24 | 1993-11-09 | Ajinomoto Co Inc | Production of microcapsule |
BR9306169A (en) * | 1992-03-30 | 1998-01-13 | Tastemaker | Process for preparing fracturable free flowing solid flavor oil capsules and food flavoring process |
DE69332222T3 (en) | 1992-06-11 | 2007-05-10 | Alkermes Controlled Therapeutics, Inc., Cambridge | ENYTHROPETINE CONTAINING THE DRUG DELIVERY SYSTEM |
JPH0731871A (en) | 1993-05-18 | 1995-02-03 | Canon Inc | Membrane structure |
US5591255A (en) * | 1993-12-29 | 1997-01-07 | Chromatic Technologies, Inc. | Thermochromic ink formulations, nail lacquer and methods of use |
DE69533188T2 (en) | 1994-10-11 | 2005-02-17 | Ajinomoto Co., Inc. | STABILIZED TRANSGLUTAMINASE AND ENZYMATIC PREPARATION CONTAINING THEREOF |
WO1996039871A1 (en) | 1995-06-07 | 1996-12-19 | Abbott Laboratories | Mineral powders with enhanced chromium solubility and preparation methods therefor |
WO1997013416A1 (en) | 1995-10-12 | 1997-04-17 | Mccormick & Company, Inc. | Double encapsulation process and flavorant compositions prepared thereby |
JP3545148B2 (en) | 1996-01-08 | 2004-07-21 | 味の素株式会社 | Edible microcapsules and foods containing the same |
US5834232A (en) | 1996-05-01 | 1998-11-10 | Zymogenetics, Inc. | Cross-linked gelatin gels and methods of making them |
JP3635801B2 (en) | 1996-08-01 | 2005-04-06 | 味の素株式会社 | Milk whey protein-containing powder and processed food using the same |
US6140107A (en) | 1996-09-25 | 2000-10-31 | Viva America Marketing, Inc. | Organometallic-metabolizing yeast |
US5846581A (en) | 1997-01-31 | 1998-12-08 | Catron; Douglas Howard | Chromium (III) salts of short chain fatty acids composition for use in animal feeds |
IT1291113B1 (en) | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | NUTRITIONAL THERAPEUTIC COMPOSITION FOR SUBJECTS WITH DIABETES MELLITUS |
ES2229443T3 (en) | 1997-08-22 | 2005-04-16 | Unilever N.V. | PROCEDURE FOR THE PRODUCTION OF ESTANOL ESTERES. |
US6143301A (en) | 1998-08-28 | 2000-11-07 | Ambi Inc. | Chromium picolinate compositions and uses thereof |
DE19838189A1 (en) | 1998-08-24 | 2000-03-02 | Basf Ag | Stable powdered vitamin and carotenoid preparations and process for their preparation |
US6197816B1 (en) | 1998-09-30 | 2001-03-06 | University Of Alabama | Use of triaqua-mu3-oxohexakis-mu-propionatotrichromium (1+), [CR3O(O2CCH2CH3)6(H2O) 3]+, as a nutritional supplement or in treatment of medical conditions |
US6103378A (en) | 1998-11-23 | 2000-08-15 | The Mead Company | Capsules having discrete solvent/color former and diluent capsule encapsulated phases |
ZA200003120B (en) | 1999-06-30 | 2001-01-02 | Givaudan Roure Int | Encapsulation of active ingredients. |
US6328995B1 (en) | 1999-09-24 | 2001-12-11 | Basf Aktiengesellschaft | Stable vitamin and/or carotenoid products in powder form and process for their production |
US6793937B2 (en) * | 1999-10-22 | 2004-09-21 | 3M Innovative Properties Company | Method of delivering active material within hydrogel microbeads |
US6375968B1 (en) * | 1999-10-22 | 2002-04-23 | 3M Innovative Properties Company | Encapsulated active material immobilized in hydrogel microbeads |
US6365189B1 (en) * | 1999-10-22 | 2002-04-02 | 3M Innovative Properties Company | Method of delivering and releasing a pheromone |
US6746529B1 (en) | 1999-11-18 | 2004-06-08 | Quest International, B.V. | Stable, spray-dried composition in a carbohydrate substrate and process for obtaining said composition |
DE10001172A1 (en) | 2000-01-13 | 2001-07-26 | Max Planck Gesellschaft | Templating solid particles with polymer multilayers |
US6534926B1 (en) | 2000-04-12 | 2003-03-18 | Tmc Enterprises, A Division Of Tasco Industries, Inc. | Portable fluorescent drop-light |
SE523211C2 (en) | 2000-04-26 | 2004-04-06 | Skaanemejerier Ekonomisk Foere | Lipid composition comprising a protective oil and a polyunsaturated fatty acid, emulsion containing such a composition and process for preparing the emulsion |
US6365176B1 (en) | 2000-08-08 | 2002-04-02 | Functional Foods, Inc. | Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy |
US6562361B2 (en) * | 2001-05-02 | 2003-05-13 | 3M Innovative Properties Company | Pheromone immobilized in stable hydrogel microbeads |
CA2449199A1 (en) | 2001-05-30 | 2002-12-05 | Laxdale Limited | Coenzyme q and eicosapentaenoic acid (epa) |
US20030044380A1 (en) | 2001-07-19 | 2003-03-06 | Zhu Yong Hua | Adhesive including medicament |
EP1371410A1 (en) | 2002-06-14 | 2003-12-17 | NIZO food research | Complex coacervates containing whey proteins |
US20060165735A1 (en) | 2002-06-18 | 2006-07-27 | Abril Jesus R | Stable emulsions of oils in aqueous solutions and methods for producing same |
US20040213886A1 (en) | 2003-04-23 | 2004-10-28 | Toves Frances Ann | Soy-based fruit and/or vegetable food product and processes for making same |
US20050227907A1 (en) * | 2004-04-13 | 2005-10-13 | Kaiping Lee | Stable fragrance microcapsule suspension and process for using same |
US8034450B2 (en) * | 2005-01-21 | 2011-10-11 | Ocean Nutrition Canada Limited | Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
CA2596023A1 (en) * | 2005-01-27 | 2006-11-09 | Ocean Nutrition Canada Ltd. | Fatty acid-benzenediol derivatives and methods of making and using thereof |
US20080206316A1 (en) * | 2005-01-27 | 2008-08-28 | Colin Barrow | Chromium-Fatty Acid Compounds and Methods of Making and Using Thereof |
US9968120B2 (en) * | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
KR20170042364A (en) | 2006-06-05 | 2017-04-18 | 디에스엠 뉴트리셔널 프라덕츠 아게 | Microcapsules with improved shells |
-
2006
- 2006-05-17 US US11/435,605 patent/US9968120B2/en active Active
- 2006-06-23 US US11/988,320 patent/US20090274791A1/en not_active Abandoned
-
2014
- 2014-03-05 US US14/198,079 patent/US20140186503A1/en not_active Abandoned
Patent Citations (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US317960A (en) * | 1885-05-19 | Sylyia a | ||
US2800457A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US2800458A (en) * | 1953-06-30 | 1957-07-23 | Ncr Co | Oil-containing microscopic capsules and method of making them |
US3190837A (en) * | 1958-12-31 | 1965-06-22 | Ncr Co | Making individual capsules by dual deposition |
US3041289A (en) * | 1959-01-02 | 1962-06-26 | Ncr Co | Method of making walled clusters of capsules |
US3526682A (en) * | 1966-08-23 | 1970-09-01 | Pfizer & Co C | Microencapsulation of pharmaceuticals |
US3697437A (en) * | 1970-05-27 | 1972-10-10 | Ncr Co | Encapsulation process by complex coacervation using inorganic polyphosphates and organic hydrophilic polymeric material |
US4273672A (en) * | 1971-08-23 | 1981-06-16 | Champion International Corporation | Microencapsulation process |
US4010038A (en) * | 1974-04-10 | 1977-03-01 | Kanzaki Paper Manufacturing Co., Ltd. | Process for producing microcapsules |
US4219439A (en) * | 1977-01-28 | 1980-08-26 | Kanzaki Paper Manufacturing Co., Ltd. | Method of making oil-containing microcapsules |
US4222891A (en) * | 1977-08-17 | 1980-09-16 | Kanzaki Paper Mfg. Co., Ltd. | Method of making oil-containing microcapsules |
US4217370A (en) * | 1977-08-25 | 1980-08-12 | Blue Wing Corporation | Lipid-containing feed supplements and foodstuffs |
US4232084A (en) * | 1978-01-25 | 1980-11-04 | Thalatta, Inc. | Sheets containing microencapsulated color-coded micromagnets |
US4891172A (en) * | 1979-10-15 | 1990-01-02 | Mitsubishi Paper Mills, Ltd. | Process for producing double-capsules |
US4485172A (en) * | 1981-01-19 | 1984-11-27 | Cpc International Inc. | Multistage process for the preparation of fats and oils |
US4695466A (en) * | 1983-01-17 | 1987-09-22 | Morishita Jintan Co., Ltd. | Multiple soft capsules and production thereof |
US4808408A (en) * | 1983-05-11 | 1989-02-28 | Bend Research, Inc. | Microcapsules prepared by coacervation |
US4670247A (en) * | 1983-07-05 | 1987-06-02 | Hoffman-Laroche Inc. | Process for preparing fat-soluble vitamin active beadlets |
US4954492A (en) * | 1983-07-08 | 1990-09-04 | The William Seroy Group | Synthetic GTF chromium material for decreasing blood lipid levels and process therefor |
US5194615A (en) * | 1983-07-08 | 1993-03-16 | The William Seroy Group | Synthetic GTF chromium nicotinate material and its preparation |
US4923855A (en) * | 1983-07-08 | 1990-05-08 | The William Seroy Group | Synthetic GTF chromium material and process therefor |
US4749620A (en) * | 1984-02-15 | 1988-06-07 | Massachusetts Institute Of Technology | Encapsulated active material system |
US4744933A (en) * | 1984-02-15 | 1988-05-17 | Massachusetts Institute Of Technology | Process for encapsulation and encapsulated active material system |
US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4851339A (en) * | 1986-04-01 | 1989-07-25 | Hills Christopher B | Extraction of anti-mutagenic pigments from algae and vegetables |
US5051304A (en) * | 1986-12-18 | 1991-09-24 | Societe Anonyme: Mero Rousselot Satia | Microcapsules based on gelatin and polysaccharides and process for obtaining same |
US5156956A (en) * | 1987-03-04 | 1992-10-20 | Ajinomoto Co., Inc. | Transgultaminase |
US4861627A (en) * | 1987-05-01 | 1989-08-29 | Massachusetts Institute Of Technology | Preparation of multiwall polymeric microcapsules |
US5130061A (en) * | 1987-05-28 | 1992-07-14 | Innova Di Ridolfi Flora & C. S.A.S. | Process for the extraction of polyunsaturated fatty acid esters from fish oils |
US4867986A (en) * | 1987-07-17 | 1989-09-19 | Pharmachem Laboratories, Inc. | Dry stabilized microemulsified omega-three acid-containing oils |
US4895725A (en) * | 1987-08-24 | 1990-01-23 | Clinical Technologies Associates, Inc. | Microencapsulation of fish oil |
US5035896A (en) * | 1988-06-15 | 1991-07-30 | Warner-Lambert Company | Water insoluble drugs coated by coacervated fish gelatin |
US5330778A (en) * | 1988-09-19 | 1994-07-19 | Opta Food Ingredients, Inc. | Hydrophobic protein microparticles |
US4946624A (en) * | 1989-02-27 | 1990-08-07 | The Procter & Gamble Company | Microcapsules containing hydrophobic liquid core |
US5059622A (en) * | 1989-08-29 | 1991-10-22 | Biosyn, Inc. | Method for reducing blood pressure levels in hypertensive persons |
US5204029A (en) * | 1989-09-25 | 1993-04-20 | Morgan Food Products, Inc. | Methods of encapsulating liquids in fatty matrices, and products thereof |
US5013569A (en) * | 1990-05-21 | 1991-05-07 | Century Laboratories, Inc. | Infant formula |
US5456985A (en) * | 1990-06-13 | 1995-10-10 | Zgoulli; Slim | Microcapsules of oily liquid |
US5324626A (en) * | 1991-07-09 | 1994-06-28 | Fuji Photo Film Co., Ltd. | Silver halide color photographic material |
US5356636A (en) * | 1991-12-14 | 1994-10-18 | Basf Aktiengesellschaft | Stable vitamin and/or carotenoid products in powder form, and the preparation thereof |
US5759599A (en) * | 1992-03-30 | 1998-06-02 | Givaudan Roure Flavors Corporation | Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils |
US5573934A (en) * | 1992-04-20 | 1996-11-12 | Board Of Regents, The University Of Texas System | Gels for encapsulation of biological materials |
US5700397A (en) * | 1992-06-16 | 1997-12-23 | Fuji Oil Co., Ltd. | Emulsifier, emulsion composition, and powder composition |
US5603961A (en) * | 1992-10-01 | 1997-02-18 | Tanabe Seiyaku Co., Ltd. | Sustained release multi-core microsphere preparation and method for producing the same |
US5378413A (en) * | 1993-01-21 | 1995-01-03 | The United States Of America As Represented By The Secretary Of The Navy | Process for preparing microcapsules having gelatin walls crosslinked with quinone |
US5788991A (en) * | 1993-04-01 | 1998-08-04 | Novartis Corporation | Coated microparticle agglomerates |
US5872140A (en) * | 1993-07-23 | 1999-02-16 | Research Institute For Medicine And Chemistry, Inc. | Vitamin D analogues |
US5993851A (en) * | 1993-07-28 | 1999-11-30 | Pharmaderm Laboratories, Ltd. | Method for preparing biphasic multilamellar lipid vesicles |
US5428014A (en) * | 1993-08-13 | 1995-06-27 | Zymogenetics, Inc. | Transglutaminase cross-linkable polypeptides and methods relating thereto |
US5482433A (en) * | 1993-11-19 | 1996-01-09 | United Technologies Corporation | Integral inner and outer shrouds and vanes |
US5997863A (en) * | 1994-07-08 | 1999-12-07 | Ibex Technologies R And D, Inc. | Attenuation of wound healing processes |
US5827531A (en) * | 1994-12-02 | 1998-10-27 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Microcapsules and methods for making |
US5603952A (en) * | 1994-12-30 | 1997-02-18 | Tastemaker | Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom |
US6020200A (en) * | 1995-03-03 | 2000-02-01 | Metabolex, Inc. | Encapsulation compositions and methods |
US5670209A (en) * | 1995-04-24 | 1997-09-23 | Brite-Line Technologies, Inc. | High brightness durable retro-reflecting microspheres and method of making the same |
US6235951B1 (en) * | 1996-01-17 | 2001-05-22 | Central Glass Company, Limited | Method for producing 1,1,1,3,3-pentafluoropropane |
US5780056A (en) * | 1996-05-10 | 1998-07-14 | Lion Corporation | Microcapsules of the multi-core structure containing natural carotenoid |
US5855826A (en) * | 1996-09-17 | 1999-01-05 | Pacific Corporation | Matrix-double encapsulation method and a cosmetic composition containing matrix-double capsules |
US5766637A (en) * | 1996-10-08 | 1998-06-16 | University Of Delaware | Microencapsulation process using supercritical fluids |
US6328176B1 (en) * | 1996-11-11 | 2001-12-11 | Keko-Varicon | Multifunctional protective component |
US6019988A (en) * | 1996-11-18 | 2000-02-01 | Bristol-Myers Squibb Company | Methods and compositions for enhancing skin permeation of drugs using permeation enhancers, when drugs and/or permeation enhancers are unstable in combination during long-term storage |
US6221401B1 (en) * | 1996-12-02 | 2001-04-24 | The Regents Of The University Of California | Bilayer structure which encapsulates multiple containment units and uses thereof |
US6039901A (en) * | 1997-01-31 | 2000-03-21 | Givaudan Roure Flavors Corporation | Enzymatically protein encapsulating oil particles by complex coacervation |
US6325951B1 (en) * | 1997-01-31 | 2001-12-04 | Givaudan Roure Flavors Corporation | Enzymatically protein-encapsulating oil particles by complex coacervation |
US6630157B1 (en) * | 1997-07-22 | 2003-10-07 | Viatris Gmbh & Co. Kg. | Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
US6063378A (en) * | 1997-08-22 | 2000-05-16 | Seikagaku Corporation | Therapeutic agent for herniated intervertebral disc |
US6106875A (en) * | 1997-10-08 | 2000-08-22 | Givaudan Roure (International) Sa | Method of encapsulating flavors and fragrances by controlled water transport into microcapsules |
US6274174B1 (en) * | 1997-10-31 | 2001-08-14 | Nisshinbo Industries, Inc. | Aggregates of spherical multivalent metal alginate microparticles and methods of making them |
US6234464B1 (en) * | 1998-07-08 | 2001-05-22 | K.D. Pharma Bexbech Gmbh | Microencapsulated unsaturated fatty acid or fatty acid compound or mixture of fatty acids and/fatty acid compounds |
US6417233B1 (en) * | 1998-10-21 | 2002-07-09 | Sigma-Tau Healthscience S.P.A. | Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiguinones and methods of using same |
US6534091B1 (en) * | 1999-07-02 | 2003-03-18 | Cognis Iberia S. L. | Microcapsules |
US6528165B2 (en) * | 1999-08-17 | 2003-03-04 | Luminex Corporation | Encapsulation of discrete quanta of fluorescent particles |
US6500463B1 (en) * | 1999-10-01 | 2002-12-31 | General Mills, Inc. | Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
US20030004438A1 (en) * | 2000-01-10 | 2003-01-02 | Eric Berthonnaud | Device for evaluating a position of balance for the human body |
US6534094B2 (en) * | 2000-05-03 | 2003-03-18 | Eriochem S.A. | Manufacturing process of microcapsules for sustained release of water soluble peptides |
US6441050B1 (en) * | 2000-08-29 | 2002-08-27 | Raj K. Chopra | Palatable oral coenzyme Q liquid |
US20030091654A1 (en) * | 2000-09-21 | 2003-05-15 | Katz David P. | Methods for the treatment of diabetes, the reduction of body fat, improvement of insulin sensitivity, reduction of hyperglycemia, and reduction of hypercholesterolemia with chromium complexes, conjugated fatty acids, and/or conjugated fatty alcohols |
US6300377B1 (en) * | 2001-02-22 | 2001-10-09 | Raj K. Chopra | Coenzyme Q products exhibiting high dissolution qualities |
US6544926B1 (en) * | 2001-10-11 | 2003-04-08 | Appleton Papers Inc. | Microcapsules having improved printing and efficiency |
US6861458B2 (en) * | 2001-11-15 | 2005-03-01 | Xerox Corporation | Photoprotective and lightfastness-enhancing siloxanes |
US6652891B2 (en) * | 2001-12-12 | 2003-11-25 | Herbasway Laboratories, Llc | Co-enzyme Q10 dietary supplement |
US20050019416A1 (en) * | 2002-04-11 | 2005-01-27 | Ocean Nutrition Canada Ltd. | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US20030193102A1 (en) * | 2002-04-11 | 2003-10-16 | Nianxi Yan | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US6974592B2 (en) * | 2002-04-11 | 2005-12-13 | Ocean Nutrition Canada Limited | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US6867471B2 (en) * | 2002-08-29 | 2005-03-15 | Infineon Technologies Ag | Universal package for an electronic component with a semiconductor chip and method for producing the universal package |
US20050067726A1 (en) * | 2002-11-04 | 2005-03-31 | Nianxi Yan | Microcapsules having multiple shells and method for the preparation thereof |
US20040106591A1 (en) * | 2002-11-22 | 2004-06-03 | Pacioretty Linda M. | Compositions and methods for the treatment of HIV-associated fat maldistribution and hyperlipidemia |
US20070027028A1 (en) * | 2003-08-14 | 2007-02-01 | Pears David A | Microencapsulated catalyst-ligand system, methods of preparation and methods of use thereof |
US6794592B1 (en) * | 2003-09-16 | 2004-09-21 | Solteam Electronics Co., Ltd. | Dustproof and waterproof switch |
US20050118285A1 (en) * | 2003-10-23 | 2005-06-02 | L'oreal | O/W emulsion containing aloe vera, uses thereof, method for making |
US6972592B2 (en) * | 2003-11-24 | 2005-12-06 | Lsi Logic Corporation | Self-timed scan circuit for ASIC fault testing |
US20070224216A1 (en) * | 2004-05-04 | 2007-09-27 | Jane Teas | Methods and Compositions Related to Antiviral Therapy Using Algae and Cyanobacteria |
US6969530B1 (en) * | 2005-01-21 | 2005-11-29 | Ocean Nutrition Canada Ltd. | Microcapsules and emulsions containing low bloom gelatin and methods of making and using thereof |
US20070059340A1 (en) * | 2005-09-09 | 2007-03-15 | Anthony Bello | Omega-3 Fatty Acids Encapsulated In Zein Coatings and Food Products Incorporating the Same |
US20070078071A1 (en) * | 2005-09-30 | 2007-04-05 | Kaiping Lee | Spray dry capsule products and methods for preparing and using same |
US20070141211A1 (en) * | 2005-12-16 | 2007-06-21 | Solae, Llc | Encapsulated Phospholipid-Stabilized Oxidizable Material |
US20100055281A1 (en) * | 2006-04-07 | 2010-03-04 | Ocean Nutrition Canada Limited | Emulsions and Microcapsules With Substances Having Low Interfacial Tension, Methods of Making and Using Thereof |
US7727692B2 (en) * | 2006-07-06 | 2010-06-01 | Fuji Xerox Co., Ltd. | Electrophotographic photoreceptor, image forming apparatus, and process cartridge |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100209524A1 (en) * | 2002-04-11 | 2010-08-19 | Ocean Nutrition Canada Ltd. | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US8968872B2 (en) | 2002-04-11 | 2015-03-03 | Dsm Nutritional Products Ag | Encapsulated agglomeration of microcapsules and method for the preparation thereof |
US20110111020A1 (en) * | 2002-11-04 | 2011-05-12 | Ocean Nutrition Canada Limited | Microcapsules Having Multiple Shells and Method for the Preparation Thereof |
US8900630B2 (en) | 2002-11-04 | 2014-12-02 | Dsm Nutritional Products | Microcapsules having multiple shells and method for the preparation thereof |
US9861115B2 (en) | 2003-04-11 | 2018-01-09 | Cargill, Incorporated | Pellet systems for preparing beverages |
US8865244B2 (en) | 2003-04-11 | 2014-10-21 | Cargill, Incorporated | Pellet systems for preparing beverages |
US20100055281A1 (en) * | 2006-04-07 | 2010-03-04 | Ocean Nutrition Canada Limited | Emulsions and Microcapsules With Substances Having Low Interfacial Tension, Methods of Making and Using Thereof |
US9968120B2 (en) | 2006-05-17 | 2018-05-15 | Dsm Nutritional Products Ag | Homogenized formulations containing microcapsules and methods of making and using thereof |
US20100173002A1 (en) * | 2006-06-05 | 2010-07-08 | Jin Yulai | Microcapsules with improved shells |
US9056058B2 (en) | 2006-06-05 | 2015-06-16 | Dsm Nutritional Products | Microcapsules with improved shells |
US10166196B2 (en) | 2007-01-10 | 2019-01-01 | Dsm Nutritional Products Ag | Vegetarian microcapsules |
US8283338B2 (en) | 2007-11-30 | 2012-10-09 | Kao Corporation | GIP secretion inhibitor |
US20110293813A1 (en) * | 2008-07-18 | 2011-12-01 | Cargill, Incorporated | Frozen pellets made with juice |
US8338389B2 (en) | 2009-06-17 | 2012-12-25 | Kao Corporation | Agent for preventing or ameliorating obesity |
WO2011044193A1 (en) * | 2009-10-07 | 2011-04-14 | Diamond Foods, Inc. | Delivery of flavors in microwave popcorn bags |
US20110217275A1 (en) * | 2010-03-04 | 2011-09-08 | Joar Opheim | Compositions comprising probiotic bacteria of the strain bacillus coagulans and omega-3 polyunsaturated fatty acids or derivatives thereof |
US20120109842A1 (en) * | 2010-10-29 | 2012-05-03 | International Business Machines Corporation | Conversion traceability for product supply network |
WO2012129528A3 (en) * | 2011-03-23 | 2014-05-01 | Feregrino Quezada Juan Carlos | Low-calorie milk product |
WO2012129528A2 (en) * | 2011-03-23 | 2012-09-27 | Feregrino Quezada Juan Carlos | Low-calorie milk product |
US20150030718A1 (en) * | 2012-03-12 | 2015-01-29 | Aker Biomarine Antarctic As | Oxidixable fatty acid composition delivery form |
AU2013234036B2 (en) * | 2012-03-12 | 2015-11-26 | Innolipid As | Oxidixable fatty acid composition delivery form |
US8747893B2 (en) * | 2012-03-30 | 2014-06-10 | Morishita Jintan Co., Ltd. | Capsule which disintegrates specifically in the large intestine |
US20130259933A1 (en) * | 2012-03-30 | 2013-10-03 | Morishita Jintan Co., Ltd. | Capsule which disintegrates specifically in the large intestine |
US20140023775A1 (en) * | 2012-07-18 | 2014-01-23 | Paulette Suzanne Fox | Bite-sized ices composed of natural ingredients and method for processing and apparatus for packaging the same |
US9795153B2 (en) * | 2012-07-18 | 2017-10-24 | Paulette Suzanne Fox | Bite-sized ices composed of natural ingredients and method for processing and apparatus for packaging the same |
US20140148532A1 (en) * | 2012-11-29 | 2014-05-29 | Omura Consulting Gmbh | Adhesive composition |
US9238761B2 (en) * | 2012-11-29 | 2016-01-19 | Omura Consulting Gmbh | Adhesive composition |
US10292413B2 (en) * | 2013-10-18 | 2019-05-21 | Innovachildfood Ab | Nutritionally balanced composite meal for infants and small children and a method of producing said meal |
CN105083792A (en) * | 2015-07-08 | 2015-11-25 | 巢湖学院 | Preparation method for instant noodle flavoring packaging bag |
US11350657B2 (en) | 2018-08-06 | 2022-06-07 | Pharmavite, Llc | Protein gummy composition |
Also Published As
Publication number | Publication date |
---|---|
US20140186503A1 (en) | 2014-07-03 |
US20070269566A1 (en) | 2007-11-22 |
US9968120B2 (en) | 2018-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20140186503A1 (en) | Food articles with delivery devices and methods for the preparation thereof | |
JP5560245B2 (en) | Food product having delivery device and method for preparing the same | |
CA2473660C (en) | Ubiquinol-enriched fat-containing foods | |
US20030099747A1 (en) | Thickened oil compositions of edible oil | |
EP2247201B1 (en) | Food products containing omega-3 fatty acids | |
CA2473663C (en) | Ubiquinone-enriched foods | |
US20090104251A1 (en) | Heat stable microcapsules and methods for making and using the same | |
US10918114B2 (en) | Prepared foods having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids | |
ZA200307862B (en) | Liquid egg product. | |
CN101287382A (en) | Food articles with delivery devices and methods for the preparation thereof | |
WO2009054841A2 (en) | Heat stable microcapsules and methods for making and using the same | |
US11589594B2 (en) | Products having high efficacy omega-6/omega-3 balanced polyunsaturated fatty acids |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: OCEAN NUTRITION CANADA LTD., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SPURVEY, SHARON ANN;ROBERT, SUZELLE REJEANNE;BOYDEN, MICHELLE M.;REEL/FRAME:023532/0967;SIGNING DATES FROM 20061002 TO 20061010 Owner name: OCEAN NUTRITION CANADA LTD., CANADA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MATTSON ANED COMPANY;REEL/FRAME:023536/0053 Effective date: 20050714 Owner name: MATTSON AND COMPANY, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MATHEW, DEEPA;REEL/FRAME:023536/0018 Effective date: 20081112 Owner name: MATTSON AND COMPANY, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MATTSON, PETER H.;GORSKI, RICHARD A.;FONG, BRENDA Y.;AND OTHERS;REEL/FRAME:023532/0978;SIGNING DATES FROM 20050713 TO 20060925 |
|
AS | Assignment |
Owner name: DSM NUTRITIONAL PRODUCTS AG, SWITZERLAND Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:OCEAN NUTRITION CANADA LIMITED;REEL/FRAME:031246/0134 Effective date: 20130705 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |